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Background: There is modest evidence that exercise referral schemes increase physical activity in
inactive individuals with chronic health conditions. There is a need to identify additional ways to
improve the effects of exercise referral schemes on long-term physical activity.
Objectives: To determine if adding the e-coachER intervention to exercise referral schemes is more
clinically effective and cost-effective in increasing physical activity after 1 year than usual exercise
referral schemes.
Design: A pragmatic, multicentre, two-arm randomised controlled trial, with a mixed-methods process
evaluation and health economic analysis. Participants were allocated in a 1 : 1 ratio to either exercise
referral schemes plus e-coachER (intervention) or exercise referral schemes alone (control).
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Setting: Patients were referred to exercise referral schemes in Plymouth, Birmingham and Glasgow.
Participants: There were 450 participants aged 16–74 years, with a body mass index of 30–40 kg/m2,
with hypertension, prediabetes, type 2 diabetes, lower limb osteoarthritis or a current/recent history of
treatment for depression, who were also inactive, contactable via e-mail and internet users.
Intervention: e-coachER was designed to augment exercise referral schemes. Participants received
a pedometer and fridge magnet with physical activity recording sheets, and a user guide to access
the web-based support in the form of seven ‘steps to health’. e-coachER aimed to build the use of
behavioural skills (e.g. self-monitoring) while strengthening favourable beliefs in the importance of
physical activity, competence, autonomy in physical activity choices and relatedness. All participants
were referred to a standard exercise referral scheme.
Primary outcome measure: Minutes of moderate and vigorous physical activity in ≥ 10-minute bouts
measured by an accelerometer over 1 week at 12 months, worn ≥ 16 hours per day for ≥ 4 days
including ≥ 1 weekend day.
Secondary outcomes: Other accelerometer-derived physical activity measures, self-reported physical
activity, exercise referral scheme attendance and EuroQol-5 Dimensions, five-level version, and
Hospital Anxiety and Depression Scale scores were collected at 4 and 12 months post randomisation.
Results: Participants had a mean body mass index of 32.6 (standard deviation) 4.4 kg/m2, were referred
primarily for weight loss and were mostly confident self-rated information technology users. Primary
outcome analysis involving those with usable data showed a weak indicative effect in favour of the
intervention group (n = 108) compared with the control group (n = 124); 11.8 weekly minutes of
moderate and vigorous physical activity (95% confidence interval –2.1 to 26.0 minutes; p = 0.10).
Sixty-four per cent of intervention participants logged on at least once; they gave generally positive
feedback on the web-based support. The intervention had no effect on other physical activity outcomes,
exercise referral scheme attendance (78% in the control group vs. 75% in the intervention group) or
EuroQol-5 Dimensions, five-level version, or Hospital Anxiety and Depression Scale scores, but did
enhance a number of process outcomes (i.e. confidence, importance and competence) compared with
the control group at 4 months, but not at 12 months. At 12 months, the intervention group incurred
an additional mean cost of £439 (95% confidence interval –£182 to £1060) compared with the control
group, but generated more quality-adjusted life-years (mean 0.026, 95% confidence interval 0.013 to
0.040), with an incremental cost-effectiveness ratio of an additional £16,885 per quality-adjusted life-year.
Limitations: A significant proportion (46%) of participants were not included in the primary analysis
because of study withdrawal and insufficient device wear-time, so the results must be interpreted
with caution. The regression model fit for the primary outcome was poor because of the considerable
proportion of participants [142/243 (58%)] who recorded no instances of ≥ 10-minute bouts of
moderate and vigorous physical activity at 12 months post randomisation.
Future work: The design and rigorous evaluation of cost-effective and scalable ways to increase
exercise referral scheme uptake and maintenance of moderate and vigorous physical activity are
needed among patients with chronic conditions.
Conclusions: Adding e-coachER to usual exercise referral schemes had only a weak indicative effect
on long-term rigorously defined, objectively assessed moderate and vigorous physical activity. The
provision of the e-coachER support package led to an additional cost and has a 63% probability of being
cost-effective based on the UK threshold of £30,000 per quality-adjusted life-year. The intervention did
improve some process outcomes as specified in our logic model.
Trial registration: Current Controlled Trials ISRCTN15644451.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health
Technology Assessment programme and will be published in full in Health Technology Assessment;
Vol. 24, No. 63. See the NIHR Journals Library website for further project information.
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Plain English summary
When health-care professionals refer patients with chronic conditions to an exercise referralscheme, the effects on long-term increases in physical activity are limited. We therefore
developed the e-coachER support package to add to usual exercise referral schemes and to prompt
the use of skills such as self-monitoring and goal-setting. This package was also intended to empower
patients to increase their levels of physical activity long term. The seven-step programme was delivered
online (via an interactive website). As part of the package, we mailed participants a guide for accessing
the online programme, a pedometer and a fridge magnet with a notepad to record physical activity.
We aimed to determine whether or not adding the e-coachER support to usual exercise referral schemes
resulted in lasting changes in moderate and vigorous physical activity and whether or not it offers good
value for money compared with exercise referral schemes alone.
A total of 450 inactive individuals were recruited across Plymouth, Birmingham and Glasgow and were
referred to an exercise referral scheme for the following participant-reported main reasons: weight
loss (50%), low mood (19%), osteoarthritis (12%), type 2 diabetes (10%) and high blood pressure (8%).
Half of the individuals were given access to the e-coachER support and the other half were not.
All individuals were mailed a wrist-worn movement sensor (accelerometer) to wear for 1 week and
a survey to assess other outcomes at the start of the study as well as at 4 and 12 months
post randomisation.
At the start of the study, the participants were inactive and most had multiple health conditions.
The participants had an average body mass index of 33 kg/m2 and an average age of 50 years.
Most (83%) were white.
Participants with access to e-coachER support were only slightly more active at 12 months than those
who did not have access, but we cannot be confident in the findings because we had data from fewer
participants than planned. The lack of a clear effect may have been as a result of around one-third
of participants not accessing the website, but otherwise there was reasonable engagement. The
provision of the e-coachER support package led to an additional cost of £439 per participant over a
12-month period.
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Scientific summary
Background
From meta-analyses of randomised trials, there is evidence that primary care exercise referral schemes
result in a modest increase in the proportion of participants achieving 90–150 minutes of self-reported
moderate and vigorous physical activity at least 6 months after randomisation, compared with usual care.
Rigorous research is needed to assess the clinical effectiveness and cost-effectiveness of new approaches to
increase exercise referral scheme uptake, adherence and change in long-term objectively assessed moderate
and vigorous physical activity among inactive patients with chronic conditions.
E-health interventions for promoting physical activity have become popular because they offer an
opportunity to target a wide range of people at a low cost, but to our knowledge no studies have
explored their use alongside exercise referral schemes that offer face-to-face support. We developed a
bespoke support system, using the LifeGuide© (LifeGuide version 1.0.7.30, University of Southampton,
Southampton, UK) platform, to empower exercise referral scheme patients with physical and mental
health conditions to become more physically active and remain motivated to do so. Building on self-
determination theory as a framework, we incorporated evidence-based components into a ‘seven steps
to health’ web-based programme called e-coachER, with support available for up to 12 months. At the
same time as an exercise referral, participants were mailed a free pedometer, a fridge magnet with
attached tear-off strips to record daily steps or minutes of moderate and vigorous physical activity, and
a user guide with instructions on how to access the web-based support. The e-coachER ‘seven steps to
health’ programme aimed to increase favourable beliefs in the importance of being physically active,
confidence in being regularly physically active, being autonomous in choosing what, where and when to
be active, and finding and using support to be physically active, whether that be face to face in the
exercise referral schemes, with friends and family or online. We defined getting to step 5 (setting a goal
and reviewing a goal online) as a sufficient ‘dose’ of the intervention to have an impact on minutes of
moderate and vigorous physical activity, although we recognised that mailing a pedometer could be
an effective intervention alone.
Objectives
The overall aim of the study was to determine whether or not adding the e-coachER intervention to
usual exercise referral schemes was more effective and cost-effective in increasing physical activity
after 1 year, compared with usual exercise referral schemes alone.
Research questions
The specific research questions were:
l Does the e-coachER intervention, when added to usual exercise referral schemes, compared with
usual exercise referral schemes alone, increase the total minutes of accelerometer-assessed
moderate and vigorous physical activity (in bouts of at least 10 minutes) per week at 12 months
post randomisation?
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l Does the e-coachER intervention, when added to usual exercise referral schemes, compared with
usual exercise referral schemes alone, improve:
¢ exercise referral scheme attendance?
¢ other accelerometer- and self-reported measures of moderate and vigorous physical activity?
¢ quality of life and mental health?
¢ process outcomes (e.g. confidence to do and importance of doing physical activity, a sense of
autonomy in deciding what physical activity to do and when, a sense of relatedness to others in
doing physical activity, and use of self-monitoring and goal-setting)?
l Is the e-coachER intervention, when added to usual exercise referral schemes, compared with usual
exercise referral schemes alone, cost-effective?
l Is the effect of the intervention moderated by participant and exercise referral scheme characteristics?
l What are the mechanisms through which the intervention has an impact on the outcomes?
Methods
The study involved an individually randomised, pragmatic, multicentre, two-arm randomised controlled
trial with follow-up at 4 and 12 months, with an embedded mixed-methods process evaluation and
health economic analysis. Patients were referred to a local exercise referral scheme in the UK cities
of Plymouth, Birmingham and Glasgow, and invited to join the study by primary care or exercise
practitioners. To maximise the generalisability of the findings, recruitment sites were chosen to
reflect a range of cultural and contextual factors, including the way in which exercise referral
schemes operated.
Participants were aged 16–74 years with a body mass index of 30–40 kg/m2 and had one or more of
the following conditions: hypertension, prediabetes, type 2 diabetes, lower limb osteoarthritis and a
current or recent history of treatment for depression. Participants were eligible if they were inactive or
moderately inactive (using the General Practice Physical Activity Questionnaire) and were an internet
user contactable via e-mail.
The primary outcome was minutes of moderate and vigorous physical activity in ≥ 10-minute bouts
measured by accelerometer over 1 week at 12 months, worn ≥ 16 hours per day for ≥ 4 days including
≥ 1 weekend day. Other accelerometer-derived physical activity measures (e.g. not in ≥ 10-minute
bouts), self-reported physical activity (7-day recall of physical activity), exercise referral scheme
attendance (at initial session with exercise referral scheme practitioner), non-validated process
measure survey items and EuroQol-5 Dimensions, five-level version, and Hospital Anxiety and
Depression Scale scores were collected at baseline, and then at 4 and 12 months.
Results
The sample (n = 450) had a mean body mass index of 32.6 kg/m2 (standard deviation 4.4 kg/m2), and
the primary participant-reported reasons for referral to the exercise referral schemes were weight
loss (50%), low mood (19%), osteoarthritis (12%), type 2 diabetes (10%) and high blood pressure (8%).
Participants identified additional reasons for referral, which were weight loss (81%), low mood (54%),
osteoarthritis (24%), type 2 diabetes (26%) and high blood pressure (33%), which indicated the high
degree of comorbidity in the sample. At baseline, only 4% of the sample achieved ≥ 150 minutes
of moderate and vigorous physical activity (accumulated in bouts of ≥ 10 minutes) for 1 week at
12 months post randomisation.
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Primary analysis
Loss to follow-up and incomplete data reduced the sample size to 232 participants for the primary
analysis (intervention, n = 108; control, n = 124). Intention-to-treat, complete-case-adjusted comparison
of groups at 12 months showed a weak indicative effect in favour of the intervention group (n = 232;
mean difference 11.8 minutes per week, 95% confidence interval –2.1 to 26.0 minutes; p = 0.10).
Because of the large proportion of participants who had zero values for the primary outcome, five
different statistical models were run in the primary analysis and only one showed a significant (p < 0.01)
effect in favour of the intervention. A secondary analysis showed that with only those with complete
data at baseline and 4 and 12 months, there was also no significant effect. In further sensitivity analyses
of the primary outcome, with less rigorous criteria applied to including participants with four different
wear-time completion thresholds (i.e. ≥ 4 days regardless of whether weekday or weekend day for
≥ 16 hours per day; ≥ 4 days regardless of weekend or weekday for ≥ 10 hours per day; ≥ 4 days
including 1 weekend day for ≥ 10 hours per day; ≥ 4 days including 1 weekend day for ≥ 10 hours
per day and weighted by number of days of valid wear), there remained no significant between-group
differences. A complier-average causal effect analysis, with consideration of whether or not participants
had completed an a priori definition of adequate intervention dose (i.e. step 5: completed at least one
goal review in e-coachER), also revealed no intervention effect.
The results of the primary analysis were not influenced by age, gender, trial site, participants’ reported
main chronic condition for referral or information technology literacy level.
In exploratory analysis of ≥ 10-minute bouts of accelerometer data, with only participants who
were included in the intention-to-treat, complete-case-adjusted analysis, the control group showed
a significant mean (standard deviation) increase of 8.2 (32.1) minutes of moderate and vigorous
physical activity from baseline to 4 months, but a non-significant decline from baseline to 12 months.
The intervention group did not change from baseline to either 4- or 12-month assessment.
Secondary analysis
Applying the same approach as in the primary analysis, there were no between-group differences at
12 months in any of the other accelerometer-derived or self-reported moderate and vigorous physical
activity outcomes, with one exception. In an intention-to-treat imputed comparison at 12 months
participants in the intervention group were more likely than the control group to self-report that
they had achieved 150 minutes of weekly moderate and vigorous physical activity (odds ratio 1.55,
95% confidence interval 0.99 to 2.42; p = 0.05). The intervention had no effect on exercise referral
scheme attendance: in the control group, 78% of the 223 participants for whom we had exercise
referral scheme attendance data attended the exercise referral scheme at least once, compared
with 167 (75%) of 223 in the intervention group. The intervention also had no effect on EuroQol-5
Dimensions, five-level version, or Hospital Anxiety and Depression Scale scores at 12 months
compared with the control group. In an intention-to-treat imputed comparison at 12 months, the
intervention group had lower Hospital Anxiety and Depression Scale depression and anxiety scores
than the control group.
Intervention engagement
Among the intervention participants, 64% logged onto the online support at least once, with generally
positive feedback on its value. The mean (standard deviation) number of goal reviews was 2.5 (4.5)
with a range of 0–24 reviews. The 144 participants who registered logged onto the online support
for a mean (standard deviation) and median number of times of 14.1 (16.7) and 6, respectively,
with a range of 1–101.
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Of the 81 (36%) participants who completed a goal review, the mean (standard deviation) and median
number of reviews was 14.4 (13.8) and 4.5, respectively, with a range of 1–52. Overall, participants
who registered online spent a mean (standard deviation) of 6.47 (7.45) minutes and a median of 4.08
minutes each time they logged into the e-coachER website. The engagement data from the LifeGuide
platform indicate that reasonable levels of engagement were achieved. The analysis of qualitative data
from 38 interviews with 26 participants suggests a generally positive assessment of the content and
functionality of e-coachER as a valuable resource, although some people identified limitations and
made recommendations for improvements.
Process outcomes
Our logic model predicted that e-coachER engagement would strengthen various beliefs that would, in
turn, translate into increases in moderate and vigorous physical activity, compared with usual exercise
referral scheme support. Among the participants included in only the primary analysis, the intervention
did increase the following up to 4 months, but not 12 months, compared with the control group:
perceived importance of doing at least 30 minutes of moderate-intensity physical activity (e.g. brisk
walk) on at least 5 days per week; confidence in achieving at least 30 minutes of moderate-intensity
physical activity on at least 5 days per week; and perceived competence in being regularly physically
active. Changes (from baseline to 4 months) in these process outcomes did not mediate changes in the
primary outcome at 12 months.
Health economics
The e-coachER intervention incurred an additional mean cost of £439 (95% confidence interval –£182
to £1060) (from additional service use and intervention delivery) and, compared with exercise referral
schemes alone, generated a small increase in quality-adjusted life-years (mean 0.026, 95% confidence
interval 0.013 to 0.040) over 12 months, with an incremental cost-effectiveness ratio of £16,885 per
quality-adjusted life-year.
Conclusion
We believe this to be the most rigorous study to date on the clinical effectiveness and cost-
effectiveness of adding web-based behavioural support to usual exercise referral schemes. Adding
the e-coachER intervention to usual exercise referral schemes led to only a weak indicative effect on
objectively assessed moderate and vigorous physical activity at 1 year post randomisation. Given this
result and the small numbers analysed, the findings must be interpreted with caution. The e-coachER
intervention had little or no benefit on other physical activity measures of moderate and vigorous
physical activity, health-related quality of life or mental health. We explored a number of ways of
analysing the data, and the findings were consistent. However, the cost of the e-coachER intervention
and the gains (albeit small) in quality-adjusted life-years indicate that e-coachER has a probability
of 63% to be a cost-effective intervention at the National Institute for Health and Care Excellence’s
willingness-to-pay threshold of £30,000 per quality-adjusted life-year. The intervention did improve
some process outcomes as specified in our logic model, but changes in perceived importance, confidence
and competence associated with being physically active from baseline to 4 months did not mediate
intervention effects on the primary outcome.
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Implications for health care
Our findings suggest that clinically meaningful increases in physical activity may not be derived from
the e-coachER intervention, but given its additional cost and associated small gains in quality-adjusted
life-years (main outcome for the economic evaluation), that such an intervention could still be a
cost-effective addition to usual exercise referral schemes (offered in different ways) for increasing
physical activity for up to 12 months. In other words, sending patients a pedometer and a fridge
magnet with tear-off physical activity self-monitoring strips, and providing access to a website that
requires virtually no human support could be a cost-effective way to improve quality of life in inactive
patients with certain chronic conditions. The process evaluation interviews identified a number of ways
in which e-coachER could be improved, such as giving patients more information about their specific
health conditions. Alternatively, improvements could be made by providing more structured guidance
in the user guide on the overall aim and content of web-based e-coachER support, including where to
find links to more information about exercise and medical conditions.
Recommendations for research
The modest engagement in the online e-coachER support suggests that work is needed to understand
what factors influenced intervention engagement and how best to further develop low-cost and
scalable support to increase exercise referral scheme uptake and maintenance of physical activity.
Once this has been done, further research could examine the effects of a modified e-coachER-type
intervention for participants with chronic conditions involved in the present study and others
(e.g. with cancer, back pain and in cardiac rehabilitation).
The e-coachER study has provided a rich data set that offers the chance to explore additional
questions including the following:
l What were the characteristics of participants that predicted changes in 4- and 12-month
physical activity?
l How did different measures of moderate and vigorous physical activity (self-report and
accelerometer derived) influence the findings, beyond what we present here?
l What other aspects of intervention engagement (derived from the LifeGuide platform) were used,
and did any influence changes in process and behavioural outcomes?
l Among subsets of the sample (e.g. those with low mood), what changes in quality of life, depression
and anxiety occurred as a result of the intervention versus usual exercise referral schemes?
Trial registration
This trial is registered as ISRCTN15644451.
Funding
This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 63.
See the NIHR Journals Library website for further project information.
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Chapter 1 Introduction
Scientific background
As described elsewhere,1 evidence-based guidelines recommend both aerobic training and strength
training for improving health markers and quality of life among those people with common chronic
metabolic conditions1–5 and musculoskeletal conditions.6 To prevent or reduce depression, mostly
aerobic exercise is recommended.7 Public health guidelines of 150 minutes of moderate activity per
week (accumulated in bouts of ≥ 10 minutes) or 75 minutes of vigorous activity per week are met
by only 66% of men and 58% of women aged ≥ 19 years in England,8 which is similar to results from
the Scottish Health Survey 20149 (68% men; 59% women), based on self-report data from a national
representative survey. The guidelines also highlight the importance of reducing sedentary behaviour
and regularly doing bouts of resistance exercise. Physical inactivity, based on data from 2013–14,
collected by Clinical Commissioning Groups in the UK, costs the NHS £455M.10
Even small increases in physical activity (PA) and reduced sedentary time, especially among the least active,10
are likely to provide health benefits.11,12 Patients with obesity, hypertension, type 2 diabetes, osteoarthritis
and depression do less PA than the general population2 and report greater barriers to increased PA.
Exercise referral schemes in the UK
A variety of approaches have been explored to promote PA within primary care, such as referring
patients to ‘exercise on prescription’ [i.e. an exercise referral scheme (ERS)]. As described previously,1
in the UK, ERSs have been popular, with an estimated 600 schemes involving up to 100,000 patients
per year in 2008.13 There is currently no single model for ERSs in the UK, but they mainly involve
referral to a programme (e.g. 10–12 weeks) of structured, supervised exercise at an exercise facility
(e.g. gym or leisure centre) or a counselling (and signposting) approach to support patients to engage in
a variety of types of PA.13 ERSs operate diversely to accommodate patient choice and local availability
of facilities, the common goal being to reduce the risk of long-term metabolic, musculoskeletal and
mental health conditions due to physical inactivity.
Evidence from a meta-analysis of eight randomised controlled trials (RCTs) involving 5190 participants
eligible for ERSs14 indicated only a small increase in the proportion of participants who achieved
90–150 minutes of PA of at least moderate intensity per week, compared with no exercise control, at
the 6- to 12-month follow-up among at-risk individuals. However, uncertainty remains regarding the
effects for patients with specific medical conditions, no study assessed long-term PA objectively and
many of the eight studies reviewed had relatively small sample sizes.
A review15 reported that the average ERS uptake (attendance at the first ERS session) ranged from
66% in observational studies to 81% in RCTs, and average levels of ‘adherence’ ranged from 49% in
observational studies to 43% in RCTs. Predictors of uptake and adherence have been explored; women
were more likely than men to begin an ERS, but less likely to adhere to it, and older people were more
likely to begin and adhere to an ERS.15 As an example of a large observational retrospective study,16 of
6894 participants who had attended an ERS over 6 years, 37.8% (n = 2608) dropped out within 6 weeks
and 50.03% (n = 3449) dropped out by the (final) 12th week, and males (p < 0.001) and older people
(p < 0.001) were more likely to adhere than females and younger people, respectively. ERSs may help
patients to become familiar with medical conditions17 and target key processes of behaviour change.
However, the following features of an ERS may reduce uptake and adherence: inconvenience, cost, limited
sustainable PA support (e.g. for 10 weeks) and low appeal for structured exercise and/or the medical
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model (i.e. ‘exercise on prescription’), which may in some schemes do little to provide autonomous support
or empower patients to develop self-determined behaviour to manage chronic medical conditions.13,18,19
It therefore appears that additional support may be needed that is accessible and is low cost, can be
tailored to support a wide range of individual needs and empowers patients to develop and use self-
regulatory skills (e.g. self-monitoring, goal-setting) to self-manage their chronic conditions. In one study,
training for ERS staff to foster self-determined behaviour increased PA more than when the ERS was
delivered by untrained staff at 3 and 6 months.20 Similarly, training of ERS staff in behaviour change
techniques and motivational interviewing led to small additional changes in self-reported PA after
12 months17 compared with no ERS. Challenges in training staff across a wide geographical area across
Wales and monitoring intervention fidelity were noted.
Intervention technologies to promote physical activity
To address the challenges with face-to-face promotion of PA noted above and to encompass the
growing use and availability of new technologies, a wide variety of online and mobile support has been
developed and used to promote PA.
As described previously,1 there is growing evidence on the effectiveness of technology-based interventions
for promotion of PA.21,22 Studies include a wide range of interventions (from quite simple self-monitoring
to interventions with multiple complex behaviour change components), targeted at different clinical
groups with different baseline levels of PA, with various PA outcomes reported (very few using objective
measures), and with mostly short-term follow-ups. In addition, some comparisons are between intervention
versus no intervention and others are versus human contact, although none reports on the effects of
adding web-based support to complement face-to-face support provided by ERSs. The impact of web-based
and technology interventions on increasing PA is small to moderate (effect size ≤ 0.4). However, there is
evidence from more rigorous studies that interventions with more behaviour change components and ones
targeting less active populations are more effective.21,22 A systematic review23 highlighted the importance of
maximising sustained engagement in web-based interventions for enhancing change in the target behaviour.
A recent study24 highlighted that self-monitoring of PA and tailored feedback were important to increase
engagement, and periodic communications helped to maintain participant engagement.
The LifeGuide© (version 1.0.7.30, University of Southampton, Southampton, UK; www.LifeGuideonline.org/;
accessed 25 February 2020) platform has been extensively used to develop and evaluate the acceptability
and impact of online behaviour change and self-management interventions with a variety of clinical groups,
including in primary care.25–27 As an example, when adding online LifeGuide support to face-to-face support
there was a greater lasting reduction in obesity than with face-to-face dietetic advice alone.28 The LifeGuide
platform provides a researcher-led tool to develop theory-driven interventions and evidence of the
effectiveness of techniques.29,30 It also provides the opportunity to capture intervention engagement
and assess the utility of different behaviour change components.
The potential for e-coachER
Following iterative development work and user group testing and involvement, drawing on some online
modules used in other LifeGuide interventions, for example in secondary prevention of coronary heart
disease,25 we developed a bespoke intervention.We called the intervention ‘e-coachER’ and it was designed
to support patients with chronic physical and mental health conditions who have been referred from
primary care to an ERS to receive face-to-face support.1 The overarching aim of the e-coachER intervention
was to facilitate long-term PA by promotion of evidence-based self-regulatory skills and to encourage
interaction with others (including the ERS professional, family and friends), and founded on self-
determination theory31 to build a sense of competence in managing PA, autonomy or control over PA,
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and connection or relatedness with others.We wanted to encourage uptake and adherence to the ERS
but if that was not acceptable or feasible for participants then we offered support to find alternative ways
to be physically active in a way that may support their needs as someone who was inactive. It was also
important that the intervention could be scaled up to promote PA for patients with obesity, hypertension,
type 2 diabetes, osteoarthritis and risk of depression at probably low cost32,33 and also potentially make it
available for patients with other chronic medical conditions (e.g. low back pain, heart disease and cancer).
Developing the e-coachER intervention
The intervention development included the piloting of the welcome pack and development of an
initial version of e-coachER, built on wide-ranging experiences from the development of other
self-management interventions using the LifeGuide platform34 and beta testing over 7 months.
Co-applicants and researchers then provided feedback on a time-truncated version, and ERS users
provided feedback on a real-time version for 5 months before the website was locked for the RCT.
The development of all components of the e-coachER intervention followed a logic model as shown
in Figure 1.1
Intervention
components 
Initial package includes
free pedometer, fridge
magnet and access to
e-coachER (a website to
promote PA via specific
BCTs):
 • Step 1: information
     about physical and
     mental health
     consequences –
     understand benefits
     of exercise and PA
      goal-setting. How to
     manage setbacks
• Step 2: social support –
    encouraged to seek
    support from friends
    and family/exercise
    coach to implement
    and maintain PA
• Step 3: self-monitoring
    of behaviour – 
    monitor steps/PA
• Step 4: goal-setting –
    set weekly step and
    PA goals
• Step 5: action-planning –
    making plans to
    achieve goals
(These are the priority
BCTs. For the full list of
BCTs, see Table 1)
Intervention
delivery 
• Participants
    progress
    through
    e-coachER
Changes to motivation
and behaviour 
• Participant motivation for
    PA is mediated by autonomy,
    competence and relatedness
• Participant autonomy,
    competence and relatedness
    are enhanced by using the
    website and implementing
    BCTs
Context
• Participants’ engagement with e-coachER may be moderated by
    participant sociodemographic and health characteristics, type and
    location of ERS and relationship with ERS coach
• Participant motivation and PA might also be moderated by the
    same contextual factors
Long-term
outcomes
• Health and
    economic
    benefits
• Quantitative
    outcome
    data in both
    trial arms,
    including
    weight and
    quality of life
Feedback loop
• Increased use of website and BCTs, motivation,
   achievement of PA goals reinforce each other
   (e.g. motivation is enhanced as levels of PA
   increase)
Short-term
outcomes
• MVPA
    increases,
    sedentary
    time
    decreases
• Quantitative
    outcome
    data in both
    trial arms
FIGURE 1 Logic model for the e-coachER intervention. BCT, behaviour change technique; MVPA, moderate and vigorous
physical activity. Reproduced with permission from Ingram et al.1 This is an Open Access article distributed in accordance
with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt
and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/. The figure includes minor additions and formatting changes to the original text.
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The key components of e-coachER include the following:
l On allocation to the intervention, all participants received a ‘welcome pack’ (Figure 2) that
contained a user guide and the participant’s unique user log-in and registration details to access the
e-coachER website, a simple pedometer (step counter) with instruction sheet and a fridge magnet
with tear-off sheets to record daily PA (complete with trial branding and e-coachER helpline
number). Participants were encouraged to use the pedometer and the PA record sheets for
self-monitoring and goal-setting in conjunction with the website.
l The e-coachER support system, hosted on the LifeGuide platform, provided support through seven
‘steps to health’ lasting approximately 5–10 minutes each, as shown in Table 1.
l The steps were designed to do the following: encourage participants to think about the benefits
of PA (motivation); seek support from an ERS practitioner, friends/family and the internet
(support/relatedness); set progressive goals; self-monitor PA with a pedometer and upload step
counts or minutes of moderate and vigorous physical activity (MVPA) (self-regulation, building
confidence/autonomy); and find ways to increase PA more sustainably in the context of day-to-day
life and deal with setbacks (building confidence). The sequential content, objectives and how this
was implemented were mapped against a taxonomy for behaviour change techniques shown in
Table 1.35 The website content is illustrated in Appendix 1.
l Participants were encouraged to use e-coachER support as an interactive tool by using pre-set or
personally set reminders to upload step counts or minutes of MVPA, and messages of encouragement.
A lack of engagement (e.g. not reviewing a goal by entering step counts 1 week later, or not signing
into the website for 1, 2 and 4 weeks) triggered reminder e-mails. Participants were reminded by
prompts to review goals the next day.
l An avatar was used throughout the content to avoid having to represent a range of individual
characteristics, such as age, gender and ethnicity. The avatar delivered brief narratives to normalise
and support behaviour change and encourage the use of e-coachER. Automatic and user-defined
e-mails generated by the LifeGuide system promoted ongoing use of functions such as recording
weekly PA and goal-setting. Participants were provided with links to reputable generic websites for
further information about the chronic conditions of interest and lifestyle, links to other websites
and apps (applications) for self-monitoring health behaviour and health, as well as modifiable listings
of local opportunities to engage in PA.
l The only webpages that were not ‘locked’ after the initial participant began the intervention were
pages for the respective recruitment sites that displayed links to the following websites: (1) local
community opportunities for engaging in PA, (2) disease-specific (e.g. Diabetes UK, Royal College of
Psychiatrists) informational sites about the role of PA in preventing and managing the condition,
and (3) sites about other methods to optimise ways to be physically active (e.g. more sophisticated
technologies to self-monitor).
l Our aim was to maximise accessibility and use. Therefore, a local researcher provided technical
support if requested, but did not support behaviour change directly. If participants did not register
on the e-coachER website within the first few weeks, they were followed up with a telephone call
to offer support to use e-coachER. If technical support to resolve any user operational issues with
the website (e.g. re-issuing passwords) was needed, participants were referred to a centralised
technician within the LifeGuide team for further support.
Trial aim and objectives
The overarching aim was to determine if e-coachER online support combined with usual ERS provided
a clinically effective and cost-effective approach to supporting increases in PA in people referred to an
ERS with a range of chronic conditions.
INTRODUCTION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
4
FIGURE 2 The e-coachER welcome pack. The welcome pack comprises a user guide, pedometer and magnet notepad for
recording PA.
TABLE 1 Sequential components of the e-coachER intervention and objectives mapped against behaviour change
techniques, and explanation of the implementation strategy
Sequential components Objectives
aBehaviour change
techniques35 Implementation strategy
Welcome pack and
pedometer and an
introduction to
web-based support
for self-directed PA
To introduce the user to
the philosophy of the
website to become
personal coach
10. Self-monitoring Explain philosophy of using
website to become own
personal coach
Build on personal support
provided by ERS using
web-based platform
Links provided to local
services and other self-help
resources to highlight
patient autonomy and choice
Support those who do not
want to/cannot engage
with ERS personnel
Offers e-coachER facilitator
to help with using technology.
Provide link to IT support in
Southampton
Support achievement of
personal goals for PA to
enhance health
Step 1: thinking about the
benefits of PA
Elevate importance of PA 82. Information about
health consequences
Quiz to engage participants
using positive framing
83. Information about
emotional consequences
Provide evidence of multiple
benefits of PA especially for
relevant health condition(s)
Elicit and address concerns
about PA, describing support
given as part of ERS and
by website
Step 2: support to
get active
To encourage user to
access and create social
support networks
1. Social support
(practical)
Explain how to make the
most of the ERS support to
learn how to become own
personal trainer in future
continued
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TABLE 1 Sequential components of the e-coachER intervention and objectives mapped against behaviour change
techniques, and explanation of the implementation strategy (continued )
Sequential components Objectives
aBehaviour change
techniques35 Implementation strategy
To encourage user to take
advantage of ERS and
face-to-face support
offered
2. Social support
(emotional)
Explain how user can create
a personal ‘PA challenge’ and
share it with family, friends,
peers, and exercise and
health professionals. The
patient may be encouraged
to tell others about how
e-coachER has been used to
support behaviour change
3. Social support
(unspecified)
Suggest ways of involving
family or friends in
longer-term support
for continued PA
Link to online sources of
local support (e.g. local
walking or jogging group,
or British Trust for
Conservation Volunteers)
How to use website to send
personalised e-mail/text
reminders, motivational
messages to self
Draw on positive normative
beliefs; identify benefits
of social interaction
(companionship). Sharing
personal PA challenge with
others, involve friends and
family, online local support
links
Identify benefits of
informational support (from
ERS) in addition to emotional
support from family and
friends)
Step 3: counting
your steps
To encourage and support
the user to monitor step
counts using a pedometer
over 1 week
10. Self-monitoring
of behaviour
Provide guidance on how to
count steps/use pedometer
Emphasise personal
experimentation
Provide guidance on how
steps can be implemented
into lifestyle
Encourage self-monitoring
using diary
Step 4: making your
step plans
To set explicit step
count goals for the
following week
66. Goal-setting
(behaviour)
Give rationale and evidence
for goal-setting for graded
increase in PA
User sets specific, achievable
goals for next week (e.g.
sessions completed, step
count using the supplied
pedometers)
Links provided to local
services and other resources
INTRODUCTION
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TABLE 1 Sequential components of the e-coachER intervention and objectives mapped against behaviour change
techniques, and explanation of the implementation strategy (continued )
Sequential components Objectives
aBehaviour change
techniques35 Implementation strategy
Step 5: making your
activity plans
To encourage and support
the user to identify
behavioural goals (types of
activities)
68. Action-planning User selects walking or
‘other physical activities’
(which include options for
facility-based activity
with practitioner support
within ERS)
Present options for facility
and lifestyle-based activity
Sets specific, achievable
goals for next week with a
particular focus on avoiding
days with less activity by
planning walking or other
activities
Keeping a PA diary
Weekly goal and PA
review
To promote adherence
and graded increase in
PA by providing tailored
feedback and advice based
on self-reported goal
progress
66. Goal-setting
(behaviour)
User records extent to
which goals are achieved in
previous week, gets progress
graph and personalised
feedback:
68. Action-planning l Praise for any goal
achievement,
encouragement to set a
more challenging goal if
not yet meeting target
PA criteria
69. Review behaviour
goals
l Encouragement where
goals not attained, with
links to webpages to
assist with increasing
motivation or confidence,
selecting different
activities or goals, making
better plans, accessing
support, overcoming
setbacks (with links to
relevant sessions below)
l Each session completed
ends with new links to
reputable information
and resources (e.g. NHS
Choices, condition-specific
PA advice websites)
l Help user plan gradual
increases in PA
Step 6: finding ways to
achieve your plans
To help the user harness
their environment to
provide support for PA
30. Restructuring the
physical environment
Make plan to use environment
to automatically support PA
(with examples, e.g. fitness
equipment in living room,
route to work/shops that
involves more PA, committing
self to specific routine)
continued
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7
The specific objectives were to:
l determine whether or not there is an increase in the total weekly minutes of MVPA at 12 months
post randomisation in the intervention group compared with the control group
l determine whether or not there is an increase in the proportion of participants in the intervention
group compared with the control group who:
¢ take up the opportunity to attend an initial consultation with an exercise practitioner
¢ maintain objectively assessed PA at 4 and 12 months post randomisation
¢ maintain self-reported PA at 4 and 12 months post randomisation
¢ have improved health-related quality of life at 4 and 12 months post randomisation
TABLE 1 Sequential components of the e-coachER intervention and objectives mapped against behaviour change
techniques, and explanation of the implementation strategy (continued )
Sequential components Objectives
aBehaviour change
techniques35 Implementation strategy
Identifying personal
motivations, building
confidence
31. Restructuring the
social environment
Advise user on how to use
website to send personalised
e-mail/text reminders,
motivational messages
32. Avoidance/reducing
exposure to cues for
behaviour
Overcoming barriers in work,
leisure, home and travel.
Building self-efficacy
Using smartphone apps for
mobile support
Invite user to identify
personal motivations for
becoming more active
Motivational messages
(text or/and e-mails)
To provide reminders of
users’ personal reasons
(not necessarily health
reasons) for becoming
more active
15. Prompts/cues Invite user to write
motivational message to be
sent weekly or monthly
detailing their own
motivations for becoming
more active
Step 7: dealing with
setbacks
To provide strategies for
overcoming relapse in
levels of PA
5. Reduce negative
emotions
Identify possible causes of
relapse (e.g. illness, holidays,
change in work hours, new
caring responsibilities) and
plan ways to overcome
barriers
Challenging catastrophic
negative thoughts about
lapses from intended PA
How to learn from a lapse
and plan to avoid or
overcome in future
Provide salient role models
of people overcoming
barriers to successfully
engage with PA
IT, information technology.
a The numbers in this column correspond to the behaviour change techniques, which are listed numerically in Michie et al.35
Reproduced with permission from Ingram et al.1 This is an Open Access article distributed in accordance with the terms
of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build
upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/
licenses/by/4.0/. The table includes minor additions and formatting changes to the original text.
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l quantify the additional costs of delivering the intervention, and determine the differences in health
utilisation and costs between the intervention and control groups at 12 months post randomisation
l assess the cost-effectiveness of the intervention compared with control at 12 months post
randomisation [incremental cost per quality-adjusted life-year (QALY)] using a previously developed
decision model to estimate future costs and benefits
l quantitatively and qualitatively explore whether or not the impact of the intervention is moderated
by medical condition, age, gender, socioeconomic status, information technology (IT) literacy or
ERS characteristics
l quantitatively and qualitatively explore the mechanisms through which the intervention may have
an impact on the outcomes, through rigorous mixed-methods process evaluation and mediation
analyses (if appropriate).
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Chapter 2 Methods
Study design
This was a multicentre, parallel, two-arm RCT with participant allocation to usual ERS alone (control)
or usual ERS plus web-based behavioural support (intervention) with parallel economic and mixed-
methods process evaluations.1 The trial design is summarised in Figure 3, from Ingram et al.1
Recruitment to the trial took place over a 21-month period (July 2015 to March 2017) in three areas
in the UK: Greater Glasgow, West Midlands and South West England (including Plymouth, Cornwall
and Mid Devon). The majority of participants lived in urban locations. Further information about the
characteristics of the cities involved and the respective ERSs to which participants were referred is
given in Ingram et al.1
Ethics approval and research governance
Ethics approval for the study was granted by North West Preston NHS Research Ethics Committee
(REC) in May 2015 (reference 15/NW/0347). Approval for activity at non-NHS sites was obtained
from the same REC for the following ERSs: Everyone Active (Plymouth), Teignbridge District Council
(Cornwall), Tempus Leisure (Cornwall), Be Active Plus (West Midlands) and Live Active (Glasgow) in
December 2015, and Docspot (West Midlands) in November 2016.
NHS Research and Development approval was granted by the Royal Devon and Exeter NHS
Foundation Trust Shared Management Service for the Plymouth site (July 2015); NIHR Clinical
Research Network (CRN) West Midlands for the Birmingham site (July 2015); and the NHS Greater
Glasgow and Clyde Health Board for the Glasgow site (January 2016).
Prior to commencing recruitment, the trial was registered with the International Standard Randomised
Controlled Trial Number Register (ISRCTN) under reference number 16900744 and NIHR CRN Portfolio
19047. A summary of the changes made to the original protocol is given later in this chapter.
Patient and public involvement
Aim
The aim was to involve public representatives throughout the study to ensure that the intervention
and trial methods were appropriate for the target population.
Methods
The target trial population was composed of patients with one or more physical and mental health
conditions; there was no single patient support group or user group that could be invited to contribute
as patient and public involvement (PPI) representatives. Hence, PPI representatives with diverse
clinical conditions were sought from an ERS provider in Plymouth. Others involved in the delivery of
ERSs as managers or practitioners were also consulted to ensure that the methods and intervention
were aligned with the usual ERS, especially in the recruitment locations.
There was comprehensive PPI in intervention development. PPI representatives provided critical
feedback in informal focus groups on the e-coachER website and registration processes, and on the use
of the pedometer and the fridge magnet (with recording strips) as a motivational tool in the e-coachER
support package.
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Accelerometer not provided
by participant 
No response
Declined
Ineligible
Declined to participate
Lost to follow-up
Patient referred to ERS by primary care practitioner
Potential participant provided with a trial information pack
and invited to contact local researcher 
Potential participant returns expression of interest to local
researcher 
Informed consent obtained (face to face or telephone)
Baseline assessment conducted with local researcher 
(face to face or telephone)
Participant issued with accelerometer to wear for 7 consecutive
days and questionnaire booklet to complete at the start of this
7-day period
Usual ERS plus
e-coachER intervention
(n = 224)
At 4 weeks, participant completes short e-mail survey on
ERS attendance 
At 4 months, participant wears accelerometer for
7 consecutive days and completes postal questionnaire booklet
at the start of this 7-day period
Potential participant screened for eligibility by local researcher
Analysis
Randomisation
(n = 450)
At 12 months, participant wears accelerometer for
7 consecutive days and completes postal questionnaire booklet
at the start of this 7-day period 
Lost to follow-up
Usual ERS
(n = 226)
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FIGURE 3 Participant pathway. Reproduced with permission from Ingram et al.1 This is an Open Access article distributed
in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute,
remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See:
http://creativecommons.org/licenses/by/4.0/. The figure includes minor additions and formatting changes to the original text.
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Patient and public involvement representatives with experience of ERSs also contributed to the study via
their membership of the e-coachER Project Management Group and Trial Steering Committee (TSC).
Results
Notable benefits included having access to PPI representatives’ perspectives on (1) participant-facing
documents, such as the e-coachER invitation materials and participant newsletter, (2) usability of the
e-coachER intervention package and (3) suggestions to overcome barriers to recruitment.
Discussion
One PPI representative was influential with regard to including a ‘personal message’ from an ERS user
in the periodic participant newsletter, the aim being to convey the importance and value of taking part
in the study from the perspective of someone who has been referred to an ERS. There were no
negative aspects of the PPI activities undertaken in the study.
Reflections
Being a resident of Plymouth, one PPI representative was able to attend all of the meetings held at the
chief investigator’s institution in person. Face-to-face contact with the PPI representative meant that a
rapport was more readily generated than would have been possible if teleconferencing had been used.
The PPI representative on the TSC provided a welcome contribution to the various discussions on the
problems faced with recruitment in the pilot phase of the trial. He took a keen interest in the wider
issues faced by the trial team, such as ERS provision in the UK, national guidelines for PA and the
choice of cut-off points for accelerometer-derived data that informed the primary outcome. The PPI
representative provided a ‘real-life’ perspective on such matters, as he saw them.
Participants
The study population was composed of patients who had been referred to an ERS administrator, or
were about to be referred, mostly by a general practitioner (GP), and occasionally by a nurse to a local
ERS for a programme of support to increase PA.
Patients were eligible for the study if they were aged between 16 and 74 years, inclusive, were contactable
via e-mail, had some experience of using the internet and had one or more of the following conditions:
l obesity [i.e. a body mass index (BMI) of 30–40 kg/m2]
l a diagnosis of hypertension
l prediabetes
l type 2 diabetes
l lower limb osteoarthritis
l current or recent history of treatment for depression
l categorised as ‘inactive’ (i.e. 0 hours per week of physical exercise and in a sedentary occupation)
or ‘moderately inactive’ (i.e. some activity but < 1 hour per week and in a sedentary occupation,
or 0 hours per week of physical exercise and in a standing occupation) according to the General
Practice Physical Activity Questionnaire (GPPAQ).36
Patients were excluded for the following reasons:
l They did not meet the eligibility criteria for their local ERS.
l They had an unstable, severe and enduring mental health problem.
l They were being treated for an alcohol or drug addiction that may have limited their involvement
with the study.
l They were unable to use written materials in English, unless they had a designated family member
or friend to act as translator.
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Intervention
All participants had been offered usual ERS. Participants allocated to the intervention group were
additionally offered access the e-coachER web-based support package. Development and delivery of
the intervention is fully described in Chapter 1, Developing the e-coachER intervention.
Usual care
There is currently no single model for ERSs in the UK, but the predominant mode of delivery involves
referral to a programme (e.g. 10–12 weeks) of structured, supervised exercise at an exercise facility
(e.g. gym or leisure centre) or a counselling approach to support patients to engage in a variety of types of
PA.13 ERSs operate diversely to accommodate patient choice and local availability of facilities, the common
goal being to reduce the risk of long-term metabolic, musculoskeletal and mental health conditions as a
result of physical inactivity. The three participating sites were selected from different regions of the UK
(different ERS providers) to provide diversity of approach; the schemes are described in Ingram et al.1
Recruitment procedures
Patients were identified as potentially eligible for the trial in a number of ways.
1. By health-care professionals in primary care at the point of being actively referred to an ERS or
having been opportunistically found to be eligible for an ERS at a consultation with the primary
care practitioner.
2. Via a search of patient databases at the participating GP practices (conducted by the local NIHR
Primary Care Research Network team).
3. Via patient self-referral to the GP arising from community-based publicity for the trial.
4. By the ERS programme administrator on receipt of an ERS referral form from a GP practice.
5. By exercise advisors at the ERS service at enrolment on the ERS. With the patient’s consent, the
exercise advisor provided the local researcher with the patient’s contact details for the purposes of
the trial.
Potentially eligible patients were approached by the primary care practitioner or the local researcher,
depending on how the patient had been identified. Some patients self-referred to the local researcher
in response to publicity campaigns. These various means of identification and approach were designed
to accommodate the variation in usual-care referral pathways to ERSs across the participating sites and
individual GP practices.
Amenable patients were offered a study-specific participant information sheet (see Report Supplementary
Material 1) by post, by e-mail or by hand (the route used largely depended on the preference of the
participating GP practice or ERS service). Interested patients were asked to communicate their expression
of interest to the local researcher via a prepaid reply slip, by telephone or by e-mail. On receipt of an
expression of interest, the local researcher contacted the potential participant by telephone to discuss the
trial, confirm eligibility and seek informed consent.
Informed consent
Informed, written consent (see Report Supplementary Material 2) was obtained prior to undertaking the
baseline assessment, either over the telephone or at a face-to-face visit, depending largely on the patient’s
preference but also on the availability of suitable venues, such as the GP practice. The original completed
informed consent forms were held securely at the site and a copy was given to the participant.
METHODS
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In the case of telephone consent, the researcher was required to sign and date the informed consent
form, but the participant was not required to sign or date their copy.
Patients who were deemed to be ineligible for inclusion in the study were informed of this outcome.
Randomisation, concealment and blinding
On receipt of the baseline accelerometer at the Peninsula Clinical Trials Unit (PenCTU) (after 1 week of
wear), participants were randomised to usual ERS or usual ERS plus access to e-coachER in a 1 : 1 ratio,
stratified by site with minimisation by participant’s perception of main medical referral reason (i.e. weight
loss, diabetes control, reduce blood pressure, manage lower limb osteoarthritis symptoms, manage
low mood/depression) and by self-reported IT literacy level on a visual analogue scale (i.e. lower or
higher confidence).
To maintain concealment, the minimisation algorithm retained a stochastic element.
Randomisation was conducted by means of a secure, password-protected web-based system created
and managed by the clinical trials unit (CTU).
Blinding of participants was not possible, given the nature of the intervention. Given that the primary
outcome was an objective measure of PA recorded by accelerometer, and the secondary outcomes
were assessed by a participant self-completed questionnaire, the risk of assessor bias was considered
to be negligible in this study. However, to minimise any potential bias, the statistical analysis was
kept blinded and the code for group allocation was not broken until the primary and secondary
analyses had been completed. The ERS practitioners would not have been aware of trial participants’
treatment allocations.
Process evaluation: qualitative interviews
Participants who had engaged with the e-coachER website (i.e. logged on to the website, as a
minimum) were invited to participate in one or more qualitative interviews to inform the process
evaluation (see Chapter 4, Qualitative process evaluation).
Data collection and management
Data were collected and stored in accordance with the Data Protection Act 199837/General Data
Protection Regulation 2016.38
Participant numbering
Following receipt of an expression of interest, each patient was allocated a unique identification number
and was then identified in all study-related documentation by this number and their initials. A record of
names, addresses, telephone numbers and e-mail addresses linked to participants’ identification numbers
was stored securely on the study database at the CTU for administrative purposes only.
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Data collection
Data were recorded on study-specific paper-based case report forms (CRFs) by the local researcher,
and participants completed a paper-based questionnaire booklet comprising validated and non-validated
self-report outcome measures.
Accelerometers [GENEActiv™ Original accelerometer (version 3.0_09.02.2015), Active Insights
Kimbolton, UK; www.geneactiv.org/ (accessed 26 February 2020)] were configured for use prior
to being issued to participants by the local researcher at baseline and the CTU thereafter, using
GENEActiv software. A recording window of 10 days, starting at midnight of the day of issue and
recording at 75 Hz, was pre-set, thus accounting for transits in the post while optimising the battery
life of the device.
Accelerometers received by the CTU following 1 week of wear by the participant were physically
cleaned with liquid detergent in accordance with the manufacturer’s instructions before data were
downloaded and linked to the participant identification number (see Accelerometer data processing).
Accelerometers were then issued to other participants in the trial as required.
Data on participants’ uptake of the ERS were collected via participant self-report at 4 weeks post
baseline and 4 months post randomisation, and via the ERS service provider.
Recording and reporting of non-serious adverse events (AEs) in this study were not required. Serious
adverse events (SAEs) were reported to the CTU via the self-report questionnaire booklet administered
at 4 and 12 months, but were also reported to the CTU or local researcher by the participant (or relative)
outside these time points, until the end of follow-up. SAEs were categorised using the Medical Dictionary
for Regulatory Activities (MedDRA) Terminology Systems Organ Classification List Internationally
Agreed Order Version 19.0, March 2016 (www.meddra.org/sites/default/files/guidance/file/intguide_19_
0_english.pdf; accessed 26 February 2020).
All persons authorised to collect and record study data at each site were listed on the study site
delegation logs, which were signed by the principal investigator.
Data processing
Accelerometer data processing
Accelerometer data were downloaded using the GENEActiv and analysed in software R (The R
Foundation for Statistical Computing, Vienna, Austria) using package GGIR version 1.2–8 (https://cran.
r-project.org/web/packages/GGIR/index.html).39 GGIR performs autocalibration with the reference of
local gravity.40 Raw acceleration data are used to compute Euclidean norm minus one (ENMO in mg).41
Data were analysed from the first to the final midnight using 5-second epochs. Participants were
included in the main analysis if they achieved a minimum of 16 hours of wear-time for a minimum
of 4 days (including at least 1 weekend day). Non-wear was detected if the standard deviation (SD)
of two axes was < 13 mg with a range of < 50 mg in windows of 60 minutes. Time spent in activity
intensities was established using published thresholds.42
Computed variables included average daily MVPA accumulated in any 5-second epochs. Ten-minute
bouts of MVPA were detected when at least 80% of a 10-minute period was above the MVPA
intensity threshold.43 Total time accumulated in bouted and unbouted MVPA minutes was calculated
by multiplying the average daily values by 7 to represent 1 full week.
Diurnal activity and nocturnal periods of inactivity were also estimated to determine if the
intervention had an effect on reducing daytime inactivity and increasing sleep. Sleep duration was
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established using sustained nocturnal inactivity bouts. An inactivity bout occurred when no change
in arm angle > 5° was observed for at least 5 minutes.44 Diurnal inactivity represents the sustained
inactivity bouts (> 5 minutes) that occur in the day,43 which includes naps, but omits other inactivity
that results in measurable movement.45 However, it is likely that some misclassification of this inactivity
may occur.43
To explore if different ways of processing accelerometer data influenced the findings, four additional
wear-time criteria were calculated:
1. ≥ 16 hours over any 4 days (irrespective of weekday/weekend day)
2. ≥ 10 hours for 4 days (including at least 1 weekend day)
3. ≥ 10 hours over any 4 days (irrespective of weekday/weekend day)
4. a minimum wear criterion of 1 day for 10 hours but with individuals weighted by the number of
valid days with ≥ 10 hours of wear.
Case report forms and questionnaire booklets
Original CRFs and questionnaire booklets were posted to the CTU, with copies of the CRF retained at the
site. All data were double-entered by CTU staff into a password-protected Structured Query Language
Server database and encrypted using Secure Sockets Layer (version V3, QuoVadis Global SSL ICA G3,
QuoVadis Online Limited, Lincolnshire, UK). Double-entered data were compared for discrepancies using
a stored procedure, and discrepant data were verified using the original CRF. Incomplete, incoherent,
unreadable or other problem data in the CRF pages were queried with site staff by staff at the CTU
during data entry to ensure a complete and valid data set. Self-reported data in the questionnaire booklet
were not queried with participants.
The CTU staff completed further validation of data items and performed logical data checks after data
collection had been completed. After all data-cleaning duties had been performed at the CTU, the final
export of anonymous data was transferred to the statistician and health economist for analysis.
Baseline assessment
Consented participants attended a baseline assessment with the local researcher. This assessment was
conducted over the telephone or in person at a suitable venue in the community.
Demographic data were collected (i.e. age, gender, BMI, blood pressure, ethnic group, relationship
status, domestic residence status, smoking status, employment status, education status, GPPAQ score,
internet use capability, requirement for translator for trial purposes and clinical condition).
Information technology literacy level was determined using a visual analogue scale for self-reported
‘confidence using the internet’, where 1 = not at all confident and 10 = totally confident. Arbitrarily,
scores of 1–5 were set to indicate a low literacy level and scores of 6–10 indicated a high literacy
level, for the purposes of stratification.
‘Clinical condition’ was the participant’s perception of the reason for referral to the ERS; where more
than one medical condition was stated, the participant ranked these in order of importance and the
most important reason was used as a stratification variable.
The participant was issued with the wrist-worn waterproof accelerometer to wear constantly for
1 whole week (day and night), and a self-report questionnaire booklet to complete at the beginning of
the week-long period. At the face-to-face baseline assessments, the accelerometer was fitted by the
local researcher; at telephone visits, the accelerometer (and self-report questionnaire booklet) were
posted to participants. All participants were provided with a bespoke guidance sheet for wearing the
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accelerometer (see Report Supplementary Material 3), including instructions to wear the accelerometer
on the wrist of the non-dominant hand (i.e. the hand not favoured for writing). After 1 week of wear,
participants were required to post the accelerometer and completed questionnaire to the CTU in a
preaddressed padded envelope provided. A prepaid postal service was used so as not to incur costs to
the participant.
The measures collected at baseline are summarised in Table 2.
Follow-up assessments
The measures collected at follow-up are summarised in Table 2.
At 4 weeks post baseline, a short survey on initial uptake of the ERS was administered via e-mail.
TABLE 2 Schedule of baseline and follow-up measures
Measure Baseline
4 weeks
post
baseline
4 months post
randomisation
12 months post
randomisation
On completion
of participants’
ERS programme
at site
Demographics ✗
Engagement with the ERS:
self-reported
✗ ✗
Engagement with the ERS: ERS
service provider’s record
✗
Accelerometer-recorded MVPA ✗ ✗ ✗
Self-reported MVPA ✗ ✗ ✗
Self-reported health and social care
resource use
✗ ✗ ✗
Self-reported quality-of-life measure
(EQ-5D-5L)
✗ ✗ ✗
Self-reported Hospital Anxiety and
Depression Scale
✗ ✗ ✗
Self-reported process evaluation
outcomes (confidence to be physically
active; importance of being physically
active, perceived frequency and
availability of support; perceived
autonomy over choices; involvement in
self-monitoring and action-planning PA)
✗ ✗ ✗
Qualitative interviews as part of the
process evaluation focusing on
participants’ experiences with the
ERS and the intervention (optional
for participants)
✗
Engagement with e-coachER
(captured from the LifeGuide
platform)
✗
EQ-5D-5L, EuroQol-5 Dimensions, five-level version.
METHODS
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At 4 and 12 months post randomisation, participants were sent an accelerometer (along with the
guidance sheet on how to wear it), a questionnaire booklet, and a pre-addressed, prepaid envelope to
return the items to the CTU.
To maximise data completeness at follow-up assessments, participants were sent standard letters from
the CTU: (1) 7 days before delivery of the accelerometer, (2) 3 days into the 10-day recording window
as a prompt to begin wearing the accelerometer (if not already doing so) and (3) at 3 and 5 weeks
after issue as a reminder to post the accelerometer to the CTU (for those participants who had not
already done so). If a participant had not sent the accelerometer back to the CTU after 6 weeks, the
local researcher telephoned the participant to remind them to return the device. Participants who
returned the accelerometer to the CTU were provided with a £20 voucher for an online store as a
token ‘thank you’ to maximise response rates.
Once a participant’s involvement in the ERS had concluded, the ERS service providers completed a
simple pro forma to confirm whether or not the participant attended an appointment with the exercise
specialist and, if so, how many appointments were available to the participant.
Measures
Primary outcome measure
The primary outcome was the number of weekly minutes of MVPA, in ≥ 10-minute bouts, measured
objectively using the GENEActiv Original accelerometer,46 over 1 week at 12 months post randomisation,
compared with the control group. To be included, participants had to have provided activity recorded
over 4 days, including a weekend day, for at least 16 hours per day.
Secondary outcome measures
l Total weekly minutes of MVPA in ≥ 10-minute bouts, measured objectively using an accelerometer,
over 1 week at 4 months.
l Achievement of at least 150 minutes of MVPA, measured objectively by accelerometer, over 1 week
at 4 and 12 months.
l Self-reported achievement of at least 150 minutes of MVPA over 1 week using the 7-day recall of
PA47 (7-day Physical Activity Recall questionnaire) at 4 and 12 months.
l Self-reported weekly minutes of MVPA at 4 and 12 months.
l Average daily hours of sedentary behaviour measured objectively using an accelerometer over
1 week at 4 and 12 months.
l Self-reported average daily hours of sleep over 1 week at 4 and 12 months.
l Self-reported health-related quality of life, assessed using the EuroQol-5 Dimensions, five-level
version (EQ-5D-5L),48 at 4 and 12 months.
l Self-reported symptoms of anxiety and depression, assessed using the Hospital Anxiety and
Depression Scale (HADS),49 at 4 and 12 months.
l Uptake of the ERS according to the attendance records held by the ERS service provider, with
imputed participant-reported attendance at 4 weeks and/or 4 months where the ERS service data
are missing.
l Adherence to PA using a composite measure to describe the proportion of participants in each arm
of the trial who achieved at least 150 minutes of MVPA in bouts of at least 10 minutes at 4 months
and were still doing so at 12 months.
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Self-reported survey process measures
The following survey items were adapted from existing measures or originally developed, using
processes to be reported elsewhere in more detail, and were used as process measures:
l importance and confidence to be physically active (single items)
l perceived competence in being regularly physically active (four items)
l autonomous in decisions about PA (four items)
l availability of support (three items)
l frequency of support (three items)
l action-planning (five items)
l self-monitoring (two items).
The respective measures were not validated but exploratory analysis, to be reported in more detail
elsewhere, indicated that Cronbach’s alpha coefficients of all scales were ≥ 0.77, using data from
participants included in the primary analysis.
In the intervention group, we measured engagement with e-coachER. This included whether or not the
participant visited the website at least once and whether or not they reached a stage of the online
support to indicate that they have set and reviewed at least one PA goal [i.e. step 5 – users make their
specific, measurable, achievable, relevant, time-bound (SMART) activity plan and then review their step
goal and SMART activity goal].
Sample size
In the absence of a published minimally important difference for MVPA, assuming a ‘small’ to
‘moderate’ standardised effect size of 0.35, we estimated that 413 participants were required, with
88% power and a two-sided alpha of 5%, assuming 20% attrition, or 90% power at a two-sided alpha
of 5% allowing for 16% attrition [using ‘sampsi’ in Stata® version 14 (StataCorp LP, College Station, TX,
USA)]. Given that the intervention was delivered at the level of the individual participant, clustering
was not factored into the sample size calculation. Based on the baseline SD for MVPA total weekly
minutes in ≥ 10-minute bouts of 104–113,50 an effect size of 0.35 corresponds to a between-group
difference of 36–39 minutes of MVPA per week.
Statistical analysis
Analyses were in accordance with International Conference on Harmonisation guideline 9 (ICH-9)
statistical guidelines51 for clinical trials and updated Consolidated Standards of Reporting Trials
(CONSORT) reporting guidelines52,53 for non-drug trials. All primary and secondary analyses were
undertaken and reported in accordance with a prespecified detailed statistical analysis plan that was
agreed with the Project Management Group, TSC and Data Monitoring Committee (DMC).
Following data lock by the CTU data manager, the statistician undertook primary analyses blinded to group
(i.e. randomised groups were coded ‘A’ or ‘B’). Following the blinded presentation of the primary results to
the Project Management Group and agreed interpretation of the results, the groups were unblinded.
Descriptive analyses
A summary of baseline characteristics and baseline outcome values in the intervention and control
groups was undertaken and between-group equivalence was assessed descriptively. Because differences
between randomised groups at baseline could have occurred by chance, no formal significance testing
will be conducted.
METHODS
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Interim analysis
No interim inferential analysis was planned and none was conducted.
Inferential analyses
Definition of comparison groups
Intention to treat (ITT), complete case: groups according to original randomised allocation in
participants with complete data (i.e. meeting required accelerometer wear-time) at 12-month follow-up.
Intention to treat, imputed: groups according to original randomised allocation in all participants.
Per protocol [complier-average casual effect (CACE)]: ITT complete-case participants who have
completed step 5 – making your activity plans.
Primary analysis
The primary analysis using a linear model (continuous outcomes – using Stata ‘regress’) or logistic
model (binary outcomes – using Stata ‘logistic’ command) compared primary and secondary outcomes
between groups according to the principle of intention to treat (i.e. according to original randomised
allocation) in participants with complete outcomes at 12 months. This adjusted for baseline outcome
values and stratification (by site) and minimisation variables (participant’s perception of main medical
reason for referral to the ERS and IT literacy level). Given that age and gender are known to be
predictive of PA, these baseline characteristics were also added to the adjusted model.
Given the overdispersion and high frequency of the primary outcome, the primary mixed-effects model
was found to be a poor fit. Therefore, alternative post hoc regression models were explored for the
analysis of the primary outcome. These included a log-transformed mixed-effects model (with a constant
added), a mixed-effect model (with outliers removed), negative binomial models and zero-inflated
binomial models.
Secondary analyses
Secondary analyses were undertaken to compare groups at follow-up across all follow-up points, using
a mixed-model repeated-measures approach (using Stata ‘xtmixed’ command). Secondary per-protocol
analysis using a CACE approach (using Stata ‘ivregress’ command) was undertaken to examine the
impact of adherence to the intervention on primary and secondary outcomes at 12 months post
randomisation.
Subgroup analyses
The primary analysis model was extended to fit interaction terms to explore possible subgroup
differences in intervention effect in stratification and minimisation variables for the primary outcome
at 12 months post randomisation. Given the relatively low power for testing interactions, these results
were to be considered as exploratory only.
Sensitivity analysis to test the effects of different ways of processing accelerometer data
Sensitivity analysis was undertaken using four additional wear-time criteria:
1. ≥ 16 hours over any 4 days (irrespective of weekday/weekend day)
2. ≥ 10 hours for 4 days (including at least 1 weekend day)
3. ≥ 10 hours over any 4 days (irrespective of weekday/weekend day)
4. a minimum wear criterion of 1 day for 10 hours but with individuals weighted by the number of
valid days with ≥ 10 hours of wear.
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Handling of missing data
Missingness was defined as those participants with the absence of data at follow-up for one or more
outcomes. Given that the proportion of patients with missing accelerometry data out of the total
number of participants who fulfil the criteria of includable PA data (n = 243) was small (i.e. 0–10
participants or < 5%), no imputation was undertaken for the primary outcome or any of the derived
secondary outcomes. For EQ-5D-5L and HADS, missing data were replaced using multiple imputation
using the covariates of age, gender, reason for referral and confidence in IT, and assuming that
unobserved measurements were missing at random (using Stata ‘mi’ command). Using the same
primary analysis model as described above, between-group outcomes were compared in ITT complete-
case and imputed data sets for primary and secondary outcomes at 12 months post randomisation.
Adverse events
Safety data and AEs were listed descriptively by group and include details of the event and the likely
relatedness to either treatment.
Data presentation
Results were reported as between-group mean differences with 95% confidence intervals (CIs); global
p-values were provided with regard to categorical explanatory variables. The threshold for determining
significant effects was p < 0.05. No adjustment of p-values was made to account for multiple testing,
although the implications of multiple testing were considered when evaluating the results of the
analyses.
Model checking and validation
All analyses were undertaken using Stata version 14.2.
Stata coding for the primary analysis was prepared independently and the analyses were
cross-checked.
Checks were undertaken to assess the robustness of models, including an assessment of model
residual normality and heteroscedasticity.
Changes to the project protocol
Primary outcome measure and sample size
The original protocol featured an internal pilot. During the internal pilot phase, 180 participants
were to be recruited over 3 months to provide sufficient information to justify progression to a main
trial. Progression from the internal pilot to the main trial was dependent on recruitment rate and
engagement with the intervention according to the scenarios in Table 3. In the main trial, an additional
1220 participants were to be recruited, giving a total of 1400 participants (recruited over 16 months).
TABLE 3 Internal pilot to main trial progression rules
Criteria Scenario 3 Scenario 2 Scenario 1
Percentage of internal pilot sample size
target (180 participants) recruited (%)
< 65 65–79 ≥ 80
Intervention engagement (% participants
who access e-coachER at least once)
< 65 65–79 ≥ 80
Proposed action No progression Discuss with TSC and funder
about progression and resources
needed to achieve target
Proceed to full trial
METHODS
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The recruitment rate during the internal pilot phase was lower than expected as a result of limitations
on the time that primary care practitioners had available to approach potential participants, a delayed
start at one of the research sites, poor uptake when patients were approached via a postal mailshot
and a high ineligibility rate among patients who were identified via a primary care database.
In response to poor recruitment, the following strategies to increase recruitment were introduced in
November 2015:
l The inclusion criterion for BMI was aligned with the ERS entry (upper BMI limit for the trial
was originally 35 kg/m2 and was raised to 40 kg/m2), and prediabetes was included as an
inclusion criterion.
l Provision was made for the Birmingham and Plymouth sites to recruit participants via the ERS
service (a strategy already in place at the Glasgow site), in addition to recruitment via primary care.
l Incentive payments to participants (for returning an accelerometer) were increased from a
maximum of £40 per participant (£10 at baseline, £10 at 4 months and £20 at 12 months) to a
maximum of £60 per participant (£20 at each of the aforementioned time points).
Having implemented these measures, the conditions for progression in terms of recruitment rate and
engagement with the intervention were not met by the end of the internal pilot phase, despite a
4-month extension period. A ‘recovery plan’ was developed in collaboration with the funders, based
on amending the choice of primary outcome.
The original primary outcome was achievement of at least 150 minutes of MVPA measured objectively
by accelerometer over 1 week at 12 months. This outcome was based on the findings of a systematic
review of ERSs14,54 demonstrating that trials had primarily reported their outcomes according to
percentage of participants reaching the NICE guidelines for PA level (i.e. 150 minutes of MVPA per
week). We estimated that recruiting 700 participants per group would allow us to detect a difference
at 12-month follow-up of at least 10% (intervention group 53% vs. control group 43%), assuming an
attrition rate of 20% and small effect of clustering (intracluster correlation coefficient 0.006) at 90%
power and 5% alpha. Thus, the original sample size was 1400 participants to be recruited over a
16-month period.
From the outset, the TSC and DMC had recommended that this dichotomous primary outcome
measure be replaced with a continuous variable (i.e. total weekly minutes of MVPA). This was because:
(a) A continuous primary outcome measure would be more relevant in this study population, in terms
of detecting a small but clinically significant increase in minutes of MVPA.
(b) Based on sample size calculations, this would offer greater statistical power than to the categorical
assessment of whether or not participants reach a threshold of 150 minutes of MVPA. This would
therefore afford a reduction in sample size.
The TSC and funders agreed to these changes (in August 2016) and the original sample size was
reduced in accordance with this new primary outcome measure and revised sample size calculation,
from 1400 to 413 participants (to be recruited over 21 months). A similar reduction in sample size was
incorporated into the qualitative component of the process evaluation work.
The primary outcome was subsequently specifically defined as total weekly minutes of MVPA in
≥ 10-minute bouts recorded objectively by accelerometer over 1 week at 12 months, in participants
with activity recorded for at least 16 hours per day on at least 4 days, including 1 weekend day.
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Capture of exercise referral scheme attendance data
Initially, uptake of the ERS was solely self-reported, captured via an e-mailed survey at approximately
4 weeks and a postal questionnaire at 4 months. Owing to poor compliance (especially at 4 weeks),
data were sought from the ERS service providers, in addition to the self-reported data. Participants
consented to the ERS service sharing their attendance data for the purposes of the trial.
Omission of Short Form questionnaire-12 items data analysis
Owing to an error in the compilation of the participant self-report questionnaire booklet, the Short
Form questionnaire-12 items (SF-12) data collected could not be analysed in this study. We had
intended to administer the SF-12 version 2 at each of the study time points but it transpired that a
number of the response options for SF-12 version 1, instead of SF-12 version 2, had been printed in
the questionnaire booklet in error.
METHODS
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Chapter 3 Trial results: quantitative results
Participant recruitment
A total of 450 participants were recruited (randomised) to the trial over a 20-month period
(3 September 2016 to 10 April 2017).
Table 4 shows the number (%) of participants who entered the trial by referral source (i.e. by mailout
from the GP or opportunistically in primary care, at the point of initial contact with the ERS providers,
or by word of mouth or community advertisement) across the different sites.
Flow of participants in the trial
Figure 4 shows the flow of participants through the trial. Of those expressing an interest in participating,
477 (63%) individuals were eligible. The main reasons for ineligibility were BMI being too high (n = 104,
14%), being too active according to the GPPAQ (n = 47, 6%) and clinical condition of interest not being
present (n = 26, 3%). An additional 27 individuals (4%) could not be contacted following their expression
of interest. A detailed CONSORT flow diagram is given in Appendix 2.
Baseline comparability
The baseline characteristics of the whole sample (n = 450) and those who were included in the primary
analysis (n = 232) are shown in Tables 5 and 6, respectively. The groups were well balanced.
Study attrition
Loss to follow-up
A total of 450 participants were randomised. A total of 94 participants (21% of those randomised)
were lost to follow-up: 47 (10%) participants declined to participate further and 47 (10%) participants
were non-contactable (see Appendix 2).
There were no differences in age, BMI, gender, IT literacy and educational attainment between
participants who were included in the primary analysis and those who were not.
TABLE 4 Route of participants into the study
Referral source
Site, n (%)
Total, n (%)Plymouth Birmingham Glasgow
ERS 38 (25) 109 (71) 141 (100) 288 (64)
Primary care 102 (66) 45 (29) 0 (0) 147 (33)
Self-referral 15 (10) 0 (0) 0 (0) 15 (3)
Total 155 (100) 154 (100) 141 (100) 450 (100)
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Responded to invitation to
participate
(n = 831)
• Declined, n = 61
• Ineligible, n = 11
• Patient not contactable, n = 4
Interested
(n = 755)
• Patient not contactable, n = 26
• Ineligible, n = 23
• Declined, n = 15
Assessed for eligibility
(n = 691)
• Ineligible at screening, n = 201
• Declined, n = 12
• Patient not contactable, n = 1
Eligible and consented
(n = 477)
• Did not return baseline
    accelerometer, n = 15
• Declined, n = 9
• Patient not contactable, n = 3
Randomised
(n = 450)
Baseline
Intervention
(n = 224)
Accelerometer wear-time criteria 
met, n = 207; not met, n = 17
Control
(n = 226)
Accelerometer wear-time criteria 
met, n = 201; not met, n = 25
Received intervention (logged
in to the e-coachER website
one or more times)
(n = 144)
• Participant not contactable,
    n = 12
• Declined, n = 8
• Participant not contactable,
    n = 9
• Declined, n = 4
4-month
follow-up 
• Accelerometer received at CTU, n = 183
    • Wear-time criteria met, n = 109; 
        not met, n = 74
• Accelerometer not received, n = 17
• Accelerometer received at CTU, n = 190
    • Wear-time criteria met, n = 128; 
        not met, n = 62
• Accelerometer not received, n = 22 
• Declined, n = 18
• Participant not contactable,
    n = 14
• Declined, n = 17
• Participant not contactable,
    n = 12
12-month
follow-up 
• Accelerometer received at CTU, n = 160
    • Wear-time criteria met, n = 110; 
        not met, n = 50
• Accelerometer not received, n = 12  
• Accelerometer received at CTU, n = 169
    • Wear-time criteria met, n = 133; 
        not met, n = 36
• Accelerometer not received, n = 15 
Analysed
(n = 110) 
Analysed
(n = 133)
Lost to follow-up
(n = 20)
Lost to follow-up
(n = 13)
Lost to follow-up
(n = 32)
Lost to follow-up
(n = 29)
FIGURE 4 Participant flow.
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TABLE 5 Baseline demographic and health-related characteristics of the sample
Variable Control group Intervention group Both groups
N 226 224 450
Gender, n male (%) 84 (37) 76 (34) 160 (36)
Age (years), mean (SD) [range] 51 (14) [18–75] 50 (13) [20–73] 50 (12) [18–75]
BMI (kg/m2), mean (SD) [range] 32.5 (4.4) [18.8–40.5] 32.7 (4.5) [18.8–40.4] 32.6 (4.4) [18.8–40.5]
Requirement for translator for trial
purposes, n (%)
3 (1.3) 3 (1.3) 6 (1.3)
GPPAQ score, n (%)
2 (inactive) 144 (63.7) 149 (66.5) 293 (65.1)
3 (moderately inactive) 82 (36.3) 75 (33.5) 157 (34.9)
Participant’s perception of any medical reason(s) for referral to ERS – prevalence, n (%)
Prediabetes 8 (4.0) 15 (7.7) 23 (5.8)
Type 2 diabetes 47 (20.8) 42 (18.8) 89 (19.8)
Osteoarthritis 64 (28.3) 45 (20.1) 109 (24.2)
Weight loss 182 (80.5) 182 (81.3) 364 (80.9)
Low mood 122 (54.0) 121 (54.0) 243 (54.0)
High blood pressure 79 (35.0) 68 (30.4) 147 (32.7)
Ethnicity, n (%)
White 195 (86.3) 179 (79.9) 374 (83.1)
Black Caribbean 3 (1.3) 8 (3.6) 11 (2.4)
Black African 3 (1.3) 6 (2.7) 9 (2.0)
Black other 1 (0.4) 4 (1.8) 5 (1.1)
Indian 4 (1.8) 12 (5.4) 16 (3.6)
Pakistani 7 (3.1) 4 (1.8) 11 (2.4)
Bangladeshi 1 (0.4) 0 (0) 1 (0.2)
Chinese 0 (0) 0 (0) 0 (0)
Other 13 (5.8) 10 (4.5) 23 (5.1)
Relationship status, n (%)
Single 78 (34.5) 78 (34.8) 156 (34.7)
Married 97 (42.9) 110 (49.1) 207 (46.0)
Civil partnership 5 (2.2) 2 (0.9) 7 (1.6)
Divorced or dissolved civil partnership 35 (15.5) 25 (11.2) 60 (13.3)
Widowed or surviving civil
partnership
11 (4.9) 9 (4.0) 20 (4.4)
Domestic residence status (live with), n (%)
Live alone 59 (26.1) 48 (21.4) 107 (23.8)
Partner 120 (53.1) 130 (58.0) 250 (55.6)
Parent 11 (4.9) 13 (5.8) 24 (5.3)
Child aged < 18 years 66 (29.2) 67 (29.9) 133 (29.6)
continued
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TABLE 5 Baseline demographic and health-related characteristics of the sample (continued )
Variable Control group Intervention group Both groups
Child aged ≥ 18 years 39 (17.3) 53 (23.7) 92 (20.4)
Other family 10 (4.4) 8 (3.6) 18 (4.0)
Non-family 9 (4.0) 12 (5.4) 21 (4.7)
Education status, n (%)
No qualifications 52 (23.0) 29 (12.9) 81 (18.0)
GCSEs 146 (64.6) 162 (72.3) 308 (68.4)
A level 71 (31.4) 96 (42.9) 167 (37.1)
First degree 36 (15.9) 54 (24.1) 90 (20.0)
Higher degree 22 (9.7) 20 (8.9) 42 (9.3)
Other 108 (47.8) 104 (46.4) 212 (47.1)
Smoking status, n (%)
Smoker 34 (15.0) 32 (14.3) 66 (14.7)
Ex-smoker 90 (39.8) 89 (39.7) 179 (39.8)
Never smoked 102 (45.1) 103 (46.0) 205 (45.6)
IT literacy level, n (%)
Low 36 (16) 35 (16) 72 (16)
High 190 (84) 189 (84) 379 (84)
Site, n (%)
Birmingham 78 (34) 76 (34) 154 (34)
Glasgow 69 (31) 72 (32) 141 (31)
Plymouth 79 (35) 76 (34) 155 (35)
Participant-reported main reason for referral, n (%)
High blood pressure 19 (8) 18 (8) 37 (8)
Low mood 42 (18) 42 (19) 84 (19)
Osteoarthritis 27 (12) 26 (12) 53 (12)
Type 2 diabetes and prediabetes 24 (11) 25 (12) 49 (11)
Weight loss 114 (50) 113 (50) 227 (50)
A level, Advanced level; GCSE, General Certificate of Secondary Education.
TABLE 6 Baseline demographic and health-related characteristics of those included in the primary analysis
Variable Control group Intervention group Both groups
N 124 108 232
Gender, n male (%) 44.0 (35.5) 36.0 (33.3) 80 (34.4)
Age (years), mean (SD) [range] 52.1 (13.4) [18.0–74.7] 49.9 (12.9) [20.6–72.9] 51.1 (13.2) [18.0–74.7]
BMI (kg/m2), mean (SD) [range] 32.3 (4.3) [18.8–40.5] 32.6 (4.9) [18.8–40.4] 32.4 (4.6) [18.8–40.5]
Requirement for translator for trial
purposes, n (%)
0 (0.0) 3 (2.8) 3 (1.3)
TRIAL RESULTS: QUANTITATIVE RESULTS
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TABLE 6 Baseline demographic and health-related characteristics of those included in the primary analysis (continued )
Variable Control group Intervention group Both groups
GPPAQ score, n (%)
2 (inactive) 82 (66.1) 70 (64.8) 152 (65.5)
3 (moderately inactive) 42 (33.9) 38 (35.2) 80 (34.5)
Participant’s perception of any medical reason(s) for referral to ERS – prevalence, n (%)
Prediabetes 4 (3.7) 4 (4.3) 8 (4.0)
Type 2 diabetes 26 (21.0) 15 (13.9) 41 (17.7)
Osteoarthritis 40 (32.3) 22 (20.4) 62 (26.7)
Weight loss 100 (80.6) 84 (77.8) 184 (79.3)
Low mood 65 (52.4) 57 (52.8) 122 (52.6)
High blood pressure 47 (37.9) 38 (35.2) 85 (36.6)
Ethnicity, n (%)
White 109 (87.9) 95 (88.0) 204 (87.9)
Black Caribbean 2 (1.6) 3 (2.8) 5 (2.2)
Black African 2 (1.6) 3 (2.8) 5 (2.2)
Black other 0 (0.0) 0 (0.0) 0 (0.0)
Indian 1 (0.8) 3 (2.8) 4 (1.7)
Pakistani 4 (3.2) 0 (0.0) 4 (1.7)
Bangladeshi 0 (0.0) 0 (0.0) 0 (0.0)
Chinese 0 (0.0) 0 (0.0) 0 (0.0)
Other 6 (4.8) 4 (3.7) 10 (4.3)
Relationship status, n (%)
Single 40 (32.3) 37 (34.3) 77 (33.2)
Married 57 (46.0) 50 (46.3) 107 (46.1)
Civil partnership 3 (2.4) 2 (1.9) 5 (2.2)
Divorced or dissolved civil partnership 19 (15.3) 13 (12.0) 32 (13.8)
Widowed or surviving civil partnership 5 (4.0) 6 (5.6) 11 (4.7)
Domestic residence status (live with), n (%)
Live alone 30 (24.2) 29 (26.9) 59 (25.4)
Partner 69 (55.6) 58 (53.7) 127 (54.7)
Parent 6 (4.8) 6 (5.6) 12 (5.2)
Child aged < 18 years 39 (31.5) 26 (24.1) 65 (28.0)
Child aged ≥ 18 years 19 (15.3) 25 (23.1) 44 (19.0)
Other family 4 (3.2) 3 (2.8) 7 (3.0)
Non-family 3 (2.4) 6 (5.6) 9 (3.9)
continued
DOI: 10.3310/hta24630 Health Technology Assessment 2020 Vol. 24 No. 63
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
29
Accelerometer and questionnaire booklet return rates
Accelerometer and questionnaire booklet return rates are given in Table 7. Receipt of the baseline
accelerometer at the CTU was a prerequisite for randomisation; therefore, there is a 100% return rate
for this accelerometer.
At 12 months, 329 participants returned the accelerometer (return rate of 92%). The wear-time criteria
were met by 243 participants, this being 54% of those randomised (Table 8). At this time point, 325
participants returned the questionnaire booklet (return rate of 91%), that is 72% of those randomised.
In Table 8, purple shading denotes the number of participants meeting the wear-time criteria. A day
was ‘valid’ when the accelerometer was worn for ≥ 16 hours on that day. Participants who did not meet
the ‘valid’ criterion (n = 181) were 94 participants lost to follow-up prior to the 12-month time point,
60 participants who returned an accelerometer at 12 months but failed to meet the wear-time criteria
and 27 participants who remained in follow-up but did not return the accelerometer at 12 months.
TABLE 6 Baseline demographic and health-related characteristics of those included in the primary analysis (continued )
Variable Control group Intervention group Both groups
Education status, n (%)
No qualifications 29 (23.4) 11 (10.2) 40 (17.2)
GCSEs 84 (67.7) 83 (76.9) 167 (72.0)
A level 39 (31.5) 50 (46.3) 89 (38.4)
First degree 18 (14.5) 28 (25.9) 46 (19.8)
Higher degree 16 (12.9) 9 (8.3) 25 (10.8)
Other 59 (47.6) 49 (45.4) 108 (46.6)
Smoking status, n (%)
Smoker 13 (10.5) 12 (11.1) 25 (10.8)
Ex-smoker 52 (41.9) 51 (47.2) 103 (44.4)
Never smoked 59 (47.6) 45 (41.7) 104 (44.8)
IT literacy level, n (%)
Low 17 (13.7) 14 (13.0) 31 (13.4)
High 107 (86.3) 94 (87.0) 201 (86.6)
Site, n (%)
Birmingham 43 (34.7) 34 (31.5) 77 (33.2)
Glasgow 29 (23.4) 34 (31.5) 63 (27.2)
Plymouth 52 (41.9) 40 (37.0) 92 (39.7)
Participant-reported main reason for referral, n (%)
High blood pressure 10 (8.1) 10 (9.3) 20 (8.6)
Low mood 15 (12.1) 22 (20.4) 37 (15.9)
Osteoarthritis 18 (14.5) 13 (12.0) 31 (13.4)
Type 2 diabetes and prediabetes 14 (11.3) 10 (9.3) 24 (10.3)
Weight loss 67 (54.0) 53 (49.1) 120 (51.7)
A level, Advanced level; GCSE, General Certificate of Secondary Education.
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Losses to follow-up and non-compliance in returning the accelerometer were balanced across the two
trial groups. Failure to meet the wear-time threshold was less consistent across the two trial groups.
Intervention engagement
Table 9 shows the level of engagement in the various steps offered online.
The sample was evenly split, with 36% of participants not registering and logging in to e-coachER and
36% progressing through the support to record at least one goal review (i.e. having set a PA goal
review, the participant logged back in about 1 week later to record PA against the goal and obtain
feedback on the PA achieved against the goal set). Participants were routinely ‘locked out’ of accessing
the web-based support to ensure that they did not complete it in one or two visits to the website, and
then reminded by e-mail after 1 week to log in and continue with the steps and later record their PA in
minutes, set goals and review them. Reaching step 5 involved > 4 weeks of intervention engagement.
TABLE 7 Accelerometer and questionnaire booklet return rates
Time point
Sent to participant (n) Returned to CTU, n (% of sent)
Intervention Control Total Intervention Control Total
Accelerometer
Baseline 224 226 450 224 (100) 226 (100) 450 (100)
4 months 203 213 417 183 (90) 190 (89) 373 (89)
12 months 172 184 356 160 (93) 169 (92) 329 (92)
Questionnaire
Baseline 224 226 450 220 (98) 220 (97) 440 (98)
4 months 204 213 417 166 (81) 183 (86) 349 (84)
12 months 172 184 356 155 (90) 170 (92) 325 (91)
TABLE 8 Accelerometer wear-time compliance at 12 months
Number of valid weekdays
Number of valid weekend days
0 1 2 3 4 Total
0 181 181
1 3 2 2 7
2 1 4 5
3 7 6 5 18
4 6 10 31 47
5 5 30 77 16 2 130
6 2 49 7 58
7 4 4
Total 203 50 172 23 2 450
Shading shows the participants meeting the wear-time criteria.
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Among all participants allocated to the intervention group, the mean number of goal reviews was
2.5 (SD 4.5), with a range of 0–52. Among the 144 participants who registered for e-coachER, they
logged in for a mean and median number of times of 14.1 (SD 16.7) and 6, respectively, with a range
of 1–101. Of these participants, 81 (36%) completed a goal review; the mean and median number of
reviews was 14.4 (SD 13.8) and 4.5, respectively, with a range of 1–52.
Table 10 shows the mean, SD and median time spent during the respective stage (session) for the
144 participants who registered or 81 participants who completed at least one goal review. These data
come with the limitation that participants may have left their browser open after some sessions rather
than logging off, which leads to an overestimation of time spent. ‘n’ refers to the number of visits used
to estimate the descriptive data for the time in sessions 1–5, the number of visits when a goal was first
set and the number of sessions when a goal was reviewed.
On the basis that participants spent approximately 6 minutes logged in for steps (sessions) 1–5, and for
3 minutes for each goal review, for those 144 participants who registered, the total mean and median
time that participants spent on steps 1–5 was 24.1 (SD 5.9) minutes and 30 minutes respectively.
For those 81 participants who completed at least one goal review, the overall mean and median time
that participants spent doing goal reviews was 43.3 (SD 37.3) minutes and 21 minutes respectively.
The 144 participants who registered spent a total mean and median time of 48.4 (SD 41.9) minutes
and 36 minutes respectively. The range was 6–186 minutes.
TABLE 9 Intervention engagement
Stage started Summary of content
Number (% of 224 in
intervention group)
Did not register 81 (36)
Step 1 Quiz on benefits of PA 144 (64)
Step 2 Support to get active 133 (59)
Step 3 Encourage self-monitoring of steps 107 (48)
Step 4 Setting SMART step-count goals for next week 99 (44)
Step 5 Setting SMART goals for any PA for next week 96 (43)
Goal review Review goal and personalised feedback 81 (36)
Step 6 Ways to achieve goals/overcoming barriers (optional) N/A
Step 7 Overcoming setbacks (optional) N/A
N/A, not applicable.
TABLE 10 Descriptive data for time (minutes) spent engaging in the intervention
Status
Mean
(minutes) SD (minutes)
Median
(minutes) n
Visited steps 1–5 (from 144 participants who registered) 9.53 9.68 6.45 539
Goal-setting initial session (from 91 participants who set a goal) 7.81 7.54 5.92 91
Goal review session (from 81 participants doing ≥ 1 goal review) 4.75 5.25 3.18 1034
Total 6.47 7.45 4.08 1664
n, number of visits used to estimate the descriptive data for the time in sessions 1–5, the number of visits when a goal
was first set and the number of sessions when a goal was reviewed.
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Descriptive data for the primary and secondary outcomes by group and time
The descriptive statistics for the primary and secondary outcomes at baseline and 4- and 12-month
follow-up are shown in Table 11 for all participants who provided data.
The groups were well balanced at baseline. Only 4% of participants achieved at least 150 minutes of
accelerometer-recorded MVPA (in ≥ 10-minute bouts) over 1 week at baseline and the average weekly
minutes of MVPA (not in 10-minute bouts) was 49 minutes, which reflects our success in recruiting inactive
or moderately inactive participants with chronic conditions. In contrast, 80% achieved 150 minutes of
accelerometer-recorded MVPA without regard for ≥ 10-minute bouts at baseline. Cassidy et al.55 have also
shown lower levels of accelerometer-recorded MVPA minutes when data are processed using ≥ 10-minute
bouts compared with bouts of at least 1 minute. This proportion drops to 36% for self-reported MVPA,
reflecting the way that the 7-day Physical Activity Recall questionnaire (7-D PAR) measure focuses on
only discrete bouts of memorable MVPA. There were also no baseline differences between groups for
the EQ-5D-5L and the two HADS scales.
Descriptive data for PA and participant-reported outcomes are also shown in Table 11 for those providing
data at baseline, 4 and 12 months by trial arm, without controlling for baseline or other covariates.
TABLE 11 Summary descriptive data for primary and secondary outcomes at baseline and 4- and 12-month follow-up
Variable
Baseline 4-month follow-up 12-month follow-up
Control
group
Intervention
group
Control
group
Intervention
group
Control
group
Intervention
group
Primary outcome
Total weekly minutes of
MVPA in ≥ 10-minute bouts,a
n (mean); SD
201 (30.2);
105.8
207 (31.8);
53.7
128 (30.9);
64.5
109 (38.4);
74.5
133 (18.7);
37.6
110 (35.4);
78.3
Secondary outcomes
Average daily minutes of
MVPA,a n (mean); SD
201 (45.6);
35.6
207 (53.1);
35.9
128 (46.3);
37.8
109 (58.3);
35.9
133 (42.6);
30.1
110 (51.9);
36.6
Weekly achievement of at
least 150 minutes of MVPA
in ≥ 10-minute bouts,a
n/N (%)
8/201 (4) 9/207 (4) 2/128 (2) 7/109 (6) 3/133 (2) 6/110 (5)
Weekly achievement of at
least 150 minutes of MVPA,a
n/N (%)
149/201 (74) 178/207 (86) 98/128 (76) 99/109 (91) 99/133 (74) 93/110 (85)
Weekly achievement of at
least 150 minutes of MVPA
self-reported, n/N (%)
83/220 (37) 77/220 (48) 94/183 (51) 88/166 (53) 76/170 (45) 76/154 (49)
Average daily diurnal
inactivity (hours),a
n (mean); SD
199 (1.7);
1.1
205 (1.5);
1.1
125 (1.4);
1.1
109 (1.4);
0.9
99 (1.4); 1.0 78 (1.5); 1.0
Average daily sleep (hours),a
n (mean); SD
199 (6.8);
1.5
205 (6.9);
1.2
125 (6.7);
1.3
109 (6.7);
1.4
128 (6.8);
1.5
110 (7.0);
1.5
EQ-5D-5L (Devlin values),
n (mean); SD
216 (0.74);
0.24
215 (0.76);
0.23
162 (0.72);
0.26
148 (0.76);
0.25
158 (0.72);
0.26
138 (0.73);
0.27
HADS-D, n (mean); SD 217 (7.6);
4.5
214 (7.4);
4.7
164 (7.4);
4.8
147 (6.0);
4.7
156 (7.1);
4.8
139 (6.3);
5.1
HADS-A, n (mean); SD 217 (8.7);
4.6
214 (8.6);
5.1
164 (8.5);
4.8
146 (7.5);
5.0
156 (8.4);
4.8
139 (7.6);
5.2
HADS-A, HADS anxiety score; HADS-D, HADS depression score.
a Fulfil the criteria of includable PA data.
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Qualitatively, the intervention group was more active than the control group at 4 and 12 months for
all primary and secondary outcomes. The intervention group also qualitatively had higher well-being
(EQ-5D-5L) and lower depression and anxiety scores than the control group at 4 and 12 months.
Primary outcomes
The primary outcome, ITT complete-case analysis showed a weak indicative effect in favour of the
intervention group in the primary outcome at 12 months (mean difference 11.8 weekly minutes of
MVPA, 95% CI –2.1 to 26.0 minutes; p = 0.10) (Table 12). A plot of the repeated-measures model
estimates for the primary outcome over time for the intervention and control groups is shown in
Appendix 3. Although the alternative model p-values varied somewhat, a similar pattern of results was
seen across alternative post hoc models. In interpreting these results, it is important to recognise the
limitations of all these models: lack of fit of the predefined primary and post hoc models, and the need
to assume data as counts with both negative binomial and zero-inflated binomial models.
The results of the CACE analysis for the primary outcome were consistent with the ITT results
(Table 13). In other words, when controlling for whether or not intervention participants completed a
prespecified ‘dose’ of the intervention [i.e. they completed a goal review (reached step 5)], this made no
difference to the findings, but qualitatively the difference between the intervention and control groups
did appear to be larger (in favour of the intervention).
TABLE 13 Complier-average casual effect analysis of the primary outcome at 12 months
Variable
Between-group difference, n, mean difference
(weekly minutes) (95% CI); p-value
Total weekly minutes of MVPA in ≥ 10-minute bouts 232, 22.9 (–3.4 to 47.8); 0.09
Model adjusted for stratification variables age, gender, baseline scores and random effects for site, and fulfil the
criteria of includable PA data.
TABLE 12 Comparison of intervention and control groups: primary analyses
Primary outcome
Primary analysis Secondary analysis
ITT complete-case comparison at
12 months, n, coefficienta (95% CI);
p-value
ITT imputed
comparison at
12 months
Complete-case comparison at
all follow-up points, p-value
for interaction between
intervention effect and time
Total weekly minutes of
MVPA in ≥ 10-minute
bouts
232, 11.8 (–2.1 to 26.0); 0.10b Not calculated 0.63
223, 2.5 (–5.8 to 10.7); 0.55c
232, 1.2 (0.8 to 1.5); 0.27d
232, RR 1.90 (0.90 to 4.00); 0.09e
232, RR 1.59 (1.13 to 2.25); 0.01f
RR, rate ratio.
a Mean difference in weekly minutes unless otherwise stated.
b Primary analysis mixed-effects model (mean difference).
c Post hoc model 1 with outliers (> 200) dropped (mean difference).
d Post hoc model 2 log with a constant of 5 added (exponentiated mean difference).
e Post hoc model 3 negative binomial model (RR).
f Post hoc model 4 zero-inflated negative binomial model (RR).
Models adjusted for stratification variables age, gender, baseline scores and random effects for site, and fulfil the
criteria of includable PA data.
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As Table 14 shows, there was no evidence of any interactions between stratification variables and age
and gender with the intervention effect for the primary outcome at 12 months. The ITT complete-case
model was adjusted for stratification variables age, gender and baseline scores, and random effects for
site and fulfil the criteria of includable PA data.
Table 15 shows the descriptive data for participants included in the primary analysis (n = 232). Data
shown for the 4-month assessment are from participants who were included in the primary analysis
and also had complete data at 4 months. The intervention group had qualitatively greater mean weekly
minutes of MVPA than the control group at baseline.
An analysis of complete data available at both baseline and 4 months (Table 16) shows that the control
group significantly increased MVPA up to 4 months, whereas the intervention group did not. Between
baseline and 12 months, there were no changes in either group, although qualitatively the control
group had reduced their MVPA.
TABLE 14 Subgroup analyses of the primary outcome at 12 months
Variable Interaction p-value Subgroup coefficient (95% CI)
Age 0.10 –0.9 (–1.2 to 0.2)a
Gender 0.91
Male 16.7 (–5.2 to 38.7)
Female 10.3 (–7.8 to 17.9)
Trial site 0.20
Plymouth 4.3 (–15.2 to 23.9)
Birmingham 19.4 (–9.8 to 48.8)
Glasgow 9.0 (–9.8 to 27.8)
Participant’s perception of main medical referral reason 0.33
Control diabetes 11.9 (–0.1 to 24.1)
Weight loss 7.3 (–9.5 to 24.2)
Lower blood pressure 20.6 (–5.9 to 27.2)
Manage lower limb osteoarthritis symptoms 21.1 (–8.1 to 32.2)
Manage mood/depression 25.1 (–32.4 to 82.7)
IT literacy level 0.59
Lower confidence 2.3 (–6.4 to 11.0)
Higher confidence 13.5 (–2.2 to 29.2)
a Per year of age increase.
TABLE 15 Accelerometer-recorded mean weekly MVPA minutes (in ≥ 10-minute bouts) among participants with
complete data at baseline and at 4 and 12 months
Variable
Baseline 4 months 12 months
Control
group
Intervention
group
Control
group
Intervention
group
Control
group
Intervention
group
MVPA minutes (in ≥ 10-minute
bouts), n, mean (SD)
124, 22.6
(60.0)
108, 33.5
(53.8)
95, 31.7
(67.3)
77, 41.8
(82.4)
124, 17.6
(35.4)
108, 36.1
(78.9)
Data from participants included as per primary analysis with 232 participants providing data at baseline and 12 months
and, of these, from the 172 who provided data at 4 months.
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Secondary outcomes
Results of the complete-case imputed ITT and repeated-measures analyses (including both 4- and
12-month follow-ups) for the PA secondary outcomes appeared consistent with the analysis for the
primary outcome (see Table 12). As Table 17 shows, there were no significant between-group
differences in ITT complete-case analyses for any of the secondary outcomes at 12 months.
TABLE 16 Changes in mean weekly MVPA minutes (recorded in ≥ 10-minute bouts) in both trial groups from baseline to
follow-up assessments
Variable
Mean difference, n, mean (SD) [95% CI]; p-value
Control group Intervention group
Baseline vs. month 4 118, 8.2 (32.1) [2.4 to 14.1]; 0.006 105, 6.4 (68.1) [–6.7 to 19.6]; 0.334
Baseline vs. month 12 124, –5.0 (52.2) [–14.3 to 4.3]; 0.288 108, 2.6 (74.5) [–11.6 to 16.8]; 0.721
TABLE 17 Comparison of intervention and control groups: secondary outcome analyses
Variable
Primary analysis Secondary analysis
ITT complete-case comparison
at 12 months, n, coefficienta
(95% CI); p-value
ITT imputed comparison at
12 months, n, coefficienta
(95% CI); p-value
Complete-case
comparison at all
follow-up points,
p-value (for interaction
between intervention
effect and time)
Average daily minutes
of accelerometer-
recorded MVPA
232, 1.9 (–3.8 to 7.7); 0.51 Not calculated 0.68
Weekly achievement
of ≥ 150 minutes of
accelerometer-recorded
MVPA in ≥ 10-minute
bouts
232, OR 3.80 (0.16 to 20.92);
0.12
Not calculated 0.03
Weekly achievement
of ≥ 150 minutes of
accelerometer-recorded
MVPA
232, OR 1.67 (0.82 to 3.42);
0.16
Not calculated 0.23
Weekly achievement
of ≥ 150 minutes of
self-reported MVPA
324, OR 1.23 (0.79 to 1.90);
0.36
450, OR 1.55 (0.99 to 2.42);
0.05
0.39
Average daily diurnal
inactivity
226, 0.6 (0.5 to 0.7); < 0.0001 Not calculated 0.66
Average daily sleep 226, 0.3 (–0.1 to 0.6); 0.11 Not calculated 0.18
ERS attendance 446, OR 1.13 (0.72 to 1.79);
0.58
450, OR 1.09 (0.70 to 1.71);
0.70
–
EQ-5D-5L Devlin
measure
290, 0.00 (–0.4 to 0.05); 0.89 450, 0.01 (–0.03 to 0.04);
0.70
0.99
HADS-D 289, –0.2 (–1.0 to 0.6); 0.44 450, –0.2 (–0.9 to 0.6); 0.63 0.02
HADS-A 289, –0.5 (–1.2 to 0.2); 0.20 450, –0.2 (–1.0 to 0.5); 0.52 0.05
OR, odds ratio.
a The coefficient is mean difference unless otherwise stated.
Models adjusted for stratification variables age, gender, baseline scores and random effects for site, and fulfil the
criteria of includable PA data.
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The ITT imputed comparison at 12 months showed that the intervention group had a greater proportion
of participants achieving ≥ 150 minutes of self-reported MVPA (p = 0.05) than the control group.
In the repeated-measures analyses (including both 4- and 12-month follow-ups), a greater proportion
of intervention participants achieved ≥ 150 minutes of accelerometer-recorded MVPA (in ≥ 10-minute
bouts) than control group participants. As Table 11 shows, 2% and 6% of the participants achieved this at
4 months in the control and intervention groups, respectively, and 2% and 5% at 12 months, respectively.
There were no significant between-group differences in the ITT complete-case or imputed comparison
analyses for EQ-5D-5L scores or for the HADS anxiety and depression scores at 12 months. In complete-
case repeated-measures analyses (including both 4- and 12-month follow-ups), the intervention
participants reported lower depression (p < 0.05) and anxiety (p = 0.05) scores than the control group.
Exercise referral scheme uptake was derived from records held by the ERS service provider, with
imputed participant-reported attendance at 4 weeks and/or 4 months where the ERS service data
were missing. Data were not available via any of the three sources for four participants (control group,
n = 3; intervention group, n = 1), resulting in 223 participants in each group with ERS uptake data.
A total of 173 participants (78%) in the control group attended the ERS at least once, compared with
167 participants (75%) in the intervention group.
Adverse events
In total, 42 SAEs were reported among 35 participants (see Appendix 4), which were all deemed to
be either ‘not related’ or ‘unlikely to be related’ to the trial. In the control group there were 26 SAEs
among 21 participants and in the intervention group there were 16 SAEs among 14 participants. One
SAE was reported as a life-threatening event (asthma attack) and all other SAEs were hospitalisations.
SAEs were consistent with the patient population.
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Chapter 4 Mixed-methods process evaluation
This chapter presents the findings from both qualitative and quantitative methods and brings the twotogether to help understand and explain the findings from the main analyses presented in Chapter 3.
Introduction
The overarching aim of the e-coachER trial was to determine whether or not adding support to usual
ERS would be more clinically effective and cost-effective than usual ERS alone for supporting increases
in PA in inactive patients referred to an ERS with a range of chronic conditions. The qualitative part of
this chapter will explore participants’ and e-coachER researchers’ views and experiences of the support
package and how it did or did not contribute to changes in PA. The quantitative part of the chapter will
seek to understand if specific survey process measures were changed by the intervention, compared
with usual ERS, as predicted from our logic model (Figure 5). Finally, we explore whether or not
changes in the process outcomes mediated intervention effects on the primary outcome.
Previous research has quantitatively and qualitatively explored the barriers to and facilitators19,56 of
engaging in ERS, and the moderators of ERS engagement.15,57,58 The e-coachER intervention was designed
to help overcome many of the reported barriers to, and enhance the use of facilitators of, attending
ERSs, becoming physically active in other ways, or both, through this primary care-based intervention.59
The e-coachER intervention is theoretically underpinned by self-determination theory,31 which asserts that
all humans possess three innate basic psychological needs (i.e. autonomy, competence and relatedness).
When met, these needs foster intrinsic motivation resulting in personal growth and satisfaction. A range
of behaviour change techniques35 based on self-determination theory were employed within e-coachER’s
seven ‘steps to health’ (see Table 1), so this process evaluation seeks to establish whether or not the
intervention influenced basic psychological needs and behaviour change processes.
A mixed-methods process evaluation seeks to best understand how participants engaged in the
intervention (and trial methods) and what the consequences were with respect to our logic model.
Qualitative process evaluation
The logic model shown in Figure 1 has been adapted to show the causal pathways proposed to
contribute to behaviour change and intervention outcomes and the objectives for the qualitative work
(see Figure 5).
Aims and objectives
The qualitative interviews primarily aimed to explore how participants experienced and engaged with
the e-coachER intervention.
The objectives were to explore:
1. whether the impact of the intervention is moderated by medical condition, age, gender,
socioeconomic status, IT literacy or ERS characteristics
2. the mechanisms through which the intervention may have an impact on the outcomes.
The implementation and delivery of the trial and recommendations for future research in this area
were also explored with participants and with the trial research assistants, who provided their views
on e-coachER and their role in the study.
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Methods
Recruitment
Semistructured interviews were originally planned with a purposeful sampling framework (considering
gender, age, underlying health condition and trial site). The trial sample size was subsequently reduced
with a corresponding reduction in the number of interview participants and a change to focus the
sampling from across the three sites. All participants who had logged on to the website (at least once)
were approached by the CTU team to take part in a qualitative interview. Those expressing an interest
were then telephoned or e-mailed by the researcher (NC or RT), who explained the interview purpose
and process. Participants were invited to take part in an initial interview and to give permission to
be contacted for follow-up telephone interviews (up to three were planned) over the course of the
intervention period. Participants provided informed consent to participate in the qualitative interview
(in addition to prior consent to take part in the RCT). As most interviews were carried out by telephone,
Intervention
components 
Initial package includes
free pedometer, fridge
magnet and access to
e-coachER (a website
to promote PA via
specific BCTs):
• Step 1: information
    about physical and
    mental health
    consequences –
    understand benefits
    of exercise and PA
    goal-setting. How to 
    manage  setbacks
• Step 2: social support –
    seek support from
    friends and families/
    exercise coach to
    implement and
    maintain PA regimen
• Step 3: self-monitoring
    of behaviour –
    monitor steps/PA
• Step 4: goal-setting –
    set weekly step and
    PA goals
• Step 5: action-
    planning –
    making plans to
    achieve goals
• Participants’ engagement with e-coachER may be moderated by participant
    sociodemographic and health characteristics, type and location of ERS and
    relationship with ERS coach
• Participant motivation and PA might also be moderated by the same contextual
    factors
• Quantitative data on contextual factors from questionnaires in both trial arms
• Qualitative interviews with intervention group only (objective 1)  
Intervention
delivery 
• Participants
    progress through
    e-coachER
• Quantitative data 
    on BCT delivery in
    intervention arm
    (via LifeGuide)
• Qualitative data
    on participant
    experiences in
    intervention arm
    (objectives 1 and 2)  
Feedback loop
• Increased use of website and BCTs, motivation,
    achievement of PA goals reinforce each other
    (e.g. motivation is enhanced as levels of PA increase)
• Quantitative modelling of interactions in one or
    both arms
• Qualitative data on these interactions (objective 2) 
Changes to motivation
and behaviour 
• Participant motivation for PA
    is mediated by autonomy,
    competence and relatedness
• Participant autonomy,
    competence and relatedness
    are enhanced by using the
    website and implementing
    BCTs 
• Quantitative measures
    of autonomy, competence
    and relatedness in both 
    trial arms
• Qualitative data on processes
    of change in intervention arm
    (objective 2) 
Long-term
outcomes
• Health and
    economic
    benefits
• Quantitative
    outcome
    data in both
    trial arms,
    including
    weight and
    quality of life
Short-term
outcomes
• MVPA
    increases,
    sedentary
    time
    decreases
• Quantitative
    outcome data
    in both trial
    arms
Context
FIGURE 5 The e-coachER logic model, adapted to show relationship with qualitative research objectives. Reproduced
with permission from Ingram et al.1 This is an Open Access article distributed in accordance with the terms of the
Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this
work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
The figure includes minor additions and formatting changes to the original.
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the informed consent form for the qualitative interview component was read point by point to the
participant and signed by the researcher. Interviews were recorded, transcribed verbatim and anonymised.
Interviews with researchers at each research site were carried out following the completion of recruitment.
Interviews
Interviews with participants
Interviews were conducted at different stages of participation in the trial as it was anticipated that
not everyone allocated to the intervention would progress through all of the steps to health. Each
individual was invited to participate in an interview and further follow-up interviews, which enabled
interviews to be conducted over the whole duration of the e-coachER intervention period (with online
support available for up to 12 months).
The interview topic guide for participants (see Appendix 5) focused on each of the steps to health.
Participants were also asked for their views on the welcome pack, the overall online support and the
pedometer. Participants were asked to identify if and how they thought e-coachER provided support
for ERSs, and for maintaining PA over and above attending their ERS. Participants were also asked to
put forward any suggestions to improve or modify e-coachER.
The topic guide was also designed to gauge the participant’s development of self-regulatory skills
(e.g. self-monitoring, goal-setting) and the extent to which the intervention enhanced a sense of
autonomy (control), competence and relatedness. However, these terms were not used explicitly;
instead, the researchers used their knowledge of the guiding principles of the e-coachER intervention
to prompt the participant to expand on their responses to the broader topic guide questions.
Interviews with research assistants
The interview topic guide (see Appendix 5) focused on exploring issues surrounding the delivery of the
trial, including recruitment and an exploration of processes that worked well, and what and where
improvements could be made.
Analysis procedure
Interviews were audio-recorded, transcribed verbatim and anonymised, with any personal data or
ways of identifying participants removed. Transcripts were imported into NVivo 11 (QSR International,
Warrington, UK) for data management and coded by one researcher (Rohini Terry) following an initial
period of coding by Nigel Charles. A thematic analysis was performed to identify key findings, initially
focusing on ‘top-level’ themes reflected in the logic model (see Figure 5). Additional in-depth analysis
took place to further explore the data. Rohini Terry, Jeffery Lambert and Sarah Dean discussed the
emerging codes and themes, and a consensus about these was reached. More in-depth analysis was
also undertaken, and this will be fully reported in a forthcoming manuscript as the main publication
arising from the qualitative research. Results are reported to (1) address the objectives and (2) give
the findings emergent from the data.
Results
Participant sample and interviews
Of the 144 participants approached for interview, 36 participants (25%) expressed an initial interest in
taking part. Thereafter, six participants who had initially expressed an interest did not respond to the
invitation for interview. It was not possible to make contact with a further three participants. Hence,
27 participants (18%) who had logged on to e-coachER at least once were recruited to take part in the
qualitative interview. Nineteen participants completed a single interview. Seven participants completed
more than one interview several weeks apart, with one participant completing four interviews, three
participants completing three interviews and three participants completing two interviews. Therefore,
38 interviews were carried out in total, each lasting between 16 and 80 minutes; the average interview
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length was approximately 48 minutes. In total, 11 participants from Plymouth, nine participants from
Birmingham and six participants from Glasgow took part in a qualitative interview. Participants had
logged on to e-coachER at least once. The majority had progressed to the point that they were
automatically locked out of the website for the first time (i.e. prior to step 2). At the time of the initial
interview being conducted, participants may not have engaged with or progressed through all of the
steps to health. Interviewing at these points, and as participants progressed through the steps, was
intentional as it was important to obtain the experiences of those who did not progress as well as
those who did. Interviews were also conducted with three research assistants, one from each site.
Table 18 provides a summary of interviewed participant demographics: gender, health condition, age,
confidence using internet/IT, geographical location and access to IT facilities.
Exploring the extent to which the impact of the intervention is moderated by
medical condition, age, gender, socioeconomic status, information technology
literacy or exercise referral scheme characteristics
A number of factors were identified as possibly affecting participant engagement with e-coachER
and/or the impact of the intervention. These reasons included ill health, issues related to time and
other issues specific to the individuals’ circumstances.
In some cases, illness and comorbidities (e.g. stroke) made it harder for participants to fully engage
with e-coachER:
I have put some goals in there, erm, but as I think I hope you are aware, erm, I had a stroke a while ago,
about 10 weeks ago, erm, so I’m being a bit slow, a bit cautious at the moment and I’m not going to,
I can’t think of the word, erm, I’m not making my goals too high.
P09
TABLE 18 Characteristics of participants (n = 26) involved in interviews
Characteristic Category
Gender (n) Female 20
Male 6
Health condition (n) Weight loss only 5
Weight loss plus other morbidities but not low mood 4
Weight loss and low mood only 7
Low mood only 2
Low mood and other morbidity but not weight loss 1
Weight loss plus low mood and other morbidities 5
No low mood, not weight loss, other physiological conditions 2
Age range (years) Female 28–69
Male 39–72
Confidence using internet/IT (n) Low 0
High 26
Participants at each research site (n) Plymouth 11
Birmingham 9
Glasgow 6
Access to IT facilities (n) Home/work access/mobile 22
Mobile not home access 3
Public only, not mobile access 1
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For some participants, other unexpected life events made it difficult to engage with or experience
benefits from e-coachER:
Yeah I mean, again, I had the motivation to do it it’s just I’ve had things going on that have forced my
hand into stopping. But now I have, I do genuinely have the intention to restart and keep it up definitely
. . . I have an illness and a loss in the family . . . It’s stopped everything in all honesty . . . Everything in my
life . . . Has been ground to a halt virtually.
P08
By contrast, other participants found that, if their health condition had a negative impact on their
motivation or ability to exercise, e-coachER provided reassurance and fostered their sense of competence:
In a way that’s saying look you haven’t achieved everything that you said you were going to that’s fine,
but there are reasons for it and do you know what, that’s OK. If you’re too sore that you couldn’t do it.
If you’re ill you couldn’t do it. You know if you were in a particularly low mood that day like if you’re in
a low mood ‘here’s a little bit of information for you’ and that little bit of information on the low mood,
I suffer from depression so the low mood one is really part of it.
P05
Access to IT facilities was generally good, and participants had high levels of confidence using
the internet. A number of participants reported IT-related difficulties that may have an impact on
e-coachER engagement and use and some felt that other apps or similar support provided more in
terms of functionality:
I didn’t feel it was that user friendly especially ’cos I had used, sort of, [a commercially available app]
and things like that in the past. And as I was comparing the two, sort of, the design of it I didn’t find
e-coachER that great just the white and the green. I also was using the [a commercially available app]
and I found that one a lot better because I was able to keep track of exactly what I was doing in a lot
more of an easier way than that.
P22
Exploring the mechanisms through which the intervention may have an impact on
the outcomes
Most participants found that e-coachER was an easy-to-understand, flexible and supportive resource:
. . . it’s [the e-coachER website] given me support as well and there’s always, as I say, sometimes there’s
information there to look at. . . . it’s changed my attitude to exercising because, as I say, I was not very
eager to do it but now I’ve done it and I’m enjoying it and I have enjoyed it from the start because it’s
just I’ve seen the results basically and that’s really given me a boost.
P02
Most reported the package, or aspects of it, to be of some utility, for example acting as a prompt to
increase PA:
I suppose really it is a reminder to actually do it.
P13
The e-coachER intervention was also described as providing an ‘incentive’ (P02), ‘a bit of a lift’ (P09) or
a ‘pat on the back’ (P11) and that simply having access to e-coachER was motivating:
My initial issue was the motivation and confidence that were missing to go and get started, which
e-coachER has been very instrumental in and then once I was started now I’ve got that and I’ve got the
benchmark of doing this.
P16
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The goal-setting aspects of the e-coachER support package, particularly in conjunction with the
pedometer and setting step-count goals, using either the e-coachER website or the tear-off slips on the
fridge magnet, were particularly important components of the package. They acted as a catalyst in
helping participants consider new ways to increase their PA:
. . . fascinating . . . Erm, well just really interesting to find out what I do every day and if I do, do
something different what impact that has, what the result of that is and it does encourage me to think,
erm, right I’ll get up and go and do whatever, anything, erm, and it makes me think in a different way
about doing things.
P09
A, erm, and it makes me think in a different way about doing things because, for instance, my doctor’s is,
err, a bus ride, it’s awkward for me to say to my family ‘can you take me?’, I’m sort of now starting to
think since I’ve got a bit more energy, my, erm, my legs are working better if you like, I’m starting to think
along the lines of, well I can catch a bus and then walk the rest of the way, I don’t need somebody to take
me and it will, that will certainly increase my steps . . .
P09
Although the aim of achieving or exceeding step goals was motivating, the desire to avoid not meeting
these goals was also motivating and participants would set their goals to avoid feelings of failure
and/or guilt, with one participant using paper-based goal-setting to avoid setting goals online
with e-coachER:
Yeah, about, like, I say, like, you keep them realistic don’t you? So you don’t, you don’t set yourself up
to fail.
P04
I haven’t as yet put anything down on e-coachER, simply because I put down on a piece of paper what I
hope to do on a given week and failed miserably to do them so I thought I didn’t want to start to put
them down, erm, until I knew that they were reasonable goals that could be achieved, not pipe dreams
that have got no chance of being achieved.
P01
Participants generally felt that e-coachER provided a reminder to think about being more physically
active, for example from the fridge magnet with tear-off PA-recording strips and use of the pedometer:
Every day I, well at the end of every day, I look at the pedometer and say ‘oh OK you’ve exceeded
your goal’.
P04
It’s just it’s another tool that you can use to, you know, either monitor or encourage or, you know,
everyone works differently I suppose and I didn’t, what I needed was something concrete, goal-wise, to do
and to achieve and like I say, you know, once I’d set that goal then and if I don’t reach it well shame on
me kind of thing.
P16
However, it became clear these aspects of the intervention were often used only initially and then
some people switched to using their phones or other devices to record activity:
I would say so, even though I’m not doing it on the, erm, website now ’cos I monitor my step counts
through my phone.
P15
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Some participants felt that the e-coachER package was instrumental in helping to ameliorate any
feelings of guilt experienced when participants perceived their efforts to increase PA were in some
way unsatisfactory. For example, the reiteration that failing to meet set goals is normal and something
that should be expected, which occurred later in the steps to health (the ‘slips, trips and falls’), was
particularly helpful for some:
Being someone who suffers from depression, I understand about triggers and setbacks . . . But you know
this part of the system is explaining to you that it’s OK, don’t worry about it, there are always going to be
times in your life where you’re not going to be able to do this and you shouldn’t beat yourself up too
badly about it.
P01
Participants reported that being able to choose their preferred level of engagement with e-coachER
was a valuable feature and allowed participants autonomy over their exercise choices:
Oh, [I would] definitely recommend it. Like I say, I know that I haven’t engaged with it as well as I could
have but the point still stands that it was instrumental in that motivation at the beginning of going and
doing it and doing exercise referral and setting those goals and trying to maintain achieving those goals
each day and then obviously upping them and it’s definitely worth it.
P16
Use of e-coachER also had the potential to help participants to develop or expand social networks
conducive to augmenting PA:
It gives you different tips and tells you who to ask and different sites to get in touch with. I went to an
osteoporosis meeting and they do an exercise thing and you can actually become a teacher with a
qualification eventually but, like I say, I can’t do anything like that at the moment. . . . they give monthly
talks and they have someone come to visit to give a talk who works and specialises in osteoporosis and
. . . and they do an exercise group once a week. . . . so it’s quite good really.
P06
However, many participants felt that they already had an adequate social support network:
I’ve already got quite a good support network, so I just utilised my work colleagues.
P14
Improvements to e-coachER
Many participants felt that e-coachER could offer more in terms of functionality and that it did not
provide as much information or as many features as could readily be obtained from other ‘app’-based
packages. For example, some participants felt that the package was not interesting or did not provide
enough information and some were disappointed by these shortcomings. Some felt that e-coachER did
not work in the way that they had expected, or were frustrated by being locked out of the website
rather than being able to progress on to the next stage when they were ready to do so:
I think you know, erm, the website is useful, erm, albeit frustrating at times but once . . . I get past
step 7 I might have a different view about that because I won’t be locked out then or I would think not,
I don’t know.
P12
Others found that the e-coachER website was ‘not that inspiring’ (P12) or ‘drab’ (P03) and one participant
referred to it as ‘death by PowerPoint’ (P04). A number of participants described the website or aspects
of it as ‘confusing’ (P02), ‘annoying and irritating’ (P07) or not ‘smart’ enough (P04). Participants went on
to offer suggestions for improvements to e-coachER, which are summarised in Table 19.
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TABLE 19 Suggestions for improvements to e-coachER
Topic
Summary of problem and/or suggestions
for improvements Participant quotations
Welcome pack The lack of language options in the
information pack and the lack of options
regarding disabilities was highlighted
I don’t see any foreign language on it. In
terms of diversity I don’t see any Arabic,
Chinese, Punjabi erm . . . Whatever so you
can have this leaflet in X, Y or Z
P04
Although straightforward in terms of ease
of understanding and clarity, some felt
that it did not look interesting or engaging
User manual should be made more visual
. . . It didn’t inspire me to turn the page . . .
It is I mean it’s not a huge criticism when
I say that, I don’t mean that as it perhaps
sounds it’s not a huge criticism, it is a bit
dull . . . I mean I read it because I had to
but I didn’t enjoy it, erm, and you know,
I wonder if how many people are skipping
over it
P05
. . . I suppose really it’s got to be generic
but . . . if you’re a woman I would like it,
sort of, a little bit more interesting just . . .
it just may be needed to be a little bit
more eye-catching I think I’m trying to say
P18
Website design, logging
on, access and navigation,
and lock-out
Although many found that the e-coachER
website was easy to navigate and use,
many found the layout of the package and
being logged out at certain predefined
points frustrating and found navigation
difficult and restrictive
. . . I thought it would be very helpful if you
could see what every stage was and then go
back to where you were rather than having
the situation where you’re in a stage and you
can’t go onto the next one. . . . but at the
moment of course you can’t move on
without being locked out . . . with the
website, you know, I’m not technically in
control of what’s on the other end so it’s sort
of going in and having a good look round
and seeing what you can and can’t do
P01
More tailored website was suggested
(e.g. could be split up into different
categories of condition for referral)
I think at the front end of the e-coachER
it might be a wider remit and then take it
out from the tree stem and then branch
off so that if it’s obesity you can look at
different goals, if its diabetes again and if
its mental health but it’s splitting them up
from each other
P04
A minority of participants experienced
IT-related problems, logging on, passwords,
accessing e-coachER, etc. These were
not difficult to resolve and logging on
was straightforward for most. Some
commented that logging on could have
been made easier as participants had to
go through the original e-mail link. Some
felt that further developments regarding
mobile access would have improved
e-coachER. Some differences in the
experience of e-coachER using different
platforms [e.g. one participant reported
not being able to access links using an
iPad (Apple Inc., Cupertino, CA, USA)]
So I think again that would be something
to say if you are having trouble if you use
I don’t know iPads, Mac [Apple Inc.,
Cupertino, CA, USA] other things just click
on the link and it will take you to it
P04
It was suggested that ‘well you’ve got
to do it through Microsoft [Microsoft
Corporation, Redmond, WA, USA], you’ve
got to do it through this, you’ve got to do it
through that’ . . . I don’t know if it would
actually work with a Mac
P04
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TABLE 19 Suggestions for improvements to e-coachER (continued )
Topic
Summary of problem and/or suggestions
for improvements Participant quotations
Stage 1 quiz Many felt that the quiz did not offer new
information
No, I mean I’m not putting myself up as a
genius but some of it is at quite simplistic level
P03
Erm, going through the quiz saying, you know,
‘did you realise that’, ah, but you know ‘if you
did this’, it did feel rather high school-ish
P05
Stage 2 links to finding
support
Some found links for external and
additional support out of date or
irrelevant. Although some found the links
thought-provoking, few directly benefited
from using these links
Some of the information that I was looking
at was actually dated for last year and all
the classes weren’t up to date
P18
Pedometer The pedometer did not always tally with
other devices
The pedometer seemed to just do its own
thing. It stopped logging them properly . . .
again the next day it was the same sort
of thing
P06
Some found that the pedometer was
difficult to open; some found that it was
difficult to wear
The other thing I’ve found quite tricky was
getting it placed properly . . . Sometimes it
was a bit uncomfortable
P04
I am using my own [fitness tracker]
anyway just purely because I think I said
to you before with the pedometer it
suggests that you put it on your waistband
well women and maybe for men I don’t
know, don’t always wear things that are
suitable for the pedometer and so it would
be easier if you could use whatever other
means you have, if you have that
P24
Entering step count onto
e-coachER website
Inputting steps on the website required
participants to round up or round down,
which may negate the message perceived
by many that ‘every little bit helps’. Some
felt that the step count should accurately
reflect the number of steps achieved
I think it would be quite useful if you could
put in the actual steps you’ve done rather
than, erm, rounding it to the 500. Because I,
well this morning, I put mine in and I’m a very
honest person and if I’ve only done 3200 I’m
not going to put in 3500. I’m going to put in
3000 but that in itself can be a little bit, erm,
disappointing because you think well actually
I’ve done a bit more than that
P09
Reminder e-mails Did not factor highly as a necessary
component of e-coachER; some found that
these reminders were unhelpful or did not
reflect their actual engagement
Erm, well I’ve been logging in every few
days but, erm, apparently I kept getting
e-mails to say, erm, where have I been and
‘it’s been 4 weeks since we heard from you’
P06
The next day I’ll get one ‘oh we noticed
you haven’t logged in for 1 week’ and what
would help is perhaps when one sets one’s
goals that a date was inserted so there’s no
argument about that
P03
continued
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e-coachER as a support for exercise referral scheme use and uptake or as an
alternative to exercise referral schemes
The aim of the e-coachER package was to support and enhance the uptake of ERSs:
And I think what . . . e-coachER did was it acted like a prompt. So, I suppose in terms of my own
personality I don’t like to let people or anybody down so if I had an appointment with the practitioner
I would make sure I got there or try my damnedest you know what I mean.
P19
TABLE 19 Suggestions for improvements to e-coachER (continued )
Topic
Summary of problem and/or suggestions
for improvements Participant quotations
Later steps: setting goals
and dealing with setbacks
Later steps used less frequently. Those
who engaged with the later stages of
e-coachER found that goals were not
always saved
What I found frustrating . . . it completely
wiped what I’d put the week before . . .
for me once I get into the routine I can
generally do the same activities just adding
more in and virtually review them but you
have to input absolutely everything again
plus the extra stuff that you were doing
that week. And I don’t I think, you know, it
wouldn’t take much for that information to
pull through and you just amend it. Rather
than rewrite it each week and if you’re
going to set up completely new goals that’s
absolutely fine but actually, you know, you
should be able to, it would be better to
pull it through and amend it . . .
P14
One participant suggested that support
regarding ‘slips, trips and falls’ may be
better placed at an earlier step
Goal-setting sections could be more
‘inspirational’
That message coming at the end if you
like although I know it’s not the end of
e-coachER but it’s the end of the steps.
If it was in earlier . . .
P13
It’s good to have inspirational stuff to help
you along . . . It wasn’t inspirational in any
way the [web]site, you know, because
you can have goals and you can have
inspiration, sort of, pushing you towards
the goals
P07
General Lack of interaction with health
professional or ‘real person’
Yes, yeah maybe, I don’t know, 2 or 3 weeks
or even 4 weeks down the line, you know
a conversation with somebody just even if
it’s just to see how they’re getting on. ‘How
are you getting on, how are you finding it?’
. . . if somebody is struggling and they’ve
thought ‘oh no I can’t do this’ in the early
days then you would have picked them up
already, do you get what I mean? . . . Just to
have somebody there as well as on the
computer sort of thing, have a bit more of
an input earlier on that’s great. As much as
we are embracing the technology of life and
all the rest of it, there is nothing more
valuable than a voice and like talking to you
P21
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One participant described a lack of support from the ERS and that e-coachER was able to mitigate the
effects of this:
Because with the exercise referral scheme . . . I had to do things myself, if that makes sense and I went
and I had my induction, she, there was, there was no come back to say ‘how are you getting on, how are
you finding things?’. The person that did the induction with me hasn’t been in touch with me again,
whereas at least with the e-coachER I can refer back to it. I can look at it at my leisure and go back and
be inspired again. Whereas I had, I’ve not had that contact with the person at the gym.
P21
Although the combined use of ERS and e-coachER was noted, a number of participants reported that
they found the ERS difficult to commit to, perhaps more so than other self-selected activities, whereas
others expressed a lack of interest in the types of exercise being offered. There were other difficulties
for some participants in accessing the facilities or services being offered by the ERS. These included
geographical location, transport issues, gym costs, the participants’ working patterns or problems with
ERS oversubscription and delays in the referral process or staffing levels. In addition, other barriers to
ERS attendance stemmed from unforeseen individual circumstances (e.g. bereavement, injury and other
health issues). e-coachER was therefore an important alternative or seen as separate to ERS:
It just feels like they’re two different things because I don’t always see my instructor all that much and
I don’t know what, how that works.
P18
Trial research assistants’ experiences and role in recruiting and supporting
participants through e-coachER
Research assistants’ suggestions for improvements to trial recruitment processes
Researchers suggested that a more direct approach to recruitment would improve rates, for example
(1) using more refined criteria for identifying possible participants and (2) using study researchers to
carry out this task:
They looked at the databases and contacted like hundreds of patients who they thought were eligible for
e-coachER and they had a really poor return. I think to be cost-effective we’re going to have to be very
clear and definite about finding the right criteria. [. . .] So I feel that that’s going to be a big way forward
is the clinical research network or somebody in the research field is going to be able to, have to go into
practices and have access to the databases and pull, going, doing that directly rather than asking the GP
to spend part of his valuable few moments that he has with patients trying to encourage them to take
part in a research study. That’s not going to happen, they just, although they are willing to do it they just
don’t have time to do it.
RA02
Broadly, simplifying the referral and paperwork, streamlining the referral system, contacting
participants via the ERS rather than via the GP, or contacting the participants directly about the
study after the ERS practitioner had sought permission to pass on contact details to the researcher
were found to be helpful:
We had approval to go straight to the exercise referrer who was receiving the exercise referral from the
GP and then ask the staff there to help us identify the people that would be suitable for our study looking
at our study criteria and then approach them to either get, give consent for the patient to pass on their
telephone details to me as the RA [research assistant]. And then I would either approach them directly or
she would give them out the patient, the trial information pack and then the patient could contact me if
they were interested in taking part and that was really successful.
RA01
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Similarly, at another research site, opportunistic sampling via general practice was slow. Engaging the
ERS team to help gave little opportunity for researcher–participant interaction, but a significant
improvement in recruitment rates:
So opportunistic recruitment didn’t work well at any point for us but the ERS, using the ERS system
mailout out to potential participants, that worked really well. I mean we really, we kind of went from
way behind to meeting our recruitment targets from the ERS, so they were really helpful.
RA03
Opportunistic recruitment it was very slow and it was also, I was constantly, kind of, chasing and
reminding the GPs. Whereas with the ERS, it was one of the data team who was sending out the packs
and she, you know, she just had to input the data and it was really a small job for her just to send out a
letter to any potential participants. So, it was really, it worked much better, it was much more fluid.
RA03
Research assistants’ suggestions for improvements to the e-coachER package
As with the study participants, researchers felt that there was some scope to refine e-coachER in
terms of functionality:
I guess I mean there was a couple of people that had said that the website should have been a little
more, I don’t know, maybe all singing all dancing sort of thing. I think the competition is now with all
these devices, apps and things that are out there, a lot of people were maybe, well not a lot, a couple of
people had flagged up that they were disappointed with how basic the website is. On the flipside of that,
it does need to be basic because a lot of people aren’t computer literate but I guess that’s a downside
with the competition now from all the apps and so many things that are out there that it maybe does
look less appealing.
RA02
Research assistants’ views of participants’ attitude towards the trial
The researchers felt that most participants were already highly motivated to take part in something
(the research) that would help them to make lifestyle changes and increase PA. Although it was less
clear that they had understood why they had been referred to an ERS, there was some confusion
regarding being contacted about the research study and being referred to an ERS:
I think they were all quite positive really. There were obviously some people who just weren’t interested
but the main thing that came out when I’ve been looking into it, there was a lot of confusion over what
they’d actually been referred to. So there was a lot of the times I had to explain that they’d been referred
by their GP and that it was the [exercise referral] scheme and I had to explain what that was but,
generally, once they kind of knew what we were doing in conjunction with that, they were very positive
. . . I think they were all interested in doing something that helped them and a couple of them were even,
you know, I think also the voucher, obviously that was a nice bonus to have but yeah they were all very
positive about doing it.
RA03
One further finding relating to participant experiences of being in the research trial arises from both
the research assistant interviews and from a final follow-up interview with one of the participants,
who remarked that just having the interview was ‘motivational’ (P13) as it was:
. . . another reminder that I need to go back to e-coachER to keep it there so you’re you [the research
interviewer] are part of the motivation.
P13
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The research assistants also noted that participants using e-coachER often described the importance of
social support, and at times either explicitly or implicitly mentioned the support obtained from the
researchers (including the qualitative interviewers). Two of the researchers commented:
Again, it wasn’t something that we have discussions with because it wasn’t part of my role, however,
I did get some e-mails from a lot of people who just felt that they wanted to tell someone that they
were logging their steps. Although they didn’t have to, a few participants have done that, it was a very
important aspect to them.
RA02
A lot of participants said it was nice to have me on the phone to contact, so it’s not just online. . . . I think
a lot of the people when they fill in the website they phoned me after to say why they haven’t been as
active . . . this week because, this month because they’d been, you know, had an injury or they’d been busy
and I think it was just that, that kind of option to explain that they don’t get via the website.
RA03
Discussion
The qualitative component of the process evaluation helped to develop a better understanding of the
participants’ experience of and engagement with e-coachER and to explore how factors both related
and unrelated to the e-coachER contents affected participants’ engagement with ERSs and the
e-coachER website itself. A further element was to understand the experiences of the researchers
working on the e-coachER trial. The findings are also of relevance beyond the e-coachER RCT, in
particular regarding the role of support, self-monitoring, goal-setting and feedback from IT support
tools. Interviews with members of the trial site teams involved in recruitment provided further
information regarding trial implementation and delivery.
The e-coachER intervention went through substantial initial piloting with public and patient input
prior to going live within the trial and some specific features of the intervention were designed for a
purpose. For example, the lock-out feature of the intervention was aimed to prevent participants going
through all seven ‘steps to health’ in the same session, which would leave less reason to return to the
website at a later date. It was inevitable that some participants found this frustrating or worthy of
comment, such as the useful suggestion that relapse management (‘slips, trips and falls’) would have
been helpful at an earlier step. Strategies that prevent existing, or developing, competencies from
being undermined were an important feature of e-coachER’s design and the ‘slips, trips and falls’ step
was instrumental in helping participants to develop and maintain competence rather than experience
failure. However, potential opportunities to develop competence by engaging in these later steps were
often not realised as participants found these stages less ‘user friendly’ than earlier steps or were not
able to proceed onto these steps when they wanted to, having been automatically locked out in the
earlier stages. Being locked out of the package may have provoked annoyance and disengagement and
may have a negative impact on the control/autonomy dimension of self-determination theory. It should
be noted that these findings arise from the relatively few participants interviewed who reached these
end steps.
We also designed the intervention to engage with participants with a range of levels of IT literacy.
However, for those interviewed it was clear that most were competent IT users, meaning that, for some
participants, e-coachER provided insufficient content and functionality. Similarly, information provided in
e-coachER was designed to be straightforward and accessible for all, for example the quiz, sometimes
described as a ‘useful reminder’, seemed to serve as a prompt to remind participants what they ‘should’
be doing. Thus, although little of the information was considered to be new, the reiteration appeared to
be valuable and some felt that the links provided useful information but others found that it was too
basic, perhaps offering insufficient challenge to allow the development of a sense of competence
around using e-coachER. It is clear that although some participants appreciated the information
provided, there is scope to add further levels of information and advice as this would both allow
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tailoring for specific conditions and help to create a sense of progression (of information detail) within
e-coachER. It is possible that the efficacy of the intervention may vary depending on the condition for
which the participant was referred, and many had multiple comorbidities. More tailored information,
which could be selected if relevant, may have added to the functionality of e-coachER and provided
further opportunities for the user to develop feelings of competence regarding undertaking more PA
with their underlying health condition. In the future, the intervention could be refined to include more
explicit statements about the intervention design features (e.g. the purpose of the lock-out, that the
pedometer is only a basic monitoring tool) as well as provide more optional levels of information
content related to specific health conditions.
Interviewed participants identified two main ‘active ingredients’ of e-coachER. The first was the skills
training and opportunity to set goals and to monitor progress by using the pedometer. This encouraged
participants to reach or exceed their personal goals. Goal-setting and self-monitoring have been found to
facilitate the ability to initiate and maintain behaviour change.29 The participants who were interviewed
did seem to set their goals realistically and they were broadly SMART; they ‘set their pace’ and
mentioned how setting and attempting to meet these goals were positive aspects of the intervention
and participants particularly valued the step-count activities. Donnachie et al.60 also described how
pedometers can provide tangible evidence of progress and demonstrate enhanced competence, with
the device being seen as an ‘ally’ to meeting goals. It was clear that participants appreciated receiving
the pedometer (and fridge magnet) and recent research has shown that providing primary care
patients with a pedometer by mail is effective in increasing PA,61 so this finding was not surprising.
However, although most participants were very enthusiastic about obtaining feedback from the
pedometer, some were disappointed by the quality of the device and wondered if the step count was
accurate. Whether or not these limitations acted as barriers to engagement with the e-coachER or the
PA (or both) is unclear, although previous research suggested that mistrust of monitoring equipment
may be detrimental.59
Second, the provision of support, for example by providing a virtual ‘reminder’ or ‘pat on the back’,
was regarded as an important aspect of e-coachER. These features provided opportunities for social
interaction and/or the support of social interaction where social interaction had been in some way
lacking. The e-coachER intervention, grounded in self-determination theory, sought to build a sense
of connection or relatedness with others. Throughout the interviews, participants referred to the
importance of social support and how this was met to varying degrees through e-coachER. Step 2 of
e-coachER encouraged participants to seek social support, highlighting opportunities for joining groups,
communities, discussion forums, etc. Although designed to be specific to the participant’s geographical
area, some felt that these were not relevant to their needs or could be improved in other ways. For
other participants, however, e-coachER did help to facilitate an open discussion about health within
the participants’ social network and provide them with an initial starting point or ‘trigger’ to try new
things. The concept of competence refers to an individual’s need to master tasks or to learn new or
different skills,31 and some participants described how e-coachER helped them to develop the
confidence to engage more with PA.
In general, most participants reported at least some benefits of using e-coachER; participants often felt
that its use was ‘motivating’ but when asked to explain more they were less clear in identifying which
specific aspects had this motivating effect. A qualitative study evaluating the effects of a walking
intervention found that many participants reported benefits of trial participation, even when objective
quantitative measures of PA did not increase.59 Although satisfied with the e-coachER website providing
a ‘starting point’ for their plans to increase PA, many found the limitations inherent in the e-coachER
package to be frustrating. For example, it is possible that the e-coachER prompts (if inappropriately
timed) undermined intrinsic motivation and this may have been compounded by a reduced sense of
control arising from being locked out of e-coachER for predefined periods of time.
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A number of participants felt that components of e-coachER were limited or could be improved, but
they often described the package as a valuable resource. This may be because participants were
already motivated to make changes and e-coachER provided additional support to do this. Many of the
participants had actively sought to attend ERSs and described a pre-existing motivation or readiness to
change.62 Those who reported few benefits from e-coachER may not have been at a stage where they
were ready to make changes and it is also possible that, over the duration of the engagement with
e-coachER, participants progressed non-linearly through stages of readiness to change. None of the
participants explicitly stated that they were not motivated to increase their PA and most were positive
about their involvement in the trial. They felt that they were supported by an intervention that was
designed to help them to achieve greater levels of PA and felt that e-coachER consolidated, directed
and focused their desire to make changes.
Strengths and limitations
Interviewing participants at different stages of engagement with the intervention, and the follow-up
interviews with seven participants, allowed us to tap into experiences at particular stages of e-coachER
and, for those giving repeat interviews, how perceptions may have changed as engagement progressed.
The present findings were prepared blind to overall trial findings before being presented at a trial
management meeting. This strengthens the findings from the qualitative research as the main trial
results did not influence the interpretation of the qualitative findings.
One limitation is that the extent to which the interviews and the support provided by the research
assistants may have affected the participants’ interaction with e-coachER is unclear. However, most of
those interviewed had only one interview (n = 19), and these contacts were relatively early on in the
intervention period. Furthermore, we could find no obvious differentiation between interviewees who
had one interview and those who had multiple interviews regarding their comments about engagement
with the other intervention components. Moreover, given the absence of a difference in the primary
outcome and most other outcomes in the trial, it is unlikely that a few additional interviews had any
influence on the findings.
It is also unclear whether or not the participants’ appreciation of being in the ‘additional’ intervention
group affected their responses to the interview questions and to e-coachER as well. Some were
apologetic about being critical of the intervention components and participants may have felt obliged
to modify their criticism.
None of the 16% of the total e-coachER study sample (n = 450) who were classified as having low
IT literacy (as a stratification variable) was interviewed and this may have limited our ability to
understand how the web-based support helped or did not help these participants. This is a limitation
but does not necessarily mean that we interviewed only those with very strong IT skills.
We did not interview any participants who were not in the e-coachER group of the trial about their
experiences of ERSs. Therefore, we do not know how trial control group participants felt about not
being selected for the intervention group or about their experiences of ERSs. A further limitation is
that we did not interview any participants at the end of their time in the trial, for example at about
12 months post enrolment, to explore their experiences over the longer term and whether or not
e-coachER had helped them maintain PA levels. Interviewing at this time point may have provided
a clearer picture of the extent to which any behaviour change achieved during interactions with
e-coachER were sustained. However, undertaking such late-stage interviews could have compounded
the co-intervention effects already mentioned and resources were not available to conduct such
interviews after the primary end point of the main trial.
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Conclusions
There has been considerable literature on the barriers to and facilitators of ERSs, so the qualitative work
focused mainly on if and how the e-coachER intervention complemented usual ERSs. The e-coachER
intervention was acceptable and was positively experienced by many of the interviewed participants, and
enhanced competence, autonomy and relatedness for many, but not all of the interviewed participants,
with several areas for enhancement and augmentation identified. Engaging in self-monitoring and
progressive goal-setting helped to build a sense of competence to increase PA. In doing so, participants
appreciated the opportunity to make personal decisions about the types of activities they engaged in and
how often. The website encouraged participants to get personal support from the ERS and this worked
for some but not others, for example those who had other competing demands on their time. We were
not able to identify specific examples in the interviews of how the website had brought people together
to share PA experiences. There were positive and negative experiences of e-coachER but these were not
necessarily of equal impact. For example, finding e-coachER a useful reminder to exercise may have more
positive impact than the dislike of the web page layout or colour scheme. Instead of focusing only on
individual positive and negative experiences of e-coachER itself, it is perhaps more important to place the
findings from the interview study into the wider context. This was a complex intervention and, as such,
may be more or less effective for individuals depending on their morbidities or comorbidities, complex
personal circumstances or whether or not they were ready to increase PA.
For future trials, it is important to ensure that recruitment and referral pathways are as direct, targeted
and straightforward as possible (i.e. not dependent on busy general practices). Future trials could be
resourced sufficiently to allow any parallel qualitative study to be balanced across trial groups.
Quantitative process evaluation
Aims and objectives of the quantitative process evaluation
Within our logic model, we expected that the e-coachER support package would more favourably
influence some key theoretical components (i.e. a sense of competence, autonomy and relatedness, and
heighten value or importance attached to the behaviour) and behaviour change processes (i.e. action-
planning, self-monitoring, enlisting social support) known to be involved in health behaviour change.
The objectives were to explore whether or not:
1. the e-coachER intervention led to more favourable process outcomes compared with usual ERS
alone at 4 and 12 months
2. any changes in the process outcomes between baseline and 4 months (during which intervention
engagement was expected to predominantly take place) mediated any intervention effects on the
primary outcome [i.e. minutes of accelerometer-recorded MVPA (in bouts of ≥ 10 minutes) at
12 months].
Methods
The survey used to capture the process outcomes was described in Chapter 2. Briefly, items were
derived from extensive reviews of the literature to ensure that they matched our expected changes
within our logic model but also were fit for purpose within a RCT. In other words, they had to make
sense for a responder whether or not they did any PA and they had to have some sensitivity to
identify change. In response to PPI input, we also had to maximise the participant completion rates so
we ensured that the questions were easy to interpret and the response format was clear. The items
and respective scales are supplied in Report Supplementary Material 4.
Questions about importance and confidence are single items using an 11-point scale. The remaining
items were chosen to represent specific constructs and create composite scores. Confirmatory factor
analysis revealed support for adding survey items to assess: perceived competence in being regularly
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physically active (four items), autonomous in decisions about PA (four items), availability of support
(three items), frequency of support (three items), action-planning (five items) and self-monitoring (two
items). The Cronbach’s alpha coefficient of all factors were found to be in excess of 0.77, indicating
good internal consistency of each. Composite scores were calculated and used in the analysis.
Using a model adjusted for age, gender, stratification variables and baseline scores, and random effects
for centre, with only participants included in the primary analysis (i.e. based on complete accelerometer
data and had completed the respective survey items), we compared each of the eight process outcomes
by group at both 4 and 12 months. We restricted the analysis to outcome data deemed valid, with no
more than 200 minutes spent in 10-minute bouts of MVPA, as per the primary analysis.
The size and significance of any mediating effects were evaluated through the product of coefficients
method.63 This was performed irrespective of the results from the main analysis, as mediation may still
be possible without having detected a significant effect of the intervention on the primary outcome.64
Referring to the causal diagram in Figure 6, the coefficient, a, for the intervention effect on process
measures in path A was derived from the mixed model of changes in process measures regressed on
the intervention, adjusted for age, gender, stratification variables and random effects for centre.
Utilising the same adjustment variables, the coefficient, b, for the change in process measures on the
primary outcome in path B was obtained by modelling the outcome on the process measure change,
also adjusting for the effect of the intervention. The coefficient of the mediating effect was, therefore,
calculated as the product a × b. The CIs were calculated using the Sobel test,65 dividing the coefficient
product by the estimated standard error used:
SEab =√(a2 × SEb2 + b2 × SEa2). (1)
Results
Descriptive data are shown in Table 20 for each of the eight outcomes at baseline and 4 and
12 months, by trial group.
Analysis of the intervention effect on the process outcomes among participants meeting the minimum
accelerometer wear-times as specified for the primary analysis indicated that intervention participants
reported greater change in beliefs from baseline to 4 months for PA beliefs about importance,
confidence and competence than the control group (Table 21). By 12 months, there was no longer
evidence of differences in change in beliefs between the intervention group and the control group.
Figure 6 shows the a priori model to be tested in the mediation analysis.
Change in process
measures from
baseline to 4 months
Intervention
Primary outcome
(minutes of MVPA in
10-minute bouts) at
12 months
A B
C
FIGURE 6 A priori path model for testing mediation effects.
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TABLE 20 Descriptive data for all the process measures among only those included in the primary analysis
Mediators
Baseline Month 4 Month 12
Control, n,
mean (SD)
Intervention,
n, mean (SD)
Control, n,
mean (SD)
Intervention,
n, mean (SD)
Control, n,
mean (SD)
Intervention,
n, mean (SD)
1. Importance 121, 5.49
(2.90)
96, 5.58
(2.58)
117, 6.53
(2.76)
95, 7.55
(2.22)
122, 6.34
(2.77)
100, 7.14
(2.55)
2. Confidence 121, 5.60
(3.10)
97, 6.06
(2.73)
117, 5.56
(3.28)
95, 6.72
(2.82)
122, 5.44
(3.28)
100, 6.07
(2.94)
3. Competence 123, 13.14
(3.65)
97, 13.74
(3.46)
113, 12.69
(3.92)
93, 14.27
(3.64)
118, 12.51
(3.94)
99, 13.40
(4.09)
4. Autonomy 121, 14.26
(3.48)
98, 14.54
(3.18)
116, 14.69
(3.64)
93, 15.31
(3.31)
121, 14.53
(3.45)
96, 15.32
(3.41)
5. Support availability 122, 9.89
(3.39)
97, 10.47
(2.93)
115, 9.77
(3.38)
94, 10.80
(2.87)
121, 9.69
(3.30)
97, 10.36
(3.18)
6. Support frequency 122, 7.01
(3.50)
99, 7.61
(3.17)
116, 7.58
(3.62)
94, 8.03
(3.41)
120, 6.97
(3.62)
100, 7.70
(3.38)
7. Use of
action-planning
117, 12.99
(5.25)
97, 13.13
(5.03)
114, 16.10
(5.00)
92, 17.09
(4.67)
120, 14.84
(5.19)
97, 15.88
(4.91)
8. Use of
self-monitoring
121, 5.17
(2.16)
98, 5.70
(1.97)
115, 6.60
(2.02)
94, 7.36
(2.03)
121, 6.32
(1.95)
99, 6.70
(2.09)
Greater values reflect more positive beliefs.
1. Perceived importance of doing at least 30 minutes of moderate-intensity PA (e.g. brisk walk) on at least 5 days
per week (using 0–10 scale: 1 item).
2. Confidence in achieving at least 30 minutes of moderate-intensity PA (e.g. brisk walk) on at least 5 days per week
(using 0–10 scale: 1 item).
3. Perceived competence in being regularly physically active (using 1–5 scale: 4 items).
4. Autonomous in decisions about PA (using 1–5 scale: 4 items).
5. Availability of support (using 1–5 scale: 3 items).
6. Frequency of support (using 1–5 scale: 3 items).
7. Action-planning (using 1–5 scale: 5 items).
8. Self-monitoring (using 1–5 scale: 2 items).
TABLE 21 Intervention effects on changes in process outcomes from baseline to 4 and 12 months
Mediators
Month 4 Month 12
n Coefficient p-value 95% CI n Coefficient p-value 95% CI
1. Importance 208 0.888 0.013 0.184 to 1.592 218 0.705 0.098 –0.129 to 1.540
2. Confidence 209 1.041 0.007 0.287 to 1.794 219 0.393 0.332 –0.401 to 1.187
3. Competence 205 1.214 0.024 0.158 to 2.269 216 0.571 0.337 –0.593 to 1.735
4. Autonomy 207 0.51 0.306 –0.466 to 1.486 216 0.495 0.335 –0.511 to 1.500
5. Support
availability
208 0.399 0.318 –0.384 to 1.182 216 0.026 0.951 –0.818 to 0.870
6. Support
frequency
211 –0.072 0.889 –1.090 to 0.945 220 0.115 0.831 –0.947 to 1.178
7. Use of
action-planning
200 1.249 0.18 –0.575 to 3.073 210 1.042 0.239 –0.694 to 2.777
8. Use of
self-monitoring
209 0.293 0.45 –0.468 to 1.054 218 –0.102 0.774 –0.798 to 0.594
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Table 22 shows the analysis of mediating effects of change in the process outcomes (from baseline
to 4 months) on the primary outcome at 12 months, using only participants included in the primary
analysis. There were no significant mediation effects. Despite there being significant intervention effects
on change in beliefs about importance, confidence and competence at 4 months, these changes in
beliefs did not translate into increases in MVPA minutes at 12 months. A possible explanation is that
the intervention effects on the primary outcome were insufficient to fully test the mediating effects,
especially given the distributions, with many participants recording zero for minutes accumulated in
bouts of ≥ 10 minutes. Another explanation may be that the 10-point scales used to assess importance
and confidence were more sensitive to identify change than a 5-point scale used for the other outcomes.
Nevertheless, according to analysis of path B in the mediation diagram (see Figure 6), the primary
outcome did appear to be sensitive to changes (from baseline to 4 months) in importance, the frequency
of support, action-planning and self-monitoring. However, in all but importance, there were insufficient
changes to assume a mediating effect in the process measures between baseline and 4 months. With
regards to importance, although paths A and B were individually significant, the combined change in this
process measure and its effect on the primary outcome according to the Sobel test was insufficient to
produce a significant mediating effect.
Summary
Our mixed-methods approach to understanding if and how the intervention worked for some participants
provided interesting insights into engagement with a novel technology-based support system and how that
complemented the available support from usual ERSs. The qualitative and quantitative approaches were
conducted independently. The interviews highlighted the role of developing self-monitoring and SMART
goal-setting skills to increase confidence, which featured strongly in being physically active on a regular
TABLE 22 Mediation effects for the process outcomes
Mediators n
Path A Path B Mediated effect
Coefficient
(SE) p-value
Coefficient
(SE) p-value
Coefficient
(SE) 95% CI p-value
1. Importance 204 0.919
(0.365)
0.012 2.483
(0.924)
0.007 2.282
(1.242)
–0.152 to 4.716 0.066
2. Confidence 205 1.056
(0.392)
0.007 1.433
(0.832)
0.085 1.513
(1.043)
–0.531 to 3.557 0.147
3. Competence 201 1.139
(0.547)
0.037 0.267
(0.614)
0.664 0.304
(0.714)
–1.095 to 1.704 0.670
4. Autonomy 203 0.478
(0.508)
0.347 0.437
(0.679)
0.520 0.209
(0.393)
–0.561 to 0.979 0.595
5. Support availability 204 0.419
(0.407)
0.303 –0.104
(0.820)
0.899 –0.044
(0.346)
–0.722 to 0.635 0.899
6. Support frequency 207 –0.065
(0.527)
0.903 1.568
(0.598)
0.009 –0.102
(0.827)
–1.723 to 1.519 0.902
7. Use of action-planning 196 1.198
(0.938)
0.201 1.012
(0.362)
0.005 1.212
(1.044)
–0.834 to 3.259 0.246
8. Use of self-monitoring 205 0.235
(0.389)
0.545 2.533
(0.828)
0.002 0.595
(1.004)
–1.373 to 2.563 0.553
SE, standard error.
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basis. The survey process outcomes confirmed that the intervention increased importance and confidence
up to 4 months but the effects (compared with usual ERSs) had dissipated by 12 months.
The qualitative interviews were mostly not able to follow intervention participants for long. The lack
of intervention effects on changes in other process outcomes (e.g. action-planning and self-monitoring) was
surprising given that 36% of the participants reached step 5 (completed a goal review). Some participants
continued to complete goal reviews for up to 12 months, but it would appear that an insufficient number
of participants did so, and most had stopped completing goal reviews long before completing the 4-month
follow-up assessment. This was also despite periodic reminders from the online system to log in.
The interviews provided a little information on how e-coachER had prompted intervention participants
to find and use social support to increase PA (e.g. support to get active – step 2). Although designed
to be specific to the participant’s geographical area, some felt that the e-coachER links to other PA
opportunities were not relevant to their needs. For other participants, however, e-coachER did help
to facilitate an open discussion about health within the participants’ social networks. It is possible that
simply talking about being in the e-coachER study (i.e. an opportunity to connect) would have been
done by participants in both of the trial groups and few actually got around to joining groups or setting
plans to exercise with others. Hence, this may explain why the intervention had no effects on the
process outcomes, namely identifying and using social support.
In this pragmatic trial, the aim was to determine if there were intervention effects in addition to
usual ERSs. An alternative explanation to null intervention effects on some of the process outcomes
is that usual ERSs have sufficient positive effects on PA beliefs to make additional effects unlikely.
The Glasgow ERS differed from the other ERSs involved in the trial, in that the exercise professional
supported participants with behaviour change counselling and signposting to different PA options. In
this sense, the Glasgow ERS may have been expected to build a sense of autonomy and the e-coachER
support may not have added much. Further analysis is needed to explore differences in intervention
effects on process outcomes by site, although site did not interact with the intervention effects on the
primary outcome. Health interventions, including ERSs, are notorious for having short-term effects on
health behaviour that dissipate with time. Given that ERSs can provide barriers to engagement and
sometimes may not promote a range of sustainable PA options, we designed e-coachER to have more
lasting appeal and to develop self-regulatory skills and the intrinsic motivation to be physically active
for managing chronic conditions, above and beyond usual ERSs. Some key processes did change as a
result of e-coachER engagement in the short term but these were not sustained, which is consistent
with the absence of any mediating effects of change in these measures on intervention effects on the
objective primary outcome of MVPA.
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Chapter 5 Economic evaluation
Introduction
This chapter reports the economic analysis of an augmented ERS with web-based behavioural support
(e-coachER) versus ERS alone. Comparing the costs and consequences of alternative approaches to
promoting health care is key to facilitating efficient allocation of resources.66
Although economic evidence on ERSs exists (mostly compared with usual care), it is unclear;17 little is
known about the value for money of an augmented ERS with online behavioural support. A review of
other reviews (n = 3) conducted by Pavey et al.54 found one study67 showing ERSs to be cost-effective,
another one68 reporting mixed findings and a third69 that found limited evidence of effectiveness but
higher cost. In an analysis of 21 economic evaluation studies published by NICE from 2006 to 2010,
Owen et al.70 found ERSs to be cost-effective at the NICE threshold of £20,000 to £30,000 per QALY.
In a systematic review of economic evaluations, Vijay et al.71 reported three studies showing a cost per
disability-adjusted life-year (DALY)/QALY estimate below £10,000 for exercise prescriptions.
The most recent NICE guideline development on ERSs identified two key gaps in knowledge.72 First,
there is paucity of cost-effectiveness evidence on alternative models of ERS. Second, information on
the cost-effectiveness of ERSs for people with comorbidities is lacking. We are aware of an ongoing
multicountry, multicentre RCT examining the cost-effectiveness of enhanced ERSs plus self-management
strategies compared with ERS alone among inactive patients.73
This chapter addresses the gaps in the literature by estimating the cost-effectiveness of e-coachER
compared with ERSs alone, in adults with range of chronic conditions. The analysis uses a 1-year time
horizon (from baseline to 12 months post randomisation) and is conducted from the viewpoint of the
NHS, Personal Social Services and patients. The base-case analysis covered NHS and Personal Social
Services perspectives.
Methods
The intervention and control population are as defined in Chapter 2. In line with the clinical effectiveness
analysis, the samples for base-case analyses are participants who provided valid accelerometry data.
Sensitivity analysis explored the impact of using the whole sample.
Measurement and valuation of cost
Total costs were expressed per participant and calculated by multiplying resource use with each
relevant unit cost and summing across the range of resource use possibilities across the 12 months of
the study.
Resource use, including those ‘in kind’, associated with both intervention and control was identified
through discussions with the management team of the trial. Following this, resources were measured
and valued without research-driven resource use. The range of resource use covered (1) set-up and
design of the intervention, (2) delivery of the intervention including handbooks, pedometers, guide
for using the LifeGuide platform, technical support and maintenance of the website, (3) consultation
provided by an exercise specialist and staff support to participants, (4) primary and secondary health
service use: GP, nurse, social worker, care worker, physiotherapist consultations (both home and
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practice visits), prescriptions, hospital admissions, accident and emergency (A&E) visits, and other (e.g.
podiatrist visits); and (5) time and money expenses borne by participants in relation to participation in
the intervention (e.g. time spent on web platform), visit to exercise specialist and PA (e.g. membership
fees for gym or sports club). Data on resource use were collected using the trial administrative records,
key informant interviews (e.g. trial manager), review of trial management records and participants’
questionnaires at baseline, 4 and 12 months.
Resources were valued using national tariffs (e.g. Unit Costs of Health and Social Care 2017,74 NHS
Reference Costs 2015 to 2016,75 Annual Survey of Hours and Earnings76) to increase generalisability.
In the absence of available national costs, unit costs came from trial administrative records. Appendix 6
provides details of unit costs. The unit cost of capital costs (i.e. pedometer) was calculated pro rata
(costs were spread over their expected lifetime) because use can occur beyond the time period
of this analysis.77 Costs were expressed in 2017/18 Great British pounds, using the Hospital and
Community Health Service (HCHS) inflation index where appropriate (PSSRU 2017).74 No discounting
was used as the time horizon of the analysis is 1 year.
Measurement and valuation of outcomes
Two types of outcomes were used for estimating cost-effectiveness: physical units (PA indicator)
and QALYs. The PA measure is the primary outcome measure of the trial (as described in Chapter 2):
total weekly minutes of MVPA in ≥ 10-minute bouts, recorded objectively by accelerometer. QALYs
were estimated by converting EQ-5D-5L utilities using the area under the curve method. EQ-5D-5L
questionnaires were completed by trial participants at baseline and 4 and 12 months. In line with the
2018 NICE recommendation,66 utility weight based on the crosswalk function78 was used to assign
utility weights. Sensitivity analysis explored the impact of using other valuation sets.
Methods of analysis
Missing data analysis
Multiple imputation was employed to replace missing values as it incorporates uncertainty around
imputed estimates. Imputed values are drawn from a regression model fitted for each variable with
missing data. Multiple imputation by chained equations was used and not multivariate normal
imputation as the variables with missing data include binary and categorical variables and these are
not suitable with the multivariate normal imputation.
Five imputations were used.79 The standard approach was followed in building the imputation model
as we ensured that the imputation model matched the model used for the analysis while including
the predictors of missingness as possible. In addition, the dependent variable was included in the
imputation model to ensure that the imputed values have the same relationship to the dependent
variable as the observed values.80
As the purpose of the multiple imputations was to replace missing values for raw data to allow the
generation of derived variables, a point estimate was required, not its variance per se. In line with
Rubin’s rules,81 we derived the overall point estimate for the imputations by averaging the estimates
of the multiply imputed data. For categorical data, the overall point estimate was rounded up to the
nearest decimal point as relevant. The mean of multiple imputations is an unbiased estimate of the
missing value, and their contributions to increased variance in subsequent analysis viewed as an
estimate of the added uncertainty caused by data missingness.81
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Incremental analyses
The within-trial analyses were twofold:
1. Incremental cost–utility analysis – this was the primary analysis of the economic evaluation and
used QALY as the effectiveness measure. The outcome of the analysis was cost per QALY.
2. Incremental cost-effectiveness analysis – analysis generated cost per change in MVPA minutes
based on accelerometer data indicated in Chapter 3.
Descriptive statistics based on mean and SD were conducted for the cost components and quality-of-
life measure. Estimations of the outcomes used regression models fitted separately for costs, QALYs
and MVPA minutes. Details of the estimation of MVPA minutes is presented in Chapter 2. Generalised
linear models fitted with gamma and binomial 1 (equivalent to beta regression) distributional families
were fitted for the costs and QALYs analyses, respectively.82,83 The modified Park test was used to
select the appropriate distributional family.82 Regression models adjusted for covariates, as recommended,
including baseline QALYs (as appropriate) and potential correlates of the dependent variables age, gender,
ethnicity and health condition. Model specification was tested using the link test. All analyses accounted
for cluster effect (based on site) through clustered standard errors. Sample means and incremental values
for costs and QALYs were estimated using the margins method82 to improve the precision of estimates.
The estimation of standard error and CIs also accounted for the cluster design.84
Uncertainty in estimations was analysed using deterministic analyses to examine the impact of
(1) using the whole sample (all randomised people) for analysis, (2) changing perspective of analysis
to include costs incurred by participants, (3) excluding costs of health and social service use, (4) using
different value sets85 to estimate quality of life and (5) complete-case analysis (excluding missing data).
In addition, subgroup analyses were conducted to explore whether or not the cost-effectiveness of
the intervention differed across different types of disease groups reported as the reason for referral
to the ERS (hypertension, low mood, type 2 diabetes, weight loss and osteoarthritis).
Probabilistic uncertainty was assessed through non-parametric bootstrapping (n = 2000 replications).
To ensure that the observations within the resampled clusters are independent in each bootstrap
replication, the bootstrap estimation was fitted with unique identifiers inter and intra clusters.61 Based
on the bootstrap samples, cost-effectiveness planes (CEPs) and cost-effectiveness acceptability curves
(CEACs) were constructed using the bsceaprogs program code.82
Results
Summary statistics (unadjusted for baseline differences) on costs to both providers and participants,
and quality of life are provided in Table 23 (see Appendices 7–9). At 12 months, the cost to providers
per participant was higher in the intervention group (£1730) than in the control group (£1385). The
biggest component of the cost borne by providers was health and social service use cost (91%) and
the least was cost associated with the provision of support to participants (< 1%, £0.60 per participant).
In terms of cost to participants, the pattern was different as participants in the control group incurred
an average cost of £298, compared with £255 in the intervention group. The vast majority of this cost
was because of cost related to participation in PA (69%). Fees paid for child/dependant care during the
exercise specialist visit were the smallest part (< 1%, £0.20 per participant). The intervention group
experienced higher quality of life at 12 months with a QALY of 0.662 (Table 23).
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Table 24 shows the main results based on regression estimates that adjusted for baseline differences.
Consistent with the pattern observed in the unadjusted estimates, the average cost per participant was
£1355 (95% CI £701 to £2008) and £1793 (95% CI £1635 to £1952) in the control and intervention
groups respectively. This represents an additional cost of £439 (95% CI –£182 to £1060) in the
intervention group, although the difference is not statistically significant. The intervention led to a
weak indicative effect on total weekly minutes of MVPA in bouts of ≥ 10 minutes (mean difference
11.8 minutes, 95% CI –2.1 to 26.0 minutes), compared with the control group. In terms of quality-of-
life outcome, the intervention group (mean 0.663, 95% CI 0.625 to 0.701) had more QALYs than the
control group (mean 0.637, 95% CI 0.585 to 0.688) (see Table 24). The difference in QALYs (0.026,
95% CI 0.013 to 0.040) between the two groups was statistically significant. The cost–utility ratio
shows that, compared with the control group, the intervention cost an additional £16,885 per QALY.
This is below the NICE threshold of £20,000–30,000 per QALY.
Table 25 shows the results of the deterministic sensitivity analyses. The base-case finding was robust
to deterministic sensitivity analyses with a few exceptions. The intervention was found to be more
TABLE 23 Descriptive statistics of costs (2017/18) and quality of life per participant (with accelerometry data)
Costs and quality of life
Mean (SD)
Control (n= 133) Intervention (n= 110)
Cost to providers at 12 months (£)
Total costs to providers 1385 (2177) 1730 (1707)
Set-up cost 0 182 (0)
Delivery cost 0 29 (0)
Cost of participants’ consultation with exercise specialist 30 (45) 29 (45)
Cost of attendance at ERS centre 3.1 (4) 2.5 (3)
Number of ERS attendancesa 11 (12) 7 (9)
Cost associated with general support to participants 0.3 (1) 1 (2)
Costs of health and social service use 1352 (2180) 1487 (1691)
Cost to participants at 12 months (£)
Total costs to participants 298 (1252) 255 (347)
Travel cost to visit the exercise specialist 13 (23) 14 (29)
Time cost in consultation with exercise specialist 43 (64) 42 (66)
Fees paid for child/dependant care during exercise specialist visit 0.3 (2) 0.1 (1)
Other expenses related to exercise specialist visit 2 (8) 4 (20)
Time cost using the e-coachER web platform 0 10 (12)
Cost of attendance to ERS centre 27 (34) 18 (26)
Costs related to PA participation 213 (1253) 168 (311)
Quality of life
QALY (1 year) 0.637 (0.245) 0.662 (0.261)
EQ-5D-5L index (baseline) 0.656 (0.240) 0.663 (0.261)
EQ-5D-5L index (4 months) 0.642 (0.257) 0.672 (0.279)
EQ-5D-5L index (12 months) 0.620 (0.286) 0.641 (0.305)
a Mean imputed attendance rates (over the period of an ERS) varied across the different sites, from 15 in Plymouth to
7 in Birmingham and 3 in Glasgow. Numbers reflect different schemes (see description of schemes elsewhere in the
report) and challenges in capturing data, rather than participant interest and success of schemes.
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TABLE 24 Costs, effects and cost-effectiveness at 12 months
Costs and effects
Control Intervention
Mean 95% CI Mean 95% CI
Within-trial analysis, costs and effects over 12 months
Total cost per participant (£) 1355 701 to 2008 1793 1635 to 1952
Incremental cost (£) – 439 –182 to 1060
Total QALYs per participant 0.637 0.585 to 0.688 0.663 0.625 to 0.701
Incremental QALYs – 0.026 0.013 to 0.040
Incremental total weekly minutes of MVPA in bouts
of ≥ 10 minutes
– 11.8 –2.1 to 26
Within-trial analysis, incremental cost-effectiveness ratio/utility ratio at 12 months
Cost per additional QALY (£) – 16,885
Cost per additional minute of MVPA in a bout
of ≥ 10 minutes (£)
– 37.20
For incremental analyses, the comparison is intervention vs. control.
TABLE 25 Sensitivity analyses
Parameter
Incremental cost (£) Incremental QALY
ICER (£)Mean 95% CI Mean 95% CI
Base case 439 124 to 754 0.026 0.013 to 0.040 16,885
Whole sample (all participants who
were randomised)
439 124 to 754 0.010 –0.005 to 0.024 43,900
Changing cost perspective (both
participants and NHS and PSS costs)
413 –266 to 1093 0.026 0.013 to 0.040 15,885
Excluding all health and social care use
cost (cost directly related to intervention)
234 216 to 251 0.026 0.013 to 0.040 9000
Complete-case analysis (exclude
missing data)
529 –166 to 1223 0.035 0.010 to 0.059 15,114
Changing the values for measuring
QALYs (based on EQ-5D-5L value set
from Devlin et al.85)
439 –182 to 1060 0.030 0.022 to 0.039 14,633
Participants with hypertension (n = 37) –46 –1260 to 1168 0.009 –0.020 to 0.038 Intervention
dominates control
Participants with low mood (n = 84) 989 637 to 1341 –0.056 –0.098 to –0.014 Control dominates
intervention
(less expensive
and more effective)
People with type 2 diabetes (n = 49) 655 –187 to 1497 0.044 –0.021 to 0.110 14,886
Participants who were overweight
(n = 227)
350 –44 to 745 0.019 –0.035 to 0.072 18,421
Participants with osteoarthritis (n = 53) 223 –781 to 1228 0.018 –0.016 to 0.052 12,389
PSS, Personal Social Services.
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expensive but produced more QALYs. Excluding health and social service use costs, or changing
the perspective of analysis, improved the cost-effectiveness of e-coachER, with incremental cost-
effectiveness ratios (ICERs) ranging between £9000 and £15,885. Using estimates based on the
whole sample (all participants who were randomised) was decisionally significant. It produced a worse
cost-effectiveness ratio, with the intervention becoming not cost-effective (£43,900 per QALY).
Compared with the base-case findings, subgroup analysis showed the intervention to be more cost-effective
in groups that reported that hypertension (dominates control) or osteoarthritis (ICER £12,389 per QALY)
or type 2 diabetes (ICER £14,886 per QALY) was the primary reason for referral. Among individuals who
reported that being overweight was the primary reason for referral, e-coachER was still cost-effective
but at a higher ICER value (£18,421 per QALY). In the group that reported that low mood was the
primary reason for referral, e-coachER was more expensive (additional cost of £989 per participant)
and less beneficial (fewer QALYs of –0.056 per participant) than the control.
Figure 7 shows the cost-effectiveness plane for the intervention compared with the control. The
majority of the cloud of points (representing mean differences in costs and QALYs) are located in the
north-east quadrant of the plane. This indicates that the intervention has high likelihood of generating
more QALYs but at higher costs. The probability of the intervention being cost-effective (compared
with control) at multiple willingness to pay per QALY values is presented in Figure 8. At £10,000 per
QALY, the intervention has about 30% chance of being cost-effective compared with the control. The
likelihood of cost-effectiveness nearly doubles (51%) at the £20,000-per-QALY threshold and increases
further to 63% at the £30,000 threshold.
Discussion
This study shows that providing online behavioural support for participants of ERSs cost providers
£1793 per person. Although the intervention costs £439 more than offering the ERS alone, it leads
to better quality-of-life outcomes (0.026 more QALYs per person) and increased participation in
PA (12 more weekly minutes of MVPA in ≥ 10-minute bouts per person). Although the differences
were mostly not statistically significant, it is important to note that this is not sufficient proof of
no significant effect, as the clinical trial was not powered to identify the changes in the economic
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FIGURE 7 Cost-effectiveness plane for intervention vs. control at 12 months.
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outcomes (cost and QALY), particularly given the small number of observations in the subgroup
analysis. Compared with the control, the intervention cost an additional £37 to gain a 1-minute
increase in weekly MVPA (in ≥ 10-minute bouts) and £16,885 per QALY gain per person. Based on the
NICE threshold of £20,000–30,000 per QALY, e-coachER could be considered more cost-effective than
ERS alone. If decision-makers are willing to pay £30,000 for 1 QALY, e-coachER has a 63% probability
of being cost-effective. The findings were robust to sensitivity analysis, including when the cost of
participants was added to total costs of the programmes. Exploratory subgroup analysis found that the
intervention was cost-effective among participants who reported that hypertension, osteoarthritis, type
2 diabetes or weight problems (i.e. being overweight) was the primary reason for referral but was not
cost-effective among those who reported that low mood was the primary reason.
The novelty of e-coachER, its comparison with usual ERSs and the disease-specific population makes
it complicated to relate the findings here meaningfully to the existing economic literature on ERSs.
We identified one comparable study. Murphy et al.,17 a pragmatic RCT, assessed the cost-effectiveness
of the Wales National Exercise Referral Scheme (NERS), a 16-week programme including motivational
interviewing, goal-setting and relapse prevention compared with usual care. Participants were inactive
people with depression and/or coronary heart disease risk. The NERS intervention was shown to be
cost-effective at 12 months, with a cost-per-QALY estimate of £12,111 and 89% likelihood at the
£30,000-per-QALY threshold.
Our analysis found that costs associated with health and social services constitute the largest proportion
of total costs associated with the intervention. Although the impact on cost-effectiveness was not
decisionally insignificant, an important consideration is why the intervention group had higher health
service use cost (mean cost of £135) than the control group. Further exploration shows that in the first
4 months of the trial, on average, the intervention group had a health service cost of £819 per participant
and the control group had a health service cost of £639 per participant (see Appendix 9). In terms of the
subcomponents of health service use cost collected in this study (n = 13), the intervention had higher
costs in all except two [A&E visits and hospital visits (outpatients)]. The reverse pattern was, however,
observed from 5 to 12 months – the control group had higher health service costs than the intervention
group (£713 vs. £668). Similarly, the control group had higher costs for all subcost components apart
from prescriptions and care worker visits. A systematic review on injury consequences of PA found that,
although relatively minor, increased activity could lead to adverse health consequences.86 However, for
older adults, improved participation reduces the risk of fall-related injuries.87 Future studies are required
to further investigate the impact of adverse effects on the cost-effectiveness of PA programmes.
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This study feeds into a limited evidence base around the efficiency of different models of ERS. To the
best of our knowledge, this is the first study to demonstrate the cost-effectiveness of online support
for an ERS and in a population with common chronic conditions. The strengths of this study include the
use of robust clinical effectiveness data from a large multicentre trial, rigorous analyses to determine
the impact variant measures of quality of life and participant perspective, subgroup analysis among
different disease groups, comprehensive coverage of health service and social care use cost. A key
limitation, however, is the short-term perspective of the analysis herein. Modelling of the long-term
costs and effects is important where benefits and costs extend beyond the end of a trial. It is of
particular relevance to this trial, where the benefits or costs could be experienced in the future too
(as resource savings from reduced disease and, therefore, benefits in terms of increased quality of life).
We expect that the impact of the long-term effects may have underestimated the cost-effectiveness of
e-coachER.
There is currently limited national public health guidance on the implementation of ERSs enhanced
with online support for participants. The results herein show that based on the NICE threshold of
£20,000–30,000 per QALY, e-coachER could be considered more cost-effective than ERS alone.
To strengthen the economic case, future studies are recommended to examine the long-term
cost-effectiveness of the e-coachER and ascertain the impact of the trajectory of activity levels
on future health service and future quality of life.
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Chapter 6 Discussion
Summary of findings
The 450 trial participants were 64% female (n = 290), had an average age of 50 years and had an average
BMI of 32.6 kg/m2; 65% and 35% were classified as inactive (n = 293) and moderately inactive (n = 157),
respectively, and 50% reported that weight loss was the primary reason for referral (n = 225), followed by
low mood (n = 85, 19%), osteoarthritis (n = 54, 12%), diabetes or prediabetes (n = 49, 11%) and high blood
pressure (n = 36, 8%). Participants also noted that weight loss (n = 364, 81%), low mood (n = 243, 54%),
high blood pressure (n= 149, 33%), diabetes or prediabetes (n= 117, 26%) and osteoarthritis (n= 108, 24%)
may have been one of the reasons for referral.
The e-coachER support package was developed, which included mailing participants a pedometer,
a fridge magnet with attached tear-off strips to record daily PA and a bespoke website to overcome
barriers to increase daily PA for some people who are not willing or able to engage in an ERS. The
e-coachER intervention demonstrated a mixed level of engagement. About one-third of participants
did not register online and about one-third completed what we thought would be an adequate ‘dose’
of at least five of the seven steps, involving at least setting a PA goal and reviewing it 1 week later.
The results show that, compared with usual ERSs, the e-coachER intervention group had slightly more, but
not significantly more, accelerometer-recorded minutes of MVPA (recorded in bouts of ≥ 10 minutes) at
12 months. The pattern was similar when considering the level of intervention engagement, with a slightly
larger difference in favour of the intervention group. Applying the same approach as in the primary
analysis, there were no between-group differences at 12 months in any of the other accelerometer-
derived or self-reported MVPA outcomes, with one exception. The intervention group had significantly
more daytime sedentary time (accumulated in blocks of ≥ 5 minutes) at 12 months. In ITT imputed
comparison at 12 months, the intervention group was more likely than the control group to self-report
that they had achieved 150 minutes of weekly MVPA (odds ratio 1.55, 95% CI 0.99 to 2.42; p = 0.05). The
intervention also had no effect on ERS attendance (78% vs. 75% in control and intervention, respectively),
or EQ-5D-5L or HADS scores at 12 months, compared with the control group. In ITT imputed comparison
at 12 months, the intervention group had lower HADS depression and anxiety scores than the control
group. The proportion of participants attending the ERS was comparable to findings from a review15 that
reported that the average ERS uptake was 81% in RCTs.
Economic evaluation
Over the 12-month follow-up, the average cost per participant was £1355 (95% CI £701 to £2008)
and £1793 (95% CI £1635 to £1952) in the control and intervention groups respectively. Compared
with the control group, the intervention group incurred an additional mean cost of £439 (95% CI
–£182 to £1060) but generated more mean QALYs (0.026, 95% CI 0.013 to 0.040), with an
incremental cost-effectiveness ratio of an additional £16,885 per QALY.
Although insignificant, an important consideration is why the intervention group had higher health
service use cost (mean cost of £135) than the control group given the intervention was effective and
led to increases in both PA and health-related quality of life. The difference in the cost, which was
not statistically significant, was observed irrespective of the central measure of tendency, mean or
median (see Appendix 9). Further exploration shows that in the 4 months of the trial, on average, the
intervention group had a health service cost of £819 and the control group had a cost of £639. In
terms of the subcomponents of health service use cost collected in this study (n = 13), the intervention
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group had higher costs in all except two components [A&E visits and hospital visits (outpatients)].
The reverse pattern was, however, observed from 5 to 12 months, with the control group qualitatively
having greater health service costs (£713 vs. £668). Similarly, the control group had higher costs for all
subcost components apart from prescriptions and care worker visits.
Effectiveness of and engagement in the intervention
One of the criticisms of e- and m-health interventions is that engagement is not appealing to enough
people and can be rather short-lived.23 The 9-month work in developing the intervention, building on
other effective LifeGuide interventions and with public and patient involvement, aimed to maximise
engagement to theoretically have the greatest impact on MVPA outcomes at 12-month follow-up.
Automated periodic e-mails were sent to intervention participants up to 12 months. The intervention
included evidence-based and theory-driven components as well as a pragmatic approach to enhance
engagement. Pedometers and recording sheets attached to fridge magnets were provided in the initial
introductory pack as basic tools for self-monitoring PA and setting and reviewing SMART goals. These
may have been sufficient to get some of the 36% of intervention participants who never registered to
think about behavioural self-regulatory processes to increase PA for managing their chronic condition
(s). Attending the ERS may also have provided sufficient support to become more physically active,
without the use of the pedometer or web-based support. Other participants may also have regarded
the pedometer as rather basic and decided to use a more sophisticated app on their smartphone.
The fact that 64% of participants did register online and completed their first step, with 36% going on
for over 4 weeks to complete a goal review, provided us with some assurance that the e-coachER
intervention was acceptable for a reasonable proportion of participants. There is evidence from
previous research with LifeGuide interventions that even limited online engagement can be effective
and there is no clear ‘adequate dose’ to optimise behavioural change. Our CACE analysis confirmed
that completing our prespecified intervention engagement level (step 5) did not lead to significantly
greater 12-month objectively recorded minutes of MVPA, recorded in ≥ 10-minute bouts, compared
with the control group, although the between-group differences were qualitatively greater (22.9 vs.
11.8 minutes).
Our logic model predicted that e-coachER engagement would strengthen various beliefs that would in
turn translate into increases in MVPA, compared with usual ERS support. Among only the participants
included in the primary analysis, the intervention did increase the following compared with the control
group: perceived importance of doing at least 30 minutes of moderate-intensity PA (e.g. brisk walk)
on at least 5 days per week, confidence in achieving at least 30 minutes of moderate-intensity PA
(e.g. brisk walk) on at least 5 days per week and perceived competence in being regularly physically
active at 4 months (but not 12 months). Changes (from baseline to 4 months) in these process
outcomes did not mediate changes in the primary outcome at 12 months.
In the qualitative part of our process evaluation, 12% of intervention participants were interviewed.
Overall, e-coachER was acceptable and positively experienced and did ‘do what it said on the tin’ in
terms of enhancing autonomy, competence and relatedness for many participants. Inevitably, because
the web-based support was available to support participants with a range of levels of IT literacy and
chronic conditions, some of the content did not appeal to everyone. That said, the idea that the support
aimed to facilitate engagement with the self-monitoring process and then encourage them to move on
to using more sophisticated devices to self-monitor PA for example, was overlooked by some participants,
but not all. Similarly, we tried to help participants to find any source of social support to support increases
in PA and a preferred form of PA that they could enjoy, whether or not that involved the ERS, and that
overarching intent ‘may have been lost’ by some of those interviewed. The user guide sent to intervention
participants initially could have spelled out some aims of the support more explicitly and if this had been
understood then some comments from participant interviews may not have been made. That said, some
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interviewees did note that they had a strong IT background and acknowledged that their comments were
personal and acknowledged the need to appeal to those with a lower level of IT literacy than themselves.
Strengths and limitations
Sample characteristics
We believe this to be the first study to recruit inactive participants with chronic conditions into a trial
involving ERSs, and then follow them up at 12 months to assess objectively measured PA. We had
planned to conduct separate analyses for different chronic conditions to explore the possibility of
establishing an evidence-based case for disease-specific ERS pathways, but the study findings have
clearly confirmed the extent of multimorbidity. Nevertheless, when considering the participant-
reported primary reason for referral, in sensitivity analysis there was no interaction between this
reason and the overall intervention effects on the 12-month MVPA primary outcome.
During the course of the study, we recalculated the sample size to recruit 430 participants (decreased
from original funding application sample size of 900), allowing for 20% attrition for the primary outcome
at 12 months. We actually recruited 450 participants, but, partly because we set a very rigorous primary
outcome threshold (wear-time of at least 4 days per week, including 1 weekend day, with data from at
least 16 hours per day), the primary analysis was based on data from 232 participants. Further analysis
explored if more lenient thresholds, which resulted in more participants being involved in the analysis,
influenced the findings. The overall findings remained consistent.
Exercise referral scheme context
The e-coachER intervention was designed with considerable public and patient input to ensure that it
would support patients with a wide range of IT expertise. We categorised 16% of trial participants as
having low IT literacy and further analysis revealed that IT literacy did not have an impact on the
primary analysis.
Exercise referral schemes are delivered in various formats across the UK and we were keen to ensure
that the trial produced findings with good generalisability. In other words, we wanted to know if
adding the e-coachER intervention improves long-term levels of MVPA in patients with chronic
conditions. The three sites in which recruitment took place offered quite different types of ERS,
which have been described elsewhere.1 For example, in Glasgow the ERS involves initial contact
with an ERS practitioner, who provides some behavioural support to increase MVPA and also helps
to signpost participants to preferred and appropriate PA opportunities, with following consultations
available at 6 and 12 months. In contrast, the schemes in Birmingham and the South West are more
traditional ERSs with support provided by an ERS professional in an exercise facility. Within the trial,
we examined the impact of site on the primary analysis and found no different effects of the
intervention across sites.
A further strength of the study was the use of an evidence-based, theory-driven intervention that
allowed us to identify website usage. The LifeGuide system provided data on number of visits (and
duration) to the website and which steps were completed. Our detailed mixed-methods process
evaluation allowed us to collate this information and explore the impact of engagement on cognitive
and behaviour processes we had proposed within our logic model. In turn, we were able to explore if
changes in these process outcomes mediated changes in the primary outcome.
Accelerometer measures at 12 months
To our knowledge, this is the first trial of an ERS to objectively assess MVPA at follow-up. Only one
previous trial has involved a 12-month follow-up to assess the long-term effects of an ERS intervention on
PA and that was based on self-reported measures. Owing to the very low levels of MVPA in the present
sample, relative to other studies, new challenges have appeared for data analysis. We prespecified our
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primary outcome and the research team, TSC and DMC have been involved in discussions about the most
appropriate approach to data analysis. The statistical analysis plan was agreed and signed before seeing
the data. In our primary analysis, we present various scenarios from extensive exploratory modelling, and
also sensitivity analysis using different thresholds for analysing raw accelerometer data. These analyses,
and those of the self-reported MVPA data, will provide valuable insights into how best to examine
within-trial PA data. At the time of writing, we understand that national and international guidelines for
completing MVPA weekly minutes are expected to no longer mention the need to accumulate MVPA
in at least 10-minute bouts. Our analyses provide a broad range of findings that will contribute to the
understanding of past and future evidence and research.
The accelerometer findings were broadly similar to self-report measures in terms of between-group
differences, but levels of activity were strongly influenced by the way the data were collected and
processed. Only participants classified as inactive or moderately inactive according to the GPPAQ were
included in the study but, at baseline, self-reported data revealed that 36% met the 150 minutes per
week MVPA guideline, and accelerometer data revealed that 80% met the guideline from non-bouted
activity and only 4% met it from activity recorded in bouts of ≥ 10 minutes. Others have also shown
lower levels of accelerometer-recorded MVPA minutes when data are processed using ≥ 10-minute
bouts compared with bouts of at least 1 minute.55 Current national and international guidelines do not
fully reflect this variability because of measurement method.
Given the overdispersion and high frequency of zero counts, the primary statistical model was found
to poorly fit and post hoc analysis models were therefore also explored. For example, for the primary
outcome of total weekly minutes of MVPA in ≥ 10-minute bouts, 142 out of 243 (58%) participants
at 12 months had zero scores and the SD (60.0) was more than two times the mean value (26.2). It is
important to recognise the limitations of all these models. These include lack of fit of the models and the
need to assume data as counts for some models. However, reassuringly, the interpretation of the impact
of the intervention on primary outcome analysis was insensitive to the choice of statistical model.
Although the effectiveness findings show only a weak indicative effect on MVPA at 12-month
follow-up, these changes were found to have a 63% probability of being cost-effective based on a UK
threshold of £30,000 per QALY.
The mixed-methods process evaluation indicated that the intervention was generally acceptable and
of value to patients with a variety of physical and mental health conditions. The intervention resulted
in changes in some but not all behaviour change processes that we designed the intervention to
change. Notably, the perception of importance of being physically active was greater as a result of the
intervention compared with the control group, at both 4 and 12 months. Step 1 in the intervention
involved a quiz about the benefits of PA for health generally and also specific chronic conditions. In
other steps, we encouraged participants to feel the broader value of being active for both physical and
mental well-being. By supporting change in MVPA it is likely that intervention participants learned to
place greater value and importance on being physically active, but improvements in confidence to be
physically active and a perception of importance of being more physically active did not mediate any
effects of the intervention on MVPA at 12 months.
Implications for health care
Offering e-coachER support had only small but non-significant effects on objectively recorded MVPA
compared with usual ERSs at 12 months. The cost–utility ratio shows that when compared with the
control, the intervention cost an additional £16,885 per QALY and has a 63% probability of being
cost-effective for increasing MVPA, compared with usual ERS.
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As a result of usual ERS alone (i.e. in the control group), across the sites there was only weak evidence
of a change in accelerometer-recorded MVPA at 4 months, but none at 12 months, albeit without
comparison with no ERS. If anything, there were small but non-significant reductions in MVPA among
only those engaging in usual ERS. The rationale for conducting the present study was that we offered
an additional ‘package’ of support (e-coachER) aimed at developing self-determined PA alongside usual
ERSs or instead of usual ERSs. If shown to add additional benefit, our intervention would be available
to primary care professionals to offer to inactive patients, with a range of physical and mental health
conditions, at the time of making a referral to a local ERS.
Providing web-based behavioural support to participants of ERSs offers an additional strategy to
augment usual ERSs to promote PA. There are a few small aspects of the intervention that we would
change based on participant feedback, but the intervention could also be extended to be suitable for
use by patients with other chronic conditions (e.g. cancer). There was reasonable engagement in
e-coachER support for participants with a range of confidence in using IT, indicating that, if implemented,
it would have low costs and moderate value in promoting PA in addition to usual ERSs. Our process
evaluation indicated that there were changes in some of the measures that we collected to assess key
components of the logic model. For example, the intervention led to improvements up to 4 months in
confidence and competence in doing PA, perceiving the importance of PA, a sense of availability of
support, action-planning and self-monitoring compared with the control group. But these intervention
effects were sustained at 12 months only for perceived importance of PA. In our exploration of whether
or not any of the changes between 0 and 4 months mediated any intervention effects on the primary
outcome (accelerometer-recorded minutes of MVPA in bouts of ≥ 10 minutes) at 12 months, there was
no evidence that this was the case. Our ability to detect these mediation effects may have been limited
by the overall intervention effects on MVPA at 12 months.
The present study found that 36% of participants did not log into the online e-coachER support, but
did receive a pedometer and a fridge magnet to record MVPA. We will further analyse the data to
determine if this was sufficient to increase MVPA compared with usual ERSs. Other evidence suggests
that providing primary care patients with a pedometer to self-monitor PA is effective in changing
objectively recorded MVPA.61 It would be relatively easy to provide patients with a pedometer at the
same time as referring them to an ERS.
The LifeGuide platform has been used to deliver evidence-based and theory-driven interventions online
to support change in a wide range of health behaviours. One of its strengths is the ability to capture
intervention engagement to help understand fidelity issues and add to the literature on how people
change as a result of e-health interventions. Although LifeGuide-delivered interventions do these things
well and have been shown to be effective in supporting change in a range of health behaviours and
weight loss, other more sophisticated technological innovations are rapidly taking over. Indeed, feedback
captured within our process evaluation noted that the e-coachER support was rather unsophisticated,
and typing step counts or minutes of MVPA accumulated in the past week into a website and getting
feedback on whether or not goals had been achieved can instead undoubtedly be done on a range
of more sophisticated devices that are embracing digital technology and artificial intelligence. For these
reasons, the LifeGuide platform will no longer support digital interventions from 2021.
We hoped that the intervention would encourage participants to go to the local ERS that they had been
referred to but this did not happen. Almost 25% of referred participants did not attend any sessions.
Future research implications
Previous research has compared usual ERSs with an enhanced ERS, involving additional exercise
practitioner training, but showed no additional effect20 on PA. The present trial provides no clear
support for adding a web-based support package to usual ERSs, to increase long-term MVPA.
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Our process evaluation revealed that some improvements to the web support could be made, such as
mobile options with smartphone apps for self-monitoring and goal-setting.
The modest engagement in the online e-coachER support suggests that work is needed to understand
which factors influenced intervention engagement and how best to further develop low-cost and
scalable support to increase ERS uptake and maintenance of PA. Once this has been done, further
research could examine the effects of a modified e-coachER-type intervention for participants with
chronic conditions involved in the present study and others (e.g. with cancer, back pain and in cardiac
rehabilitation).
The e-coachER study has provided a rich data set, which offers the chance to explore additional
questions including the following:
l What were the characteristics of participants that predicted changes in 4- and 12-month PA?
l How did different measures of MVPA (i.e. self-report and accelerometer derived) influence the
findings, beyond what we present here?
l What other aspects of intervention engagement (derived from the LifeGuide platform) were used,
and did any influence changes in process and behavioural outcomes?
l Among subsets of the sample (e.g. those with low mood), what changes in quality of life, depression
and anxiety occurred as a result of the intervention versus usual ERSs?
Conclusions
With modest engagement in the evidence-based and theory-driven e-coachER intervention, which
was captured by the web-based system, the intervention effects on a rigorously defined, objectively
assessed, PA primary outcome at 12 months were only small and not significant, and, because of a
smaller sample size than intended, should be treated with caution.
In the cost-effectiveness analyses, the cost–utility ratio shows that, compared with an ERS alone,
ERS plus the e-coachER intervention cost an additional £16,885 per QALY and has a 63% probability
of being cost-effective based on the UK threshold of £30,000 per QALY.
DISCUSSION
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Appendix 1 Illustrative screenshots from
the e-coachER website
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Appendix 2 The CONSORT flow
diagram (detailed)
Responded to invitation
to participate
(n = 831)
• Declined, n = 61
    • No reason given, n = 29
    • No time to devote to ERS/trial, n = 10
    • Other reason, n = 9
    • ERS/trial is not useful, n = 8
    •  Ill health, n = 5
• Ineligible, n = 11
    • No e-mail/internet, n = 4
    • Other reason, n = 3
    • Age outside range, n = 1
    • Doesn’t meet ERS criteria, n = 1
    • No clinical condition of interest, n = 1
    • Too active (physically active occupation),
        n = 1
• Patient not contactable, n = 4
Interested
(n = 755)
• Patient not contactable, n = 26
• Ineligible, n = 23
    • No e-mail/internet, n = 9
    •  Other reason, n = 6
    • Doesn’t meet ERS criteria, n = 4
    • Unable to use trial materials in
        English and no translator, n = 2
    • Age outside range, n = 1
    • Too active (physically active occupation),
        n = 1
• Declined, n = 15
    • No reason given, n = 5
    • No time to devote to ERS/trial, n = 4
    • Other reason, n = 2
    • ERS/trial is not useful, n = 2
    • Ill health, n = 2 
Assessed for eligibility
 (n = 691)
• Ineligible at screening, n = 201
    • BMI outside range, n = 104
    • Too active on GPPAQ, n = 46
    • No clinical condition of interest, n = 26
    • Age outside range, n = 10
    • No e-mail/internet, n = 6
    • Substance abuse problem, n = 3
    • Other reason, n = 3
    • Doesn’t meet ERS criteria, n = 2
    • Blood pressure outside range, n = 1
• Declined, n = 12
    • Other reason, n = 5
    • No reason given, n = 3
    • Ill health, n = 2
    • ERS/trial is not useful, n = 1
    • No time to devote to ERS/trial, n = 1
• Patient not contactable, n = 1
Eligible and consented
 (n = 477)
• Did not return baseline accelerometer, n = 15
• Declined, n = 9
    • No reason given, n = 5
    • Other reason, n = 3
    • Ill health, n = 1
• Patient not contactable, n = 3
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Randomised
(n =450)
• Wear-time criteria met, n =207
• Wear-time criteria not met, n =17
• Wear-time criteria met, n =201
• Wear-time criteria not met, n =25
Received intervention
(n =144)
(Logged in to the e-coachER
website one or more times)
• Declined, n =8
    • No time for ERS/trial, n =4
    • ERS/trial is not useful, n =1
    • Ill health, n =1
    • Other reason, n =2
• Participant not contactable, n =12
• Declined, n =4
    • No time for ERS/trial, n =3
    • Ill health, n =1
• Participant not contactable, n =9
                   4-month follow-up
• Accelerometer returned, n =183
    • Wear-time criteria met, n =109
    • Wear-time criteria not met, n =74
• Accelerometer not returned, n =20
                           Analysed
                            (n =109)
                    4-month follow-up
• Accelerometer returned, n =190
    • Wear-time criteria met, n=128
    • Wear-time criteria not met, n =62
• Accelerometer not returned, n =23
                               Analysed 
                                (n =128)
Lost to follow-up
(n =32)
Lost to follow-up
(n =29)
Lost to follow-up
(n =20)
Control (ERS)
(n =226)
Accelerometer returned
(n =226)
Intervention
(ERS plus e-coachER)
(n =224)
Accelerometer returned
(n =224)
Lost to follow-up
(n =13)
• Declined, n = 18
    • No reason given, n = 8
    • No time for ERS/trial, n = 3
    • ERS/trial is not useful, n = 3
    • Other reason, n = 2
    •  Ill health, n = 1
    • Rash due to accelerometer, n = 1
• Participant not contactable, n = 14
• Declined, n = 17
    • No reason given, n = 7
    • No time for ERS/trial, n = 4
    • Other reason, n = 3
    • Ill health, n = 2
    • ERS/trial is not useful, n = 1
• Participant not contactable, n = 12
• Accelerometer returned, n = 160
    • Wear-time criteria met, n = 110
    • Wear-time criteria not met, n = 50
• Accelerometer not returned, n = 12
• Accelerometer returned, n = 169
    • Wear-time criteria met, n = 133
    • Wear-time criteria not met, n = 36
• Accelerometer not returned, n = 15
Analysed
(n = 133)
Analysed
(n = 110)
12-month follow-up 12-month follow-up
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Appendix 3 Estimates for repeated-measures
model for the primary outcome
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Appendix 4 Serious adverse events
Serious adverse events reported in the control group
Serious AEs were hospitalisations, with the exception of SAE010029/001 (Morton’s neuroma), which
was categorised as ‘persistent/significant disability/incapacity’.
Site SAE log number Outcome
Relationship
of the event
to the study
processes
MedDRA organ
system Summary description of event
03 SAE030003/002 Recovered
with sequelae
Not related Neoplasms (2) Diagnosed with chronic myeloid
leukaemia
03 SAE030210/002 Recovered Not related Neoplasms (2) Prolonged hospitalisation caused
by recurrence of breast cancer
03 SAE030184/001 Ongoing Unlikely Psychiatric (7) Inpatient stay on mental
health ward
03 SAE030210/001 Recovered Not related Psychiatric (7) Hospitalised for depression
01 SAE010029/001 Ongoing Not related Nervous system (8) Morton’s neuroma
01 SAE010081/001 Recovered Unlikely Respiratory (13) Treated in hospital for fluid on
the lungs
03 SAE030157/001 Recovered Not related Gastrointestinal (14) Varices of gastrointestinal tract.
Prolonged inpatient stay caused
by major organ system
involvement
02 SAE020261/001 Recovered Not related Musculoskeletal (17) Admitted to hospital because
unable to walk
02 SAE020194/001 Recovered Not related Pregnancy (19) Childbirth and postnatal
inpatient stay
03 SAE030157/002 Recovered Not related Investigations (23) Admitted to hospital with
symptoms of meningitis
02 SAE020193/001 Recovered
with sequelae
Not related Investigations (23) Collapse. No diagnosis made
01 SAE010007/001 Recovered Not related Surgical/medical (25) Planned admission for
femorodistal bypass (peripheral
vascular disease), subsequent
infection/abscess behind knee
03 SAE030003/001 Recovered Not related Surgical/medical (25) Hospitalised for treatment of boils
in groin
01 SAE010139/001 Recovered Not related Surgical/medical (25) Planned hospital admission for
bunion removal
01 SAE010139/002 Recovered Not related Surgical/medical (25) Planned hospital admission for
bunion removal
03 SAE030065/001 Recovered Unlikely Surgical/medical (25) Hospital admission for treatment
for diverticular bleeding
02 SAE020342/001 Recovered Not related Surgical/medical (25) Injury to foot led to planned
admission for partial amputation
of left great toe
01 SAE010088/001 Recovered Not related Surgical/medical (25) Planned hospital admission for
right hip replacement
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Serious adverse events reported in the intervention group
Serious AEs were hospitalisations, with the exception of SAE010011/001 (asthma attack), which was
categorised as a life-threatening event.
Site SAE log number Outcome
Relationship
of the event
to the study
processes
MedDRA organ
system Summary description of event
03 SAE030171/001 Recovered Not related Surgical/medical (25) Planned hospitalisation for total
hip replacement
01 SAE010098/001 Recovered Not related Surgical/medical (25) Planned hospital admission for
total knee replacement
02 SAE020111/001 Recovered Not related Surgical/medical (25) Preplanned hospitalisation for
knee surgery because of
osteoarthritis
02 SAE020195/001 Recovered
with sequelae
Not related Surgical/medical (25) Planned admission for total right
knee replacement
02 SAE020195/002 Recovered
with sequelae
Not related Surgical/medical (25) Planned admission following
infected right knee joint –
continuing physiotherapy and
using crutches
02 SAE020313/001 Recovered Not related Surgical/medical (25) Hospitalisation for emergency
operation on knee following a
number of falls and pre-existing
weakness in knee
01 SAE010063/001 Recovered Not related Surgical/medical (25) Hospital admission for surgical
repair of bulging disc in lower
back
02 SAE020185/001 Recovered Not related Surgical/medical (25) Hospitalised because of
complications from type 2
diabetes and heart failure
The number of SAEs reported per participant is indicated in the suffix of the SAE log number. Some participants had
two SAEs, as indicated by ‘002’ in bold text.
Site SAE log number Outcome
Relationship
of the event
to the study
processes
MedDRA organ
system Summary description of event
01 SAE010104/001 Recovered Not related Cardiac (11) Admitted to hospital with
abnormal ECG. Diagnosis:
paroxysmal atrial fibrillation
03 SAE030240/001 Recovered Not related Cardiac (11) Hospitalised because of a
heart attack
03 SAE030134/001 Recovered Unlikely Vascular (12) Hospitalised because of
minor stroke
01 SAE010011/001 Recovered Not related Respiratory (13) Asthma attack
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Site SAE log number Outcome
Relationship
of the event
to the study
processes
MedDRA organ
system Summary description of event
01 SAE010119/001 Recovered Not related Investigations (23) Hospital admission for suspected
meningitis. No formal diagnosis
made. Symptoms attributed to
adverse effects of prescription
medication
01 SAE010159/001 Recovered Not related Investigations (23) Fall resulting in fracture of left
radius. Admitted for investigations
of reasons for the fall
01 SAE010160/002 Recovered Not related Surgical/medical (25) Admitted to hospital following fall
with fracture to right ankle and
trauma to right knee
01 SAE010115/002 Recovered Not related Surgical/medical (25) Preplanned hospital admission for
abdominal surgery
03 SAE030078/001 Recovered Not related Surgical/medical (25) Planned hospitalisation for
operation on right ankle
02 SAE020290/001 Recovered Not related Surgical/medical (25) Admitted to hospital for 1 day
(day case) because of
osteoarthritis
01 SAE010201/001 Recovered Not related Surgical/medical (25) Planned hospital admission for
tendon surgery on hand related to
rheumatoid arthritis
03 SAE030049/001 Recovered Unlikely Surgical/medical (25) Hospital admission for treatment
of rheumatoid arthritis flare-up
02 SAE020354/001 Recovered Not related Surgical/medical (25) Inpatient stay for removal of
Bartholin’s cyst
01 SAE010115/001 Recovered Not related Surgical/medical (25) Planned hospital admission for
knee replacement
01 SAE010160/001 Recovered Not related Surgical/medical (25) Planned admission for partial right
knee replacement
03 SAE030102/001 Recovered Not related Surgical/medical (25) Hospitalised for surgery on
both knees, as treatment for
long-standing osteoarthritis
ECG, electrocardiogram.
The number of SAEs reported per participant is indicated in the suffix of the SAE log number. Some participants had
two SAEs, as indicated by ‘002’ in bold text.
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Appendix 5 Participant telephone interview
topic guide
Participant telephone interview schedule
Preamble script
Thank you very much for agreeing to participate in this phone interview in order to help us understand
what it has been like to be part of the e-coachER study, we really appreciate your time.
Just to recap on the information we sent you, the purpose of this interview is to understand your
experience of e-coachER and any impact it may have had so that we can learn for future development.
Please say anything you wish, we want to hear all types of feedback and are keen to hear your views
on how things might be done differently to improve the study.
The interview will take around 45 minutes and will be audio-taped to ensure that we do not miss
anything. All information you provide will be anonymised; if we use any quotes from you we will not
give your name but use a false name.
Before we begin do you have any questions about doing the interview?
Are you therefore willing to give consent to do this interview . . . thank you.
When we are ready to start I will switch the recorder on, say your name and the date; is that OK?
OK so the recorder is now going on . . .
Take verbal consent
Background
Can you begin by telling me about why you were prescribed the exercise referral scheme?
How did you hear about e-coachER?
Have you been referred to an exercise centre? Which one? Has a programme been devised for you?
You should have received a welcome pack in the post – what did you think of the welcome pack?
How did you find the user guide?
Is there anything you’d recommend we changed about the user guide?
Did register on e-coachER website? If no:
It is not a problem that you decided not to visit the website; but we are keen to find out your reasons so
we can change things for the better in the future . . . so please will you tell me a little bit more about why
you did not go to the website? Were there any technical barriers/problems . . . was something else putting
you off . . . Now conclude interview
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In general what did you think of the website? (Prompt – what were your first impressions? We will go
through it in more detail in a minute)
So did you register? How was it to do this? . . . is there anything that could be changed to help make
registering easier?
There was also an e-coachER facilitator to help you with the technology . . . did you make use of this? . . .
in what ways was this helpful? Tell me more about the help you received . . . or would have liked to have
been given?
In Step 1 there was a quiz
Do you remember doing this?
What did you think about the quiz?
What were its key messages about the benefits of activity for someone with your condition?
In Step 2 you were encouraged to find support to get physically active. Can you tell me more about how
you used this part of e-coachER?
Did you involve family or friends?
In Step 2 you were also introduced to the ‘Links’ pages on the website which gives information about local
exercise referral schemes and other local support for becoming physically active. These pages also provided
general information about becoming physically active.
Did you use the links?
What did you think about the information provided?
Were the links page useful?
What links were most helpful?
How did you use this support?
In Step 3 you were asked to use the pedometer to count your steps. This is the little device you wear on
your belt.
How did you get on with using this?
In what ways was it useful for you to use the pedometer?
In what ways was the pedometer difficult to use?
Is there anything else you’d like to say about the pedometer, anything we should do differently?
In Step 4 you were asked to set step count goals.
What did you understand about the purpose/usefulness of setting these goals?
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Tell me more about your goal-setting:
Was it easy to set step count goals that were . . . specific . . . achievable . . . realistic . . .?
In what ways was the pedometer helpful for achieving your step count goals?
. . . it was useful (for measuring/seeing progress)?
. . . it was not helpful because?
In the welcome pack there was a fridge magnet with tear off strips to record your steps.
Did you use these?
Did you put them up on your fridge (or elsewhere)?
How have you used these strips to record your steps?
How have you found these strips useful or not useful?
In Step 5 you were asked to make some physical activity plans.
Did you use this step to make plans for moderate physical activity?
In what ways was it easy or hard to set weekly goals?
How did you find the advice about setting SMART goals helpful or unhelpful?
In what ways was it easy or hard to keep to a weekly goal?
In what ways was it easy or hard to review your weekly goals?
In what ways was reviewing your step goals helpful or unhelpful?
In this step there was some advice on other opportunities to be physically active, for example, travel,
leisure time, household chores.
Did you find this advice helpful or useful?
What did you think about the progress graph? . . .
What did you think about the personalised feedback? . . . was the praise . . . encouragement helpful?
What was it like not to achieve your goals?
To what extent have you used e-coachER to set yourself new step goals each week?
In Step 6 you were asked about finding ways to help you achieve your physical activity plans. Dealing with
the influences in your environment on your physical activity.
Did you use this part of the website? How helpful did you find the advice?
DOI: 10.3310/hta24630 Health Technology Assessment 2020 Vol. 24 No. 63
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
95
Please tell me a little more about what you did?
Did you make any changes, for example to your daily routine in order to meet your goals?
What did you find most motivating?
Did you make use of the motivational messages/text/e-mails?
In Step 7 you were asked to identify any barriers or obstacles to carrying on with your physical activity
plans. . . . how did you get on with this task?
Were you able to identify any causes of stopping your activity programme? (e.g. something to do with your
health condition . . . holidays . . . sickness . . . change at work/caring, etc.)
In what way have you found it easy – or not – to challenge negative thoughts about not doing your
planned physical activity?
Do you feel you have learned how to plan and avoid lapses in physical activity in the future?
I would like to ask you some more general questions about e-coachER.
How relevant was it for you?
Overall, how did it help you to set and manage your own goals to increase your physical activity?
To what extent did it provide you with new information?
How well were you able to engage with e-coachER?
How easy was e-coachER to navigate? (e.g. layout of ‘steps to health’/main menu, goals)
How was the general tone of the website? (Was the language appropriate? Was it supportive? Were the
success stories relevant/helpful?)
What did you think about the structure/look of the website? (e.g. font size, colour, length of sessions,
ability to unlock sessions after set time period).
When did you use e-coachER – where were you?/what were you doing?
What was the most useful aspect of the e-coachER support package?
Is there anything else that we have not talked about that you would like to discuss about e-coachER?
Did using e-coachER support you in the ERS?
Was e-coachER useful on its own?
Thank participant for their time, etc.
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Interview topic guide for e-coachER study research assistants
Thank you very much for taking part in an interview to talk about your experiences of working on
e-coachER. The aim of the interview is hear your views and experiences of what worked well and
what could be done differently if a full trial were to be carried out. Additionally, it is hoped that your
experiences and views can help to develop a clearer understanding of ‘general’ issues related to the
research process, particularly recruitment of patients to a trial.
Topic Specific questions and prompts
Background Can you begin by telling me about your role in the e-coachER trial?
Recruitment/your role in
supporting patients through
e-coachER
How have you been involved in recruiting participants? Has your role changed during
the study?
After addressing the earlier recruitment issues, can you tell me about things that
worked well in the recruitment process? Anything that did not work so well, even in the
later stages of recruitment?
What further improvements do you feel could be made to the recruitment process?
Is there anything else that you feel is important to consider in relation to recruitment
to e-coachER? More generally, to a trial?
Could you tell me about the role you played in supporting participants after they had
logged on and begun using e-coachER
About the patients How do you feel patients have felt about (or reacted to) being invited to participate in
the study?
What do you feel are the main reasons why patients agreed to participate in
e-coachER? In a trial?
What do you feel have been the main barriers for patients to participating in
e-coachER? (Also in relation to invite, reply slips, registration process, logging on?)
What do we know about patients opening the information pack and reading the
contents? What else could be done to encourage this (for e-coachER, more generally)?
After the changes had been made to the protocol, do you feel that anything could/has
put participants off (i) opening info pack (ii) returning the reply slips? How can these
issues be resolved?
What do we know about patients who are signing up for the study but not logging on
to e-coachER? What might have put them off?
Have you had any feedback from patients about the benefits of e-coachER support/
participating in a trial?
Is there anything else you feel is important in relation to what patients have told you
about e-coachER/participating in the study? Anything that could have been done
differently?
About primary care/ERS Which primary care/ERS staff were involved in recruitment? How did they recruit to
e-coachER?
Can you tell me about any feedback you have had from primary care/ERS staff about in
the study?
Can you tell me about any specific issues faced by different primary care and ERS staff
groups when recruiting to e-coachER?
Finishing up What do you feel is the most beneficial aspect of e-coachER for participants? Least
beneficial aspect of the package?
What do you feel are the main ‘lessons learned’ from working on e-coachER, in general
and for a larger e-coachER trial?
Anything else you feel is important for future recruiting to a trial (i) generally, (ii) for
e-coachER?
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Appendix 6 Economic evaluation: overview
of unit costs
Type of resource
Unit cost adjusted to
2017/18 prices as
appropriate (£) Source
GP visit at practice (9.22 minutes) 37 PSSRU 201774
Nurse visit at practice (15.5 minutes) 11 PSSRU 201774
A&E visit (weighted average accounting for activity) 158 NHS Reference Costs 2015
to 201675
Social worker visit (30 minutes) 29.50 PSSRU 201774
Prescriptions 8 PSSRU 201774
Hospital visit (as outpatient) (weighted average
accounting for activity)
137 PSSRU 201774
GP home visit 135 PSSRU 201088
Nurse home visit 23 PSSRU 201088
Physiotherapy appointment (1-hour appointment) 33 PSSRU 201774
Care worker/advisor visit (30 minutes) 13 PSSRU 201774
Hospital visit (as day case) (weighted average
accounting for activity)
727 PSSRU 201774
Hospital visit (as inpatient) (weighted average
accounting for activity)
1478 NHS Reference Costs 2015
to 201675
Mental health support (DBT assessment/counsellor) 9 PSSRU 201774
Dentist 127 PSSRU 201774
Occupational therapist (1 hour) 35 PSSRU 201774
Psychiatrist (1 hour) 108 PSSRU 201774
Psychologist (1 hour) 53 PSSRU 201774
Podiatrist (1 hour) 33 PSSRU 201774
Ambulance service 119 PSSRU 201774
Fitness instructor 7.46 www.payscale.com/
research/UK/Job=Fitness_
Instructor/Hourly_Rate
(accessed 7 May 2018)
Wage rate per hour for participantsa Employed (18–21 years, 8.77;
22–29 years, 12.76; 30–39
years, 16.83; 40–49 years,
18.29; 50–59 years, 17.69;
≥ 60 years, 15.69)
ONS (2017)76
Not employed (18–21 years,
4.39; 22–29 years, 6.38;
30–39 years, 8.42; 40–49
years, 9.15; 50–59 years, 8.85;
≥ 60 years, 7.85)
DBT, dialectical behaviour therapy; ONS, Office for National Statistics.
a Time of employed participants was valued at the full wage rate, and for not employed participants we apply half of
that estimate.89
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Appendix 7 Economic evaluation: resource
use associated with the set-up cost of
the intervention
Design was included as these activities may happen in the future following further learning fromthis trial.
Activity
Resource: discussions with chief investigator
and trial manager, review of trial records,
diaries and routine administrative records
Total
quantity
Cost per participant
(unit cost values are
omitted to maintain
confidentiality) (£)
Design
Designing of intervention
(welcome pack contents)
Time (in hours) spent by:
Assistant trial manager 20 8.90
Professor 20
PPI representative (in kind) 20
Designing of website Time (in hours) spent by:
Technical specialists 960 172.01
Professor 48
Publicity campaigns/identification of participants
Community-based
publicity campaigns/
identification of
participants
Time (in hours) spent by:
PPI representatives (in kind) 21 8.21
Research assistants 84
Centre administrators 9
Money costs of travel:
Car trips 150 miles 0.30
Advertising:
Posters 150 posters 10.00
Newspaper advert 3 adverts 3.33
Total cost per participant 180.91
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Appendix 8 Economic evaluation: resource
use associated with the delivery cost of
the intervention
Activity Resource (from trial records)
Total quantity
of resource
items
Unit cost (from
invoice and trial
records) (£)
Cost per
patient (£)
Handbooks for participants Number of handbooks 225 0.04 0.04
Welcome pack boxes Number of welcome pack
unit boxes
225 0.28 0.28
Pedometer Number of pedometers 225 4.05 4.05
Recording sheets for weekly PA
activity (a fridge magnet)
Number of sheets 225 1.01 1.01
Guide for using e-coachER
website
Number of website guides 225 0.04 0.04
Postage/packaging of
welcome pack
Number of postage packs 225 10.33 10.33
Maintenance/technical support
(for participants) of e-coachER
website
Time spent (in hours) by:
Technical specialist 128 n/a 13.43
Research assistants 16
Total cost per participant 29.17
n/a, not applicable.
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Appendix 9 Economic evaluation: costs of
health and social service use
Cost
Cost (£), mean (SD)
Which group
had higher cost?
Whole sample
(n= 243)
Control
(n= 133)
e-coachER
intervention
(n= 110)
Costs at 4 months
Cost of GP practice visit 85 (89) 84.5 (96) 85 (80) Intervention
Cost of nurse practice visit 15 (33) 13 (18) 17 (44) Intervention
Cost of A&E visit 31 (57) 37 (64) 25 (47) Control
Cost of social worker visit 6 (61) 3 (26) 10 (85) Intervention
Cost of prescriptions 33 (68) 32 (86) 35 (38) Intervention
Cost of hospital (outpatients) 133 (184) 136 (189) 130 (178) Control
Cost of GP home visit 3 (14) 2 (14) 3 (15) Intervention
Cost of nurse home visit 3 (13) 2 (14) 3 (13) Intervention
Cost of physiotherapist visit 27 (75) 22 (44) 32 (101) Intervention
Cost of care worker visit 3 (17) 0.6 (4) 5 (25) Intervention
Cost of hospital day case 185 (375) 158 (351) 218 (402) Intervention
Cost of hospital (inpatient) 190 (595) 144 (442) 245 (738) Intervention
Costs of other health service 8 (57) 4 (34) 12 (77) Intervention
Total cost at 4 months 721 (952) 639 (842) 819 (1065) Intervention
Costs at 5–12 months
Cost of GP practice visit 111 (139) 114 (170) 108 (89) Control
Cost of nurse practice visit 16 (18) 16 (21) 15 (14) Control
Cost of A&E visit 24 (65) 27 (74) 20 (53) Control
Cost of social worker visit 2 (11) 3 (14) 1 (6) Control
Cost of prescriptions 43 (189) 28 (31) 60 (279) Intervention
Cost of hospital (outpatients) 132 (221) 136 (250) 128 (180) Control
Cost of GP home visit 1 (9) 2 (12) 0.5 (4) Control
Cost of nurse home visit 1 (12) 0.6 (4) 2 (18) Intervention
Cost of physiotherapist visit 24 (62) 24 (64) 23 (60) Control
Cost of care worker visit 5 (29) 4 (20) 6 (37) Intervention
Cost of hospital day case 204 (885) 224 (1119) 180 (472) Control
Cost of hospital (inpatient) 128 (528) 131 (573) 124 (469) Control
Costs of other health service 2 (19) 3 (24) 1 (11) Control
Total cost (5–12 months after the study) 692 (1432) 713 (1761) 668 (891) Control
Total costs at 12 months 1413 (1971) 1352 (2180) 1487 (1691) Intervention
DOI: 10.3310/hta24630 Health Technology Assessment 2020 Vol. 24 No. 63
© Queen’s Printer and Controller of HMSO 2020. This work was produced by Taylor et al. under the terms of a commissioning contract issued by the Secretary of State for
Health and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in
professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial
reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House,
University of Southampton Science Park, Southampton SO16 7NS, UK.
105


EME
HS&DR
HTA
PGfAR
PHR
Part of the NIHR Journals Library
www.journalslibrary.nihr.ac.uk
This report presents independent research funded by the National Institute for Health Research (NIHR).  
The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the  
Department of Health and Social Care
Published by the NIHR Journals Library
